<!DOCTYPE html><html  lang="en" data-capo=""><head><meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Frontiers | Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis</title>
<link rel="stylesheet" href="/ap-2024/_nuxt/entry.CWBB-NGm.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/vue-core.B-WA3Vg5.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/explainer.CMppEa5M.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleDetails.B93eTAmx.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleLayoutHeader.CKWUz2Al.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/AnnouncementCard.Db7nmstV.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/FloatingButtons.xuP8gC33.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleEvent.D0PaxIW7.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/SimilarArticles.BMee4Fk4.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleTemplateBanner.CXmOJ7NH.css">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/v1IBIWh4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/B674Mi_H.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BXedFy5e.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/eQMj-Fph.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Y8NTh2i4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUyL5Z_3.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/m8mdd2tc.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DHv8pTSw.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BHPWSuhB.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/x5HZk7Le.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CNJXQ6ZR.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dss5ciUI.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Do5q9QoL.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BhVAcJSK.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/y69VltF1.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Bw-bWKkJ.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/sQBxgu5L.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/D5YKKJGW.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CSLdjdGS.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUN89Jk2.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CCeQzihV.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DVDwh0-U.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dw4ta0fP.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CYv-CzHi.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/U-mJlaMn.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/NhyIC1F3.js">
<link rel="prefetch" as="style" crossorigin href="/ap-2024/_nuxt/ArticleHubLayout.q6CU8_bN.css">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/CKQJuUlk.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/D3plh7Cs.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/GWtHKqLR.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/DS3EY-DL.js">
<meta name="theme-color" content="#0C4DED">
<meta name="mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-capable" content="yes">
<script type="text/javascript" data-hid="4cd079c">window.NREUM||(NREUM={});NREUM.info = {"agent":"","beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"598a124f17","applicationID":"586843029","agentToken":null,"applicationTime":3.678695,"transactionName":"MQcDMkECCkNSW0YMWghNLwlBDgVcWkJXAWAUC04MXBYWXlJUQUpYCQ4EBUYPBUIeWlsKRgULBAhQBhcfUkpGDFYKBxJJGUwCXVxUUEsHVlBTSAtQXQkCDx0DQAoO","queueTime":0,"ttGuid":"e52006ee4bea01fe"}; (window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},feature_flags:["soft_nav"],distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"594460232",accountID:"230385",trustKey:"230385",xpid:"VgUHUl5WGwYIUllWBAEFXw==",licenseKey:"598a124f17",applicationID:"586843029",browserID:"594460232"};;/*! For license information please see nr-loader-spa-1.303.0.min.js.LICENSE.txt */
(()=>{var e,t,r={384:(e,t,r)=>{"use strict";r.d(t,{NT:()=>s,US:()=>d,Zm:()=>a,bQ:()=>u,dV:()=>c,pV:()=>l});var n=r(6154),i=r(1863),o=r(1910);const s={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return n.gm.NREUM||(n.gm.NREUM={}),void 0===n.gm.newrelic&&(n.gm.newrelic=n.gm.NREUM),n.gm.NREUM}function c(){let e=a();return e.o||(e.o={ST:n.gm.setTimeout,SI:n.gm.setImmediate||n.gm.setInterval,CT:n.gm.clearTimeout,XHR:n.gm.XMLHttpRequest,REQ:n.gm.Request,EV:n.gm.Event,PR:n.gm.Promise,MO:n.gm.MutationObserver,FETCH:n.gm.fetch,WS:n.gm.WebSocket},(0,o.i)(...Object.values(e.o))),e}function u(e,t){let r=a();r.initializedAgents??={},t.initializedAt={ms:(0,i.t)(),date:new Date},r.initializedAgents[e]=t}function d(e,t){a()[e]=t}function l(){return function(){let e=a();const t=e.info||{};e.info={beacon:s.beacon,errorBeacon:s.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),c(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},782:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewTiming},860:(e,t,r)=>{"use strict";r.d(t,{$J:()=>d,K7:()=>c,P3:()=>u,XX:()=>i,Yy:()=>a,df:()=>o,qY:()=>n,v4:()=>s});const n="events",i="jserrors",o="browser/blobs",s="rum",a="browser/logs",c={ajax:"ajax",genericEvents:"generic_events",jserrors:i,logging:"logging",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",softNav:"soft_navigations",spa:"spa"},u={[c.pageViewEvent]:1,[c.pageViewTiming]:2,[c.metrics]:3,[c.jserrors]:4,[c.spa]:5,[c.ajax]:6,[c.sessionTrace]:7,[c.softNav]:8,[c.sessionReplay]:9,[c.logging]:10,[c.genericEvents]:11},d={[c.pageViewEvent]:s,[c.pageViewTiming]:n,[c.ajax]:n,[c.spa]:n,[c.softNav]:n,[c.metrics]:i,[c.jserrors]:i,[c.sessionTrace]:o,[c.sessionReplay]:o,[c.logging]:a,[c.genericEvents]:"ins"}},944:(e,t,r)=>{"use strict";r.d(t,{R:()=>i});var n=r(3241);function i(e,t){"function"==typeof console.debug&&(console.debug("New Relic Warning: https://github.com/newrelic/newrelic-browser-agent/blob/main/docs/warning-codes.md#".concat(e),t),(0,n.W)({agentIdentifier:null,drained:null,type:"data",name:"warn",feature:"warn",data:{code:e,secondary:t}}))}},993:(e,t,r)=>{"use strict";r.d(t,{A$:()=>o,ET:()=>s,TZ:()=>a,p_:()=>i});var n=r(860);const i={ERROR:"ERROR",WARN:"WARN",INFO:"INFO",DEBUG:"DEBUG",TRACE:"TRACE"},o={OFF:0,ERROR:1,WARN:2,INFO:3,DEBUG:4,TRACE:5},s="log",a=n.K7.logging},1687:(e,t,r)=>{"use strict";r.d(t,{Ak:()=>u,Ze:()=>f,x3:()=>d});var n=r(3241),i=r(7836),o=r(3606),s=r(860),a=r(2646);const c={};function u(e,t){const r={staged:!1,priority:s.P3[t]||0};l(e),c[e].get(t)||c[e].set(t,r)}function d(e,t){e&&c[e]&&(c[e].get(t)&&c[e].delete(t),p(e,t,!1),c[e].size&&h(e))}function l(e){if(!e)throw new Error("agentIdentifier required");c[e]||(c[e]=new Map)}function f(e="",t="feature",r=!1){if(l(e),!e||!c[e].get(t)||r)return p(e,t);c[e].get(t).staged=!0,h(e)}function h(e){const t=Array.from(c[e]);t.every(([e,t])=>t.staged)&&(t.sort((e,t)=>e[1].priority-t[1].priority),t.forEach(([t])=>{c[e].delete(t),p(e,t)}))}function p(e,t,r=!0){const s=e?i.ee.get(e):i.ee,c=o.i.handlers;if(!s.aborted&&s.backlog&&c){if((0,n.W)({agentIdentifier:e,type:"lifecycle",name:"drain",feature:t}),r){const e=s.backlog[t],r=c[t];if(r){for(let t=0;e&&t<e.length;++t)g(e[t],r);Object.entries(r).forEach(([e,t])=>{Object.values(t||{}).forEach(t=>{t[0]?.on&&t[0]?.context()instanceof a.y&&t[0].on(e,t[1])})})}}s.isolatedBacklog||delete c[t],s.backlog[t]=null,s.emit("drain-"+t,[])}}function g(e,t){var r=e[1];Object.values(t[r]||{}).forEach(t=>{var r=e[0];if(t[0]===r){var n=t[1],i=e[3],o=e[2];n.apply(i,o)}})}},1741:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(944),i=r(4261);class o{#e(e,...t){if(this[e]!==o.prototype[e])return this[e](...t);(0,n.R)(35,e)}addPageAction(e,t){return this.#e(i.hG,e,t)}register(e){return this.#e(i.eY,e)}recordCustomEvent(e,t){return this.#e(i.fF,e,t)}setPageViewName(e,t){return this.#e(i.Fw,e,t)}setCustomAttribute(e,t,r){return this.#e(i.cD,e,t,r)}noticeError(e,t){return this.#e(i.o5,e,t)}setUserId(e){return this.#e(i.Dl,e)}setApplicationVersion(e){return this.#e(i.nb,e)}setErrorHandler(e){return this.#e(i.bt,e)}addRelease(e,t){return this.#e(i.k6,e,t)}log(e,t){return this.#e(i.$9,e,t)}start(){return this.#e(i.d3)}finished(e){return this.#e(i.BL,e)}recordReplay(){return this.#e(i.CH)}pauseReplay(){return this.#e(i.Tb)}addToTrace(e){return this.#e(i.U2,e)}setCurrentRouteName(e){return this.#e(i.PA,e)}interaction(e){return this.#e(i.dT,e)}wrapLogger(e,t,r){return this.#e(i.Wb,e,t,r)}measure(e,t){return this.#e(i.V1,e,t)}consent(e){return this.#e(i.Pv,e)}}},1863:(e,t,r)=>{"use strict";function n(){return Math.floor(performance.now())}r.d(t,{t:()=>n})},1910:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(944);const i=new Map;function o(...e){return e.every(e=>{if(i.has(e))return i.get(e);const t="function"==typeof e&&e.toString().includes("[native code]");return t||(0,n.R)(64,e?.name||e?.toString()),i.set(e,t),t})}},2555:(e,t,r)=>{"use strict";r.d(t,{D:()=>a,f:()=>s});var n=r(384),i=r(8122);const o={beacon:n.NT.beacon,errorBeacon:n.NT.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0};function s(e){try{return!!e.licenseKey&&!!e.errorBeacon&&!!e.applicationID}catch(e){return!1}}const a=e=>(0,i.a)(e,o)},2614:(e,t,r)=>{"use strict";r.d(t,{BB:()=>s,H3:()=>n,g:()=>u,iL:()=>c,tS:()=>a,uh:()=>i,wk:()=>o});const n="NRBA",i="SESSION",o=144e5,s=18e5,a={STARTED:"session-started",PAUSE:"session-pause",RESET:"session-reset",RESUME:"session-resume",UPDATE:"session-update"},c={SAME_TAB:"same-tab",CROSS_TAB:"cross-tab"},u={OFF:0,FULL:1,ERROR:2}},2646:(e,t,r)=>{"use strict";r.d(t,{y:()=>n});class n{constructor(e){this.contextId=e}}},2843:(e,t,r)=>{"use strict";r.d(t,{u:()=>i});var n=r(3878);function i(e,t=!1,r,i){(0,n.DD)("visibilitychange",function(){if(t)return void("hidden"===document.visibilityState&&e());e(document.visibilityState)},r,i)}},3241:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(6154);const i="newrelic";function o(e={}){try{n.gm.dispatchEvent(new CustomEvent(i,{detail:e}))}catch(e){}}},3304:(e,t,r)=>{"use strict";r.d(t,{A:()=>o});var n=r(7836);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())??""}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}return""}}},3333:(e,t,r)=>{"use strict";r.d(t,{$v:()=>d,TZ:()=>n,Xh:()=>c,Zp:()=>i,kd:()=>u,mq:()=>a,nf:()=>s,qN:()=>o});const n=r(860).K7.genericEvents,i=["auxclick","click","copy","keydown","paste","scrollend"],o=["focus","blur"],s=4,a=1e3,c=2e3,u=["PageAction","UserAction","BrowserPerformance"],d={RESOURCES:"experimental.resources",REGISTER:"register"}},3434:(e,t,r)=>{"use strict";r.d(t,{Jt:()=>o,YM:()=>u});var n=r(7836),i=r(5607);const o="nr@original:".concat(i.W),s=50;var a=Object.prototype.hasOwnProperty,c=!1;function u(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");const s="-"===n.charAt(0);for(let a=0;a<t.length;a++){const c=t[a],u=e[c];l(u)||(e[c]=r(u,s?c+n:n,i,c,o))}},r.flag=o,r;function r(t,r,n,c,u){return l(t)?t:(r||(r=""),nrWrapper[o]=t,function(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach(function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})}),t}catch(e){d([e],r)}for(var n in e)a.call(e,n)&&(t[n]=e[n])}(t,nrWrapper,e),nrWrapper);function nrWrapper(){var o,a,l,f;let h;try{a=this,o=[...arguments],l="function"==typeof n?n(o,a):n||{}}catch(t){d([t,"",[o,a,c],l],e)}i(r+"start",[o,a,c],l,u);const p=performance.now();let g;try{return f=t.apply(a,o),g=performance.now(),f}catch(e){throw g=performance.now(),i(r+"err",[o,a,e],l,u),h=e,h}finally{const e=g-p,t={start:p,end:g,duration:e,isLongTask:e>=s,methodName:c,thrownError:h};t.isLongTask&&i("long-task",[t,a],l,u),i(r+"end",[o,a,f],l,u)}}}function i(r,n,i,o){if(!c||t){var s=c;c=!0;try{e.emit(r,n,i,t,o)}catch(t){d([t,r,n,i],e)}c=s}}}function d(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function l(e){return!(e&&"function"==typeof e&&e.apply&&!e[o])}},3606:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(9908);o.on=s;var i=o.handlers={};function o(e,t,r,o){s(o||n.d,i,e,t,r)}function s(e,t,r,i,o){o||(o="feature"),e||(e=n.d);var s=t[o]=t[o]||{};(s[r]=s[r]||[]).push([e,i])}},3738:(e,t,r)=>{"use strict";r.d(t,{He:()=>i,Kp:()=>a,Lc:()=>u,Rz:()=>d,TZ:()=>n,bD:()=>o,d3:()=>s,jx:()=>l,sl:()=>f,uP:()=>c});const n=r(860).K7.sessionTrace,i="bstResource",o="resource",s="-start",a="-end",c="fn"+s,u="fn"+a,d="pushState",l=1e3,f=3e4},3785:(e,t,r)=>{"use strict";r.d(t,{R:()=>c,b:()=>u});var n=r(9908),i=r(1863),o=r(860),s=r(8154),a=r(993);function c(e,t,r={},c=a.p_.INFO,u,d=(0,i.t)()){(0,n.p)(s.xV,["API/logging/".concat(c.toLowerCase(),"/called")],void 0,o.K7.metrics,e),(0,n.p)(a.ET,[d,t,r,c,u],void 0,o.K7.logging,e)}function u(e){return"string"==typeof e&&Object.values(a.p_).some(t=>t===e.toUpperCase().trim())}},3878:(e,t,r)=>{"use strict";function n(e,t){return{capture:e,passive:!1,signal:t}}function i(e,t,r=!1,i){window.addEventListener(e,t,n(r,i))}function o(e,t,r=!1,i){document.addEventListener(e,t,n(r,i))}r.d(t,{DD:()=>o,jT:()=>n,sp:()=>i})},3962:(e,t,r)=>{"use strict";r.d(t,{AM:()=>s,O2:()=>l,OV:()=>o,Qu:()=>f,TZ:()=>c,ih:()=>h,pP:()=>a,t1:()=>d,tC:()=>i,wD:()=>u});var n=r(860);const i=["click","keydown","submit"],o="popstate",s="api",a="initialPageLoad",c=n.K7.softNav,u=5e3,d=500,l={INITIAL_PAGE_LOAD:"",ROUTE_CHANGE:1,UNSPECIFIED:2},f={INTERACTION:1,AJAX:2,CUSTOM_END:3,CUSTOM_TRACER:4},h={IP:"in progress",PF:"pending finish",FIN:"finished",CAN:"cancelled"}},4234:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(7836),i=r(1687);class o{constructor(e,t){this.agentIdentifier=e,this.ee=n.ee.get(e),this.featureName=t,this.blocked=!1}deregisterDrain(){(0,i.x3)(this.agentIdentifier,this.featureName)}}},4261:(e,t,r)=>{"use strict";r.d(t,{$9:()=>d,BL:()=>c,CH:()=>p,Dl:()=>R,Fw:()=>w,PA:()=>v,Pl:()=>n,Pv:()=>A,Tb:()=>f,U2:()=>s,V1:()=>E,Wb:()=>T,bt:()=>y,cD:()=>b,d3:()=>x,dT:()=>u,eY:()=>g,fF:()=>h,hG:()=>o,hw:()=>i,k6:()=>a,nb:()=>m,o5:()=>l});const n="api-",i=n+"ixn-",o="addPageAction",s="addToTrace",a="addRelease",c="finished",u="interaction",d="log",l="noticeError",f="pauseReplay",h="recordCustomEvent",p="recordReplay",g="register",m="setApplicationVersion",v="setCurrentRouteName",b="setCustomAttribute",y="setErrorHandler",w="setPageViewName",R="setUserId",x="start",T="wrapLogger",E="measure",A="consent"},4387:(e,t,r)=>{"use strict";function n(e={}){return!(!e.id||!e.name)}function i(e){return"string"==typeof e&&e.trim().length<501||"number"==typeof e}function o(e,t){if(2!==t?.harvestEndpointVersion)return{};const r=t.agentRef.runtime.appMetadata.agents[0].entityGuid;return n(e)?{"mfe.id":e.id,"mfe.name":e.name,eventSource:e.eventSource,"parent.id":e.parent?.id||r}:{"entity.guid":r,appId:t.agentRef.info.applicationID}}r.d(t,{Ux:()=>o,c7:()=>n,yo:()=>i})},5205:(e,t,r)=>{"use strict";r.d(t,{j:()=>_});var n=r(384),i=r(1741);var o=r(2555),s=r(3333);const a=e=>{if(!e||"string"!=typeof e)return!1;try{document.createDocumentFragment().querySelector(e)}catch{return!1}return!0};var c=r(2614),u=r(944),d=r(8122);const l="[data-nr-mask]",f=e=>(0,d.a)(e,(()=>{const e={feature_flags:[],experimental:{allow_registered_children:!1,resources:!1},mask_selector:"*",block_selector:"[data-nr-block]",mask_input_options:{color:!1,date:!1,"datetime-local":!1,email:!1,month:!1,number:!1,range:!1,search:!1,tel:!1,text:!1,time:!1,url:!1,week:!1,textarea:!1,select:!1,password:!0}};return{ajax:{deny_list:void 0,block_internal:!0,enabled:!0,autoStart:!0},api:{get allow_registered_children(){return e.feature_flags.includes(s.$v.REGISTER)||e.experimental.allow_registered_children},set allow_registered_children(t){e.experimental.allow_registered_children=t},duplicate_registered_data:!1},browser_consent_mode:{enabled:!1},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},get feature_flags(){return e.feature_flags},set feature_flags(t){e.feature_flags=t},generic_events:{enabled:!0,autoStart:!0},harvest:{interval:30},jserrors:{enabled:!0,autoStart:!0},logging:{enabled:!0,autoStart:!0},metrics:{enabled:!0,autoStart:!0},obfuscate:void 0,page_action:{enabled:!0},page_view_event:{enabled:!0,autoStart:!0},page_view_timing:{enabled:!0,autoStart:!0},performance:{capture_marks:!1,capture_measures:!1,capture_detail:!0,resources:{get enabled(){return e.feature_flags.includes(s.$v.RESOURCES)||e.experimental.resources},set enabled(t){e.experimental.resources=t},asset_types:[],first_party_domains:[],ignore_newrelic:!0}},privacy:{cookies_enabled:!0},proxy:{assets:void 0,beacon:void 0},session:{expiresMs:c.wk,inactiveMs:c.BB},session_replay:{autoStart:!0,enabled:!1,preload:!1,sampling_rate:10,error_sampling_rate:100,collect_fonts:!1,inline_images:!1,fix_stylesheets:!0,mask_all_inputs:!0,get mask_text_selector(){return e.mask_selector},set mask_text_selector(t){a(t)?e.mask_selector="".concat(t,",").concat(l):""===t||null===t?e.mask_selector=l:(0,u.R)(5,t)},get block_class(){return"nr-block"},get ignore_class(){return"nr-ignore"},get mask_text_class(){return"nr-mask"},get block_selector(){return e.block_selector},set block_selector(t){a(t)?e.block_selector+=",".concat(t):""!==t&&(0,u.R)(6,t)},get mask_input_options(){return e.mask_input_options},set mask_input_options(t){t&&"object"==typeof t?e.mask_input_options={...t,password:!0}:(0,u.R)(7,t)}},session_trace:{enabled:!0,autoStart:!0},soft_navigations:{enabled:!0,autoStart:!0},spa:{enabled:!0,autoStart:!0},ssl:void 0,user_actions:{enabled:!0,elementAttributes:["id","className","tagName","type"]}}})());var h=r(6154),p=r(9324);let g=0;const m={buildEnv:p.F3,distMethod:p.Xs,version:p.xv,originTime:h.WN},v={consented:!1},b={appMetadata:{},get consented(){return this.session?.state?.consent||v.consented},set consented(e){v.consented=e},customTransaction:void 0,denyList:void 0,disabled:!1,harvester:void 0,isolatedBacklog:!1,isRecording:!1,loaderType:void 0,maxBytes:3e4,obfuscator:void 0,onerror:void 0,ptid:void 0,releaseIds:{},session:void 0,timeKeeper:void 0,registeredEntities:[],jsAttributesMetadata:{bytes:0},get harvestCount(){return++g}},y=e=>{const t=(0,d.a)(e,b),r=Object.keys(m).reduce((e,t)=>(e[t]={value:m[t],writable:!1,configurable:!0,enumerable:!0},e),{});return Object.defineProperties(t,r)};var w=r(5701);const R=e=>{const t=e.startsWith("http");e+="/",r.p=t?e:"https://"+e};var x=r(7836),T=r(3241);const E={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},A=e=>(0,d.a)(e,E),S=new Set;function _(e,t={},r,s){let{init:a,info:c,loader_config:u,runtime:d={},exposed:l=!0}=t;if(!c){const e=(0,n.pV)();a=e.init,c=e.info,u=e.loader_config}e.init=f(a||{}),e.loader_config=A(u||{}),c.jsAttributes??={},h.bv&&(c.jsAttributes.isWorker=!0),e.info=(0,o.D)(c);const p=e.init,g=[c.beacon,c.errorBeacon];S.has(e.agentIdentifier)||(p.proxy.assets&&(R(p.proxy.assets),g.push(p.proxy.assets)),p.proxy.beacon&&g.push(p.proxy.beacon),e.beacons=[...g],function(e){const t=(0,n.pV)();Object.getOwnPropertyNames(i.W.prototype).forEach(r=>{const n=i.W.prototype[r];if("function"!=typeof n||"constructor"===n)return;let o=t[r];e[r]&&!1!==e.exposed&&"micro-agent"!==e.runtime?.loaderType&&(t[r]=(...t)=>{const n=e[r](...t);return o?o(...t):n})})}(e),(0,n.US)("activatedFeatures",w.B),e.runSoftNavOverSpa&&=!0===p.soft_navigations.enabled&&p.feature_flags.includes("soft_nav")),d.denyList=[...p.ajax.deny_list||[],...p.ajax.block_internal?g:[]],d.ptid=e.agentIdentifier,d.loaderType=r,e.runtime=y(d),S.has(e.agentIdentifier)||(e.ee=x.ee.get(e.agentIdentifier),e.exposed=l,(0,T.W)({agentIdentifier:e.agentIdentifier,drained:!!w.B?.[e.agentIdentifier],type:"lifecycle",name:"initialize",feature:void 0,data:e.config})),S.add(e.agentIdentifier)}},5270:(e,t,r)=>{"use strict";r.d(t,{Aw:()=>s,SR:()=>o,rF:()=>a});var n=r(384),i=r(7767);function o(e){return!!(0,n.dV)().o.MO&&(0,i.V)(e)&&!0===e?.session_trace.enabled}function s(e){return!0===e?.session_replay.preload&&o(e)}function a(e,t){try{if("string"==typeof t?.type){if("password"===t.type.toLowerCase())return"*".repeat(e?.length||0);if(void 0!==t?.dataset?.nrUnmask||t?.classList?.contains("nr-unmask"))return e}}catch(e){}return"string"==typeof e?e.replace(/[\S]/g,"*"):"*".repeat(e?.length||0)}},5289:(e,t,r)=>{"use strict";r.d(t,{GG:()=>o,Qr:()=>a,sB:()=>s});var n=r(3878);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.sp)("load",e,t)}function s(e){if(i())return e();(0,n.DD)("DOMContentLoaded",e)}function a(e){if(i())return e();(0,n.sp)("popstate",e)}},5607:(e,t,r)=>{"use strict";r.d(t,{W:()=>n});const n=(0,r(9566).bz)()},5701:(e,t,r)=>{"use strict";r.d(t,{B:()=>o,t:()=>s});var n=r(3241);const i=new Set,o={};function s(e,t){const r=t.agentIdentifier;o[r]??={},e&&"object"==typeof e&&(i.has(r)||(t.ee.emit("rumresp",[e]),o[r]=e,i.add(r),(0,n.W)({agentIdentifier:r,loaded:!0,drained:!0,type:"lifecycle",name:"load",feature:void 0,data:e})))}},6154:(e,t,r)=>{"use strict";r.d(t,{A4:()=>a,OF:()=>d,RI:()=>i,WN:()=>h,bv:()=>o,gm:()=>s,lR:()=>f,m:()=>u,mw:()=>c,sb:()=>l});var n=r(1863);const i="undefined"!=typeof window&&!!window.document,o="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),s=i?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a="complete"===s?.document?.readyState,c=Boolean("hidden"===s?.document?.visibilityState),u=""+s?.location,d=/iPad|iPhone|iPod/.test(s.navigator?.userAgent),l=d&&"undefined"==typeof SharedWorker,f=(()=>{const e=s.navigator?.userAgent?.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),h=Date.now()-(0,n.t)()},6344:(e,t,r)=>{"use strict";r.d(t,{BB:()=>d,Qb:()=>l,TZ:()=>i,Ug:()=>s,Vh:()=>o,_s:()=>a,bc:()=>u,yP:()=>c});var n=r(2614);const i=r(860).K7.sessionReplay,o="errorDuringReplay",s=.12,a={DomContentLoaded:0,Load:1,FullSnapshot:2,IncrementalSnapshot:3,Meta:4,Custom:5},c={[n.g.ERROR]:15e3,[n.g.FULL]:3e5,[n.g.OFF]:0},u={RESET:{message:"Session was reset",sm:"Reset"},IMPORT:{message:"Recorder failed to import",sm:"Import"},TOO_MANY:{message:"429: Too Many Requests",sm:"Too-Many"},TOO_BIG:{message:"Payload was too large",sm:"Too-Big"},CROSS_TAB:{message:"Session Entity was set to OFF on another tab",sm:"Cross-Tab"},ENTITLEMENTS:{message:"Session Replay is not allowed and will not be started",sm:"Entitlement"}},d=5e3,l={API:"api",RESUME:"resume",SWITCH_TO_FULL:"switchToFull",INITIALIZE:"initialize",PRELOAD:"preload"}},6389:(e,t,r)=>{"use strict";function n(e,t=500,r={}){const n=r?.leading||!1;let i;return(...r)=>{n&&void 0===i&&(e.apply(this,r),i=setTimeout(()=>{i=clearTimeout(i)},t)),n||(clearTimeout(i),i=setTimeout(()=>{e.apply(this,r)},t))}}function i(e){let t=!1;return(...r)=>{t||(t=!0,e.apply(this,r))}}r.d(t,{J:()=>i,s:()=>n})},6630:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewEvent},6774:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.jserrors},7295:(e,t,r)=>{"use strict";r.d(t,{Xv:()=>s,gX:()=>i,iW:()=>o});var n=[];function i(e){if(!e||o(e))return!1;if(0===n.length)return!0;for(var t=0;t<n.length;t++){var r=n[t];if("*"===r.hostname)return!1;if(a(r.hostname,e.hostname)&&c(r.pathname,e.pathname))return!1}return!0}function o(e){return void 0===e.hostname}function s(e){if(n=[],e&&e.length)for(var t=0;t<e.length;t++){let r=e[t];if(!r)continue;0===r.indexOf("http://")?r=r.substring(7):0===r.indexOf("https://")&&(r=r.substring(8));const i=r.indexOf("/");let o,s;i>0?(o=r.substring(0,i),s=r.substring(i)):(o=r,s="");let[a]=o.split(":");n.push({hostname:a,pathname:s})}}function a(e,t){return!(e.length>t.length)&&t.indexOf(e)===t.length-e.length}function c(e,t){return 0===e.indexOf("/")&&(e=e.substring(1)),0===t.indexOf("/")&&(t=t.substring(1)),""===e||e===t}},7378:(e,t,r)=>{"use strict";r.d(t,{$p:()=>x,BR:()=>b,Kp:()=>R,L3:()=>y,Lc:()=>c,NC:()=>o,SG:()=>d,TZ:()=>i,U6:()=>p,UT:()=>m,d3:()=>w,dT:()=>f,e5:()=>E,gx:()=>v,l9:()=>l,oW:()=>h,op:()=>g,rw:()=>u,tH:()=>A,uP:()=>a,wW:()=>T,xq:()=>s});var n=r(384);const i=r(860).K7.spa,o=["click","submit","keypress","keydown","keyup","change"],s=999,a="fn-start",c="fn-end",u="cb-start",d="api-ixn-",l="remaining",f="interaction",h="spaNode",p="jsonpNode",g="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=(0,n.dV)().o.ST,w="-start",R="-end",x="-body",T="cb"+R,E="jsTime",A="fetch"},7485:(e,t,r)=>{"use strict";r.d(t,{D:()=>i});var n=r(6154);function i(e){if(0===(e||"").indexOf("data:"))return{protocol:"data"};try{const t=new URL(e,location.href),r={port:t.port,hostname:t.hostname,pathname:t.pathname,search:t.search,protocol:t.protocol.slice(0,t.protocol.indexOf(":")),sameOrigin:t.protocol===n.gm?.location?.protocol&&t.host===n.gm?.location?.host};return r.port&&""!==r.port||("http:"===t.protocol&&(r.port="80"),"https:"===t.protocol&&(r.port="443")),r.pathname&&""!==r.pathname?r.pathname.startsWith("/")||(r.pathname="/".concat(r.pathname)):r.pathname="/",r}catch(e){return{}}}},7699:(e,t,r)=>{"use strict";r.d(t,{It:()=>o,KC:()=>a,No:()=>i,qh:()=>s});var n=r(860);const i=16e3,o=1e6,s="SESSION_ERROR",a={[n.K7.logging]:!0,[n.K7.genericEvents]:!1,[n.K7.jserrors]:!1,[n.K7.ajax]:!1}},7767:(e,t,r)=>{"use strict";r.d(t,{V:()=>i});var n=r(6154);const i=e=>n.RI&&!0===e?.privacy.cookies_enabled},7836:(e,t,r)=>{"use strict";r.d(t,{P:()=>a,ee:()=>c});var n=r(384),i=r(8990),o=r(2646),s=r(5607);const a="nr@context:".concat(s.W),c=function e(t,r){var n={},s={},d={},l=!1;try{l=16===r.length&&u.initializedAgents?.[r]?.runtime.isolatedBacklog}catch(e){}var f={on:p,addEventListener:p,removeEventListener:function(e,t){var r=n[e];if(!r)return;for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)},emit:function(e,r,n,i,o){!1!==o&&(o=!0);if(c.aborted&&!i)return;t&&o&&t.emit(e,r,n);var a=h(n);g(e).forEach(e=>{e.apply(a,r)});var u=v()[s[e]];u&&u.push([f,e,r,a]);return a},get:m,listeners:g,context:h,buffer:function(e,t){const r=v();if(t=t||"feature",f.aborted)return;Object.entries(e||{}).forEach(([e,n])=>{s[n]=t,t in r||(r[t]=[])})},abort:function(){f._aborted=!0,Object.keys(f.backlog).forEach(e=>{delete f.backlog[e]})},isBuffering:function(e){return!!v()[s[e]]},debugId:r,backlog:l?{}:t&&"object"==typeof t.backlog?t.backlog:{},isolatedBacklog:l};return Object.defineProperty(f,"aborted",{get:()=>{let e=f._aborted||!1;return e||(t&&(e=t.aborted),e)}}),f;function h(e){return e&&e instanceof o.y?e:e?(0,i.I)(e,a,()=>new o.y(a)):new o.y(a)}function p(e,t){n[e]=g(e).concat(t)}function g(e){return n[e]||[]}function m(t){return d[t]=d[t]||e(f,t)}function v(){return f.backlog}}(void 0,"globalEE"),u=(0,n.Zm)();u.ee||(u.ee=c)},8122:(e,t,r)=>{"use strict";r.d(t,{a:()=>i});var n=r(944);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.R)(3);if(!t||"object"!=typeof t)return(0,n.R)(4);const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let s in o)if(void 0!==e[s])try{if(null===e[s]){r[s]=null;continue}Array.isArray(e[s])&&Array.isArray(t[s])?r[s]=Array.from(new Set([...e[s],...t[s]])):"object"==typeof e[s]&&"object"==typeof t[s]?r[s]=i(e[s],t[s]):r[s]=e[s]}catch(e){r[s]||(0,n.R)(1,e)}return r}catch(e){(0,n.R)(2,e)}}},8139:(e,t,r)=>{"use strict";r.d(t,{u:()=>f});var n=r(7836),i=r(3434),o=r(8990),s=r(6154);const a={},c=s.gm.XMLHttpRequest,u="addEventListener",d="removeEventListener",l="nr@wrapped:".concat(n.P);function f(e){var t=function(e){return(e||n.ee).get("events")}(e);if(a[t.debugId]++)return t;a[t.debugId]=1;var r=(0,i.YM)(t,!0);function f(e){r.inPlace(e,[u,d],"-",p)}function p(e,t){return e[1]}return"getPrototypeOf"in Object&&(s.RI&&h(document,f),c&&h(c.prototype,f),h(s.gm,f)),t.on(u+"-start",function(e,t){var n=e[1];if(null!==n&&("function"==typeof n||"object"==typeof n)&&"newrelic"!==e[0]){var i=(0,o.I)(n,l,function(){var e={object:function(){if("function"!=typeof n.handleEvent)return;return n.handleEvent.apply(n,arguments)},function:n}[typeof n];return e?r(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=e[1]=i}}),t.on(d+"-start",function(e){e[1]=this.wrapped||e[1]}),t}function h(e,t,...r){let n=e;for(;"object"==typeof n&&!Object.prototype.hasOwnProperty.call(n,u);)n=Object.getPrototypeOf(n);n&&t(n,...r)}},8154:(e,t,r)=>{"use strict";r.d(t,{z_:()=>o,XG:()=>a,TZ:()=>n,rs:()=>i,xV:()=>s});r(6154),r(9566),r(384);const n=r(860).K7.metrics,i="sm",o="cm",s="storeSupportabilityMetrics",a="storeEventMetrics"},8374:(e,t,r)=>{r.nc=(()=>{try{return document?.currentScript?.nonce}catch(e){}return""})()},8990:(e,t,r)=>{"use strict";r.d(t,{I:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},9300:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.ajax},9324:(e,t,r)=>{"use strict";r.d(t,{AJ:()=>s,F3:()=>i,Xs:()=>o,Yq:()=>a,xv:()=>n});const n="1.303.0",i="PROD",o="CDN",s="@newrelic/rrweb",a="1.0.1"},9566:(e,t,r)=>{"use strict";r.d(t,{LA:()=>a,ZF:()=>c,bz:()=>s,el:()=>u});var n=r(6154);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function s(){const e=n.gm?.crypto||n.gm?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(30))),i.split("").map(e=>"x"===e?o(t,r++).toString(16):"y"===e?(3&o()|8).toString(16):e).join("")}function a(e){const t=n.gm?.crypto||n.gm?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(e)));const s=[];for(var a=0;a<e;a++)s.push(o(r,i++).toString(16));return s.join("")}function c(){return a(16)}function u(){return a(32)}},9908:(e,t,r)=>{"use strict";r.d(t,{d:()=>n,p:()=>i});var n=r(7836).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce((t,r)=>(i.f[r](e,t),t),[])),i.u=e=>({212:"nr-spa-compressor",249:"nr-spa-recorder",478:"nr-spa"}[e]+"-1.303.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA-1.303.0.PROD:",i.l=(r,n,o,s)=>{if(e[r])e[r].push(n);else{var a,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var l=u[d];if(l.getAttribute("src")==r||l.getAttribute("data-webpack")==t+o){a=l;break}}if(!a){c=!0;var f={478:"sha512-Q1pLqcoiNmLHv0rtq3wFkJBA3kofBdRJl0ExDl0mTuAoCBd0qe/1J0XWrDlQKuNlUryL6aZfVkAMPLmoikWIoQ==",249:"sha512-695ZzudsxlMtHKnpDNvkMlJd3tdMtY03IQKVCw9SX12tjUC+f7Nrx5tnWO72Vg9RFf6DSY6wVmM3cEkRM12kkQ==",212:"sha512-18Gx1wIBsppcn0AnKFhwgw4IciNgFxiw3J74W393Ape+wtg4hlg7t6SBKsIE/Dk/tfl2yltgcgBFvYRs283AFg=="};(a=document.createElement("script")).charset="utf-8",i.nc&&a.setAttribute("nonce",i.nc),a.setAttribute("data-webpack",t+o),a.src=r,0!==a.src.indexOf(window.location.origin+"/")&&(a.crossOrigin="anonymous"),f[s]&&(a.integrity=f[s])}e[r]=[n];var h=(t,n)=>{a.onerror=a.onload=null,clearTimeout(p);var i=e[r];if(delete e[r],a.parentNode&&a.parentNode.removeChild(a),i&&i.forEach(e=>e(n)),t)return t(n)},p=setTimeout(h.bind(null,void 0,{type:"timeout",target:a}),12e4);a.onerror=h.bind(null,a.onerror),a.onload=h.bind(null,a.onload),c&&document.head.appendChild(a)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.p="https://js-agent.newrelic.com/",(()=>{var e={38:0,788:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise((r,i)=>n=e[t]=[r,i]);r.push(n[2]=o);var s=i.p+i.u(t),a=new Error;i.l(s,r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),s=r&&r.target&&r.target.src;a.message="Loading chunk "+t+" failed.\n("+o+": "+s+")",a.name="ChunkLoadError",a.type=o,a.request=s,n[1](a)}},"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[s,a,c]=r,u=0;if(s.some(t=>0!==e[t])){for(n in a)i.o(a,n)&&(i.m[n]=a[n]);if(c)c(i)}for(t&&t(r);u<s.length;u++)o=s[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=self["webpackChunk:NRBA-1.303.0.PROD"]=self["webpackChunk:NRBA-1.303.0.PROD"]||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})(),(()=>{"use strict";i(8374);var e=i(9566),t=i(1741);class r extends t.W{agentIdentifier=(0,e.LA)(16)}var n=i(860);const o=Object.values(n.K7);var s=i(5205);var a=i(9908),c=i(1863),u=i(4261),d=i(3241),l=i(944),f=i(5701),h=i(8154);function p(e,t,i,o){const s=o||i;!s||s[e]&&s[e]!==r.prototype[e]||(s[e]=function(){(0,a.p)(h.xV,["API/"+e+"/called"],void 0,n.K7.metrics,i.ee),(0,d.W)({agentIdentifier:i.agentIdentifier,drained:!!f.B?.[i.agentIdentifier],type:"data",name:"api",feature:u.Pl+e,data:{}});try{return t.apply(this,arguments)}catch(e){(0,l.R)(23,e)}})}function g(e,t,r,n,i){const o=e.info;null===r?delete o.jsAttributes[t]:o.jsAttributes[t]=r,(i||null===r)&&(0,a.p)(u.Pl+n,[(0,c.t)(),t,r],void 0,"session",e.ee)}var m=i(1687),v=i(4234),b=i(5289),y=i(6154),w=i(5270),R=i(7767),x=i(6389),T=i(7699);class E extends v.W{constructor(e,t){super(e.agentIdentifier,t),this.agentRef=e,this.abortHandler=void 0,this.featAggregate=void 0,this.loadedSuccessfully=void 0,this.onAggregateImported=new Promise(e=>{this.loadedSuccessfully=e}),this.deferred=Promise.resolve(),!1===e.init[this.featureName].autoStart?this.deferred=new Promise((t,r)=>{this.ee.on("manual-start-all",(0,x.J)(()=>{(0,m.Ak)(e.agentIdentifier,this.featureName),t()}))}):(0,m.Ak)(e.agentIdentifier,t)}importAggregator(e,t,r={}){if(this.featAggregate)return;const n=async()=>{let n;await this.deferred;try{if((0,R.V)(e.init)){const{setupAgentSession:t}=await i.e(478).then(i.bind(i,8766));n=t(e)}}catch(e){(0,l.R)(20,e),this.ee.emit("internal-error",[e]),(0,a.p)(T.qh,[e],void 0,this.featureName,this.ee)}try{if(!this.#t(this.featureName,n,e.init))return(0,m.Ze)(this.agentIdentifier,this.featureName),void this.loadedSuccessfully(!1);const{Aggregate:i}=await t();this.featAggregate=new i(e,r),e.runtime.harvester.initializedAggregates.push(this.featAggregate),this.loadedSuccessfully(!0)}catch(e){(0,l.R)(34,e),this.abortHandler?.(),(0,m.Ze)(this.agentIdentifier,this.featureName,!0),this.loadedSuccessfully(!1),this.ee&&this.ee.abort()}};y.RI?(0,b.GG)(()=>n(),!0):n()}#t(e,t,r){if(this.blocked)return!1;switch(e){case n.K7.sessionReplay:return(0,w.SR)(r)&&!!t;case n.K7.sessionTrace:return!!t;default:return!0}}}var A=i(6630),S=i(2614);class _ extends E{static featureName=A.T;constructor(e){var t;super(e,A.T),this.setupInspectionEvents(e.agentIdentifier),t=e,p(u.Fw,function(e,r){"string"==typeof e&&("/"!==e.charAt(0)&&(e="/"+e),t.runtime.customTransaction=(r||"http://custom.transaction")+e,(0,a.p)(u.Pl+u.Fw,[(0,c.t)()],void 0,void 0,t.ee))},t),this.importAggregator(e,()=>i.e(478).then(i.bind(i,1983)))}setupInspectionEvents(e){const t=(t,r)=>{t&&(0,d.W)({agentIdentifier:e,timeStamp:t.timeStamp,loaded:"complete"===t.target.readyState,type:"window",name:r,data:t.target.location+""})};(0,b.sB)(e=>{t(e,"DOMContentLoaded")}),(0,b.GG)(e=>{t(e,"load")}),(0,b.Qr)(e=>{t(e,"navigate")}),this.ee.on(S.tS.UPDATE,(t,r)=>{(0,d.W)({agentIdentifier:e,type:"lifecycle",name:"session",data:r})})}}var O=i(384);var N=i(2843),I=i(3878),P=i(782);class j extends E{static featureName=P.T;constructor(e){super(e,P.T),y.RI&&((0,N.u)(()=>(0,a.p)("docHidden",[(0,c.t)()],void 0,P.T,this.ee),!0),(0,I.sp)("pagehide",()=>(0,a.p)("winPagehide",[(0,c.t)()],void 0,P.T,this.ee)),this.importAggregator(e,()=>i.e(478).then(i.bind(i,9917))))}}class k extends E{static featureName=h.TZ;constructor(e){super(e,h.TZ),y.RI&&document.addEventListener("securitypolicyviolation",e=>{(0,a.p)(h.xV,["Generic/CSPViolation/Detected"],void 0,this.featureName,this.ee)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,6555)))}}var C=i(6774),L=i(3304);class H{constructor(e,t,r,n,i){this.name="UncaughtError",this.message="string"==typeof e?e:(0,L.A)(e),this.sourceURL=t,this.line=r,this.column=n,this.__newrelic=i}}function M(e){return U(e)?e:new H(void 0!==e?.message?e.message:e,e?.filename||e?.sourceURL,e?.lineno||e?.line,e?.colno||e?.col,e?.__newrelic,e?.cause)}function K(e){const t="Unhandled Promise Rejection: ";if(!e?.reason)return;if(U(e.reason)){try{e.reason.message.startsWith(t)||(e.reason.message=t+e.reason.message)}catch(e){}return M(e.reason)}const r=M(e.reason);return(r.message||"").startsWith(t)||(r.message=t+r.message),r}function D(e){if(e.error instanceof SyntaxError&&!/:\d+$/.test(e.error.stack?.trim())){const t=new H(e.message,e.filename,e.lineno,e.colno,e.error.__newrelic,e.cause);return t.name=SyntaxError.name,t}return U(e.error)?e.error:M(e)}function U(e){return e instanceof Error&&!!e.stack}function F(e,t,r,i,o=(0,c.t)()){"string"==typeof e&&(e=new Error(e)),(0,a.p)("err",[e,o,!1,t,r.runtime.isRecording,void 0,i],void 0,n.K7.jserrors,r.ee),(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,r.ee)}var W=i(4387),B=i(993),V=i(3785);function G(e,{customAttributes:t={},level:r=B.p_.INFO}={},n,i,o=(0,c.t)()){(0,V.R)(n.ee,e,t,r,i,o)}function z(e,t,r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.hG,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function Z(e,t,r,i,o=(0,c.t)()){const{start:s,end:d,customAttributes:f}=t||{},h={customAttributes:f||{}};if("object"!=typeof h.customAttributes||"string"!=typeof e||0===e.length)return void(0,l.R)(57);const p=(e,t)=>null==e?t:"number"==typeof e?e:e instanceof PerformanceMark?e.startTime:Number.NaN;if(h.start=p(s,0),h.end=p(d,o),Number.isNaN(h.start)||Number.isNaN(h.end))(0,l.R)(57);else{if(h.duration=h.end-h.start,!(h.duration<0))return(0,a.p)(u.Pl+u.V1,[h,e,i],void 0,n.K7.genericEvents,r.ee),h;(0,l.R)(58)}}function q(e,t={},r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.fF,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function X(e){p(u.eY,function(t){return Y(e,t)},e)}function Y(e,t,r){const i={};(0,l.R)(54,"newrelic.register"),t||={},t.eventSource="MicroFrontendBrowserAgent",t.licenseKey||=e.info.licenseKey,t.blocked=!1,t.parent=r||{};let o=()=>{};const s=e.runtime.registeredEntities,u=s.find(({metadata:{target:{id:e,name:r}}})=>e===t.id);if(u)return u.metadata.target.name!==t.name&&(u.metadata.target.name=t.name),u;const d=e=>{t.blocked=!0,o=e};e.init.api.allow_registered_children||d((0,x.J)(()=>(0,l.R)(55))),(0,W.c7)(t)||d((0,x.J)(()=>(0,l.R)(48,t))),(0,W.yo)(t.id)&&(0,W.yo)(t.name)||d((0,x.J)(()=>(0,l.R)(48,t)));const f={addPageAction:(r,n={})=>m(z,[r,{...i,...n},e],t),log:(r,n={})=>m(G,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),measure:(r,n={})=>m(Z,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),noticeError:(r,n={})=>m(F,[r,{...i,...n},e],t),register:(t={})=>m(Y,[e,t],f.metadata.target),recordCustomEvent:(r,n={})=>m(q,[r,{...i,...n},e],t),setApplicationVersion:e=>g("application.version",e),setCustomAttribute:(e,t)=>g(e,t),setUserId:e=>g("enduser.id",e),metadata:{customAttributes:i,target:t}},p=()=>(t.blocked&&o(),t.blocked);p()||s.push(f);const g=(e,t)=>{p()||(i[e]=t)},m=(t,r,i)=>{if(p())return;const o=(0,c.t)();(0,a.p)(h.xV,["API/register/".concat(t.name,"/called")],void 0,n.K7.metrics,e.ee);try{return e.init.api.duplicate_registered_data&&"register"!==t.name&&t(...r,void 0,o),t(...r,i,o)}catch(e){(0,l.R)(50,e)}};return f}class J extends E{static featureName=C.T;constructor(e){var t;super(e,C.T),t=e,p(u.o5,(e,r)=>F(e,r,t),t),function(e){p(u.bt,function(t){e.runtime.onerror=t},e)}(e),function(e){let t=0;p(u.k6,function(e,r){++t>10||(this.runtime.releaseIds[e.slice(-200)]=(""+r).slice(-200))},e)}(e),X(e);try{this.removeOnAbort=new AbortController}catch(e){}this.ee.on("internal-error",(t,r)=>{this.abortHandler&&(0,a.p)("ierr",[M(t),(0,c.t)(),!0,{},e.runtime.isRecording,r],void 0,this.featureName,this.ee)}),y.gm.addEventListener("unhandledrejection",t=>{this.abortHandler&&(0,a.p)("err",[K(t),(0,c.t)(),!1,{unhandledPromiseRejection:1},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),y.gm.addEventListener("error",t=>{this.abortHandler&&(0,a.p)("err",[D(t),(0,c.t)(),!1,{},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,2176)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var Q=i(8990);let ee=1;function te(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===y.gm?0:(0,Q.I)(e,"nr@id",function(){return ee++})}function re(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,L.A)(e).length}catch(e){return}}}var ne=i(8139),ie=i(7836),oe=i(3434);const se={},ae=["open","send"];function ce(e){var t=e||ie.ee;const r=function(e){return(e||ie.ee).get("xhr")}(t);if(void 0===y.gm.XMLHttpRequest)return r;if(se[r.debugId]++)return r;se[r.debugId]=1,(0,ne.u)(t);var n=(0,oe.YM)(r),i=y.gm.XMLHttpRequest,o=y.gm.MutationObserver,s=y.gm.Promise,a=y.gm.setInterval,c="readystatechange",u=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],d=[],f=y.gm.XMLHttpRequest=function(e){const t=new i(e),o=r.context(t);try{r.emit("new-xhr",[t],o),t.addEventListener(c,(s=o,function(){var e=this;e.readyState>3&&!s.resolved&&(s.resolved=!0,r.emit("xhr-resolved",[],e)),n.inPlace(e,u,"fn-",b)}),(0,I.jT)(!1))}catch(e){(0,l.R)(15,e);try{r.emit("internal-error",[e])}catch(e){}}var s;return t};function h(e,t){n.inPlace(t,["onreadystatechange"],"fn-",b)}if(function(e,t){for(var r in e)t[r]=e[r]}(i,f),f.prototype=i.prototype,n.inPlace(f.prototype,ae,"-xhr-",b),r.on("send-xhr-start",function(e,t){h(e,t),function(e){d.push(e),o&&(p?p.then(v):a?a(v):(g=-g,m.data=g))}(t)}),r.on("open-xhr-start",h),o){var p=s&&s.resolve();if(!a&&!s){var g=1,m=document.createTextNode(g);new o(v).observe(m,{characterData:!0})}}else t.on("fn-end",function(e){e[0]&&e[0].type===c||v()});function v(){for(var e=0;e<d.length;e++)h(0,d[e]);d.length&&(d=[])}function b(e,t){return t}return r}var ue="fetch-",de=ue+"body-",le=["arrayBuffer","blob","json","text","formData"],fe=y.gm.Request,he=y.gm.Response,pe="prototype";const ge={};function me(e){const t=function(e){return(e||ie.ee).get("fetch")}(e);if(!(fe&&he&&y.gm.fetch))return t;if(ge[t.debugId]++)return t;function r(e,r,n){var i=e[r];"function"==typeof i&&(e[r]=function(){var e,r=[...arguments],o={};t.emit(n+"before-start",[r],o),o[ie.P]&&o[ie.P].dt&&(e=o[ie.P].dt);var s=i.apply(this,r);return t.emit(n+"start",[r,e],s),s.then(function(e){return t.emit(n+"end",[null,e],s),e},function(e){throw t.emit(n+"end",[e],s),e})})}return ge[t.debugId]=1,le.forEach(e=>{r(fe[pe],e,de),r(he[pe],e,de)}),r(y.gm,"fetch",ue),t.on(ue+"end",function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(ue+"done",[null,r],n)}else t.emit(ue+"done",[e],n)}),t}var ve=i(7485);class be{constructor(e){this.agentRef=e}generateTracePayload(t){const r=this.agentRef.loader_config;if(!this.shouldGenerateTrace(t)||!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var s=(0,e.ZF)(),a=(0,e.el)(),c=Date.now(),u={spanId:s,traceId:a,timestamp:c};return(t.sameOrigin||this.isAllowedOrigin(t)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(s,a),u.traceContextStateHeader=this.generateTraceContextStateHeader(s,c,n,i,o)),(t.sameOrigin&&!this.excludeNewrelicHeader()||!t.sameOrigin&&this.isAllowedOrigin(t)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(s,a,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof y.gm?.btoa))return null;var s={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(s.d.tk=o),btoa((0,L.A)(s))}shouldGenerateTrace(e){return this.agentRef.init?.distributed_tracing?.enabled&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var t=!1;const r=this.agentRef.init?.distributed_tracing;if(e.sameOrigin)t=!0;else if(r?.allowed_origins instanceof Array)for(var n=0;n<r.allowed_origins.length;n++){var i=(0,ve.D)(r.allowed_origins[n]);if(e.hostname===i.hostname&&e.protocol===i.protocol&&e.port===i.port){t=!0;break}}return t}excludeNewrelicHeader(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.exclude_newrelic_header}useNewrelicHeaderForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!1!==e.cors_use_newrelic_header}useTraceContextHeadersForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.cors_use_tracecontext_headers}}var ye=i(9300),we=i(7295);function Re(e){return"string"==typeof e?e:e instanceof(0,O.dV)().o.REQ?e.url:y.gm?.URL&&e instanceof URL?e.href:void 0}var xe=["load","error","abort","timeout"],Te=xe.length,Ee=(0,O.dV)().o.REQ,Ae=(0,O.dV)().o.XHR;const Se="X-NewRelic-App-Data";class _e extends E{static featureName=ye.T;constructor(e){super(e,ye.T),this.dt=new be(e),this.handler=(e,t,r,n)=>(0,a.p)(e,t,r,n,this.ee);try{const e={xmlhttprequest:"xhr",fetch:"fetch",beacon:"beacon"};y.gm?.performance?.getEntriesByType("resource").forEach(t=>{if(t.initiatorType in e&&0!==t.responseStatus){const r={status:t.responseStatus},i={rxSize:t.transferSize,duration:Math.floor(t.duration),cbTime:0};Oe(r,t.name),this.handler("xhr",[r,i,t.startTime,t.responseEnd,e[t.initiatorType]],void 0,n.K7.ajax)}})}catch(e){}me(this.ee),ce(this.ee),function(e,t,r,i){function o(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},t.latestLongtaskEnd=0,e.addEventListener("load",function(r){A(t,e)},(0,I.jT)(!1)),y.lR||e.addEventListener("progress",function(e){t.lastSize=e.loaded},(0,I.jT)(!1))}function s(e){this.params={method:e[0]},Oe(this,e[1]),this.metrics={}}function u(t,r){e.loader_config.xpid&&this.sameOrigin&&r.setRequestHeader("X-NewRelic-ID",e.loader_config.xpid);var n=i.generateTracePayload(this.parsedOrigin);if(n){var o=!1;n.newrelicHeader&&(r.setRequestHeader("newrelic",n.newrelicHeader),o=!0),n.traceContextParentHeader&&(r.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&r.setRequestHeader("tracestate",n.traceContextStateHeader),o=!0),o&&(this.dt=n)}}function d(e,r){var n=this.metrics,i=e[0],o=this;if(n&&i){var s=re(i);s&&(n.txSize=s)}this.startTime=(0,c.t)(),this.body=i,this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof r.onload)&&"function"==typeof o.end)&&o.end(r)}catch(e){try{t.emit("internal-error",[e])}catch(e){}}};for(var a=0;a<Te;a++)r.addEventListener(xe[a],this.listener,(0,I.jT)(!1))}function l(e,t,r){this.cbTime+=e,t?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof r.onload||"function"!=typeof this.end||this.end(r)}function f(e,t){var r=""+te(e)+!!t;this.xhrGuids&&!this.xhrGuids[r]&&(this.xhrGuids[r]=!0,this.totalCbs+=1)}function p(e,t){var r=""+te(e)+!!t;this.xhrGuids&&this.xhrGuids[r]&&(delete this.xhrGuids[r],this.totalCbs-=1)}function g(){this.endTime=(0,c.t)()}function m(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-added",[e[1],e[2]],r)}function v(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-removed",[e[1],e[2]],r)}function b(e,t,r){t instanceof Ae&&("onload"===r&&(this.onload=!0),("load"===(e[0]&&e[0].type)||this.onload)&&(this.xhrCbStart=(0,c.t)()))}function w(e,r){this.xhrCbStart&&t.emit("xhr-cb-time",[(0,c.t)()-this.xhrCbStart,this.onload,r],r)}function R(e){var t,r=e[1]||{};if("string"==typeof e[0]?0===(t=e[0]).length&&y.RI&&(t=""+y.gm.location.href):e[0]&&e[0].url?t=e[0].url:y.gm?.URL&&e[0]&&e[0]instanceof URL?t=e[0].href:"function"==typeof e[0].toString&&(t=e[0].toString()),"string"==typeof t&&0!==t.length){t&&(this.parsedOrigin=(0,ve.D)(t),this.sameOrigin=this.parsedOrigin.sameOrigin);var n=i.generateTracePayload(this.parsedOrigin);if(n&&(n.newrelicHeader||n.traceContextParentHeader))if(e[0]&&e[0].headers)a(e[0].headers,n)&&(this.dt=n);else{var o={};for(var s in r)o[s]=r[s];o.headers=new Headers(r.headers||{}),a(o.headers,n)&&(this.dt=n),e.length>1?e[1]=o:e.push(o)}}function a(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,c.t)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r=this.opts||{},n=this.target;Oe(this,Re(n));var i=(""+(n&&n instanceof Ee&&n.method||r.method||"GET")).toUpperCase();this.params.method=i,this.body=r.body,this.txSize=re(r.body)||0}function T(e,t){if(this.endTime=(0,c.t)(),this.params||(this.params={}),(0,we.iW)(this.params))return;let i;this.params.status=t?t.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(i=+this.rxSize);const o={txSize:this.txSize,rxSize:i,duration:(0,c.t)()-this.startTime};r("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,n.K7.ajax)}function E(e){const t=this.params,i=this.metrics;if(!this.ended){this.ended=!0;for(let t=0;t<Te;t++)e.removeEventListener(xe[t],this.listener,!1);t.aborted||(0,we.iW)(t)||(i.duration=(0,c.t)()-this.startTime,this.loadCaptureCalled||4!==e.readyState?null==t.status&&(t.status=0):A(this,e),i.cbTime=this.cbTime,r("xhr",[t,i,this.startTime,this.endTime,"xhr"],this,n.K7.ajax))}}function A(e,r){e.params.status=r.status;var i=function(e,t){var r=e.responseType;return"json"===r&&null!==t?t:"arraybuffer"===r||"blob"===r||"json"===r?re(e.response):"text"===r||""===r||void 0===r?re(e.responseText):void 0}(r,e.lastSize);if(i&&(e.metrics.rxSize=i),e.sameOrigin&&r.getAllResponseHeaders().indexOf(Se)>=0){var o=r.getResponseHeader(Se);o&&((0,a.p)(h.rs,["Ajax/CrossApplicationTracing/Header/Seen"],void 0,n.K7.metrics,t),e.params.cat=o.split(", ").pop())}e.loadCaptureCalled=!0}t.on("new-xhr",o),t.on("open-xhr-start",s),t.on("open-xhr-end",u),t.on("send-xhr-start",d),t.on("xhr-cb-time",l),t.on("xhr-load-added",f),t.on("xhr-load-removed",p),t.on("xhr-resolved",g),t.on("addEventListener-end",m),t.on("removeEventListener-end",v),t.on("fn-end",w),t.on("fetch-before-start",R),t.on("fetch-start",x),t.on("fn-start",b),t.on("fetch-done",T)}(e,this.ee,this.handler,this.dt),this.importAggregator(e,()=>i.e(478).then(i.bind(i,3845)))}}function Oe(e,t){var r=(0,ve.D)(t),n=e.params||e;n.hostname=r.hostname,n.port=r.port,n.protocol=r.protocol,n.host=r.hostname+":"+r.port,n.pathname=r.pathname,e.parsedOrigin=r,e.sameOrigin=r.sameOrigin}const Ne={},Ie=["pushState","replaceState"];function Pe(e){const t=function(e){return(e||ie.ee).get("history")}(e);return!y.RI||Ne[t.debugId]++||(Ne[t.debugId]=1,(0,oe.YM)(t).inPlace(window.history,Ie,"-")),t}var je=i(3738);function ke(e){p(u.BL,function(t=Date.now()){const r=t-y.WN;r<0&&(0,l.R)(62,t),(0,a.p)(h.XG,[u.BL,{time:r}],void 0,n.K7.metrics,e.ee),e.addToTrace({name:u.BL,start:t,origin:"nr"}),(0,a.p)(u.Pl+u.hG,[r,u.BL],void 0,n.K7.genericEvents,e.ee)},e)}const{He:Ce,bD:Le,d3:He,Kp:Me,TZ:Ke,Lc:De,uP:Ue,Rz:Fe}=je;class We extends E{static featureName=Ke;constructor(e){var t;super(e,Ke),t=e,p(u.U2,function(e){if(!(e&&"object"==typeof e&&e.name&&e.start))return;const r={n:e.name,s:e.start-y.WN,e:(e.end||e.start)-y.WN,o:e.origin||"",t:"api"};r.s<0||r.e<0||r.e<r.s?(0,l.R)(61,{start:r.s,end:r.e}):(0,a.p)("bstApi",[r],void 0,n.K7.sessionTrace,t.ee)},t),ke(e);if(!(0,R.V)(e.init))return void this.deregisterDrain();const r=this.ee;let o;Pe(r),this.eventsEE=(0,ne.u)(r),this.eventsEE.on(Ue,function(e,t){this.bstStart=(0,c.t)()}),this.eventsEE.on(De,function(e,t){(0,a.p)("bst",[e[0],t,this.bstStart,(0,c.t)()],void 0,n.K7.sessionTrace,r)}),r.on(Fe+He,function(e){this.time=(0,c.t)(),this.startPath=location.pathname+location.hash}),r.on(Fe+Me,function(e){(0,a.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,n.K7.sessionTrace,r)});try{o=new PerformanceObserver(e=>{const t=e.getEntries();(0,a.p)(Ce,[t],void 0,n.K7.sessionTrace,r)}),o.observe({type:Le,buffered:!0})}catch(e){}this.importAggregator(e,()=>i.e(478).then(i.bind(i,6974)),{resourceObserver:o})}}var Be=i(6344);class Ve extends E{static featureName=Be.TZ;#n;recorder;constructor(e){var t;let r;super(e,Be.TZ),t=e,p(u.CH,function(){(0,a.p)(u.CH,[],void 0,n.K7.sessionReplay,t.ee)},t),function(e){p(u.Tb,function(){(0,a.p)(u.Tb,[],void 0,n.K7.sessionReplay,e.ee)},e)}(e);try{r=JSON.parse(localStorage.getItem("".concat(S.H3,"_").concat(S.uh)))}catch(e){}(0,w.SR)(e.init)&&this.ee.on(u.CH,()=>this.#i()),this.#o(r)&&this.importRecorder().then(e=>{e.startRecording(Be.Qb.PRELOAD,r?.sessionReplayMode)}),this.importAggregator(this.agentRef,()=>i.e(478).then(i.bind(i,6167)),this),this.ee.on("err",e=>{this.blocked||this.agentRef.runtime.isRecording&&(this.errorNoticed=!0,(0,a.p)(Be.Vh,[e],void 0,this.featureName,this.ee))})}#o(e){return e&&(e.sessionReplayMode===S.g.FULL||e.sessionReplayMode===S.g.ERROR)||(0,w.Aw)(this.agentRef.init)}importRecorder(){return this.recorder?Promise.resolve(this.recorder):(this.#n??=Promise.all([i.e(478),i.e(249)]).then(i.bind(i,4866)).then(({Recorder:e})=>(this.recorder=new e(this),this.recorder)).catch(e=>{throw this.ee.emit("internal-error",[e]),this.blocked=!0,e}),this.#n)}#i(){this.blocked||(this.featAggregate?this.featAggregate.mode!==S.g.FULL&&this.featAggregate.initializeRecording(S.g.FULL,!0,Be.Qb.API):this.importRecorder().then(()=>{this.recorder.startRecording(Be.Qb.API,S.g.FULL)}))}}var Ge=i(3962);function ze(e){const t=e.ee.get("tracer");function r(){}p(u.dT,function(e){return(new r).get("object"==typeof e?e:{})},e);const i=r.prototype={createTracer:function(r,i){var o={},s=this,d="function"==typeof i;return(0,a.p)(h.xV,["API/createTracer/called"],void 0,n.K7.metrics,e.ee),e.runSoftNavOverSpa||(0,a.p)(u.hw+"tracer",[(0,c.t)(),r,o],s,n.K7.spa,e.ee),function(){if(t.emit((d?"":"no-")+"fn-start",[(0,c.t)(),s,d],o),d)try{return i.apply(this,arguments)}catch(e){const r="string"==typeof e?new Error(e):e;throw t.emit("fn-err",[arguments,this,r],o),r}finally{t.emit("fn-end",[(0,c.t)()],o)}}}};["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach(t=>{p.apply(this,[t,function(){return(0,a.p)(u.hw+t,[(0,c.t)(),...arguments],this,e.runSoftNavOverSpa?n.K7.softNav:n.K7.spa,e.ee),this},e,i])}),p(u.PA,function(){e.runSoftNavOverSpa?(0,a.p)(u.hw+"routeName",[performance.now(),...arguments],void 0,n.K7.softNav,e.ee):(0,a.p)(u.Pl+"routeName",[(0,c.t)(),...arguments],this,n.K7.spa,e.ee)},e)}class Ze extends E{static featureName=Ge.TZ;constructor(e){if(super(e,Ge.TZ),ze(e),!y.RI||!(0,O.dV)().o.MO)return;const t=Pe(this.ee);try{this.removeOnAbort=new AbortController}catch(e){}Ge.tC.forEach(e=>{(0,I.sp)(e,e=>{s(e)},!0,this.removeOnAbort?.signal)});const r=()=>(0,a.p)("newURL",[(0,c.t)(),""+window.location],void 0,this.featureName,this.ee);t.on("pushState-end",r),t.on("replaceState-end",r),(0,I.sp)(Ge.OV,e=>{s(e),(0,a.p)("newURL",[e.timeStamp,""+window.location],void 0,this.featureName,this.ee)},!0,this.removeOnAbort?.signal);let n=!1;const o=new((0,O.dV)().o.MO)((e,t)=>{n||(n=!0,requestAnimationFrame(()=>{(0,a.p)("newDom",[(0,c.t)()],void 0,this.featureName,this.ee),n=!1}))}),s=(0,x.s)(e=>{(0,a.p)("newUIEvent",[e],void 0,this.featureName,this.ee),o.observe(document.body,{attributes:!0,childList:!0,subtree:!0,characterData:!0})},100,{leading:!0});this.abortHandler=function(){this.removeOnAbort?.abort(),o.disconnect(),this.abortHandler=void 0},this.importAggregator(e,()=>i.e(478).then(i.bind(i,4393)),{domObserver:o})}}var qe=i(7378);const Xe={},Ye=["appendChild","insertBefore","replaceChild"];function Je(e){const t=function(e){return(e||ie.ee).get("jsonp")}(e);if(!y.RI||Xe[t.debugId])return t;Xe[t.debugId]=!0;var r=(0,oe.YM)(t),n=/[?&](?:callback|cb)=([^&#]+)/,i=/(.*)\.([^.]+)/,o=/^(\w+)(\.|$)(.*)$/;function s(e,t){if(!e)return t;const r=e.match(o),n=r[1];return s(r[3],t[n])}return r.inPlace(Node.prototype,Ye,"dom-"),t.on("dom-start",function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var o=(a=e.src,c=a.match(n),c?c[1]:null);var a,c;if(!o)return;var u=function(e){var t=e.match(i);if(t&&t.length>=3)return{key:t[2],parent:s(t[1],window)};return{key:e,parent:window}}(o);if("function"!=typeof u.parent[u.key])return;var d={};function l(){t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}function f(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",l,(0,I.jT)(!1)),e.addEventListener("error",f,(0,I.jT)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])}),t}const $e={};function Qe(e){const t=function(e){return(e||ie.ee).get("promise")}(e);if($e[t.debugId])return t;$e[t.debugId]=!0;var r=t.context,n=(0,oe.YM)(t),i=y.gm.Promise;return i&&function(){function e(r){var o=t.context(),s=n(r,"executor-",o,null,!1);const a=Reflect.construct(i,[s],e);return t.context(a).getCtx=function(){return o},a}y.gm.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return i.toString()},Object.setPrototypeOf(e,i),["all","race"].forEach(function(r){const n=i[r];e[r]=function(e){let i=!1;[...e||[]].forEach(e=>{this.resolve(e).then(s("all"===r),s(!1))});const o=n.apply(this,arguments);return o;function s(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}}),["resolve","reject"].forEach(function(r){const n=i[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}}),e.prototype=i.prototype;const o=i.prototype.then;i.prototype.then=function(...e){var i=this,s=r(i);s.promise=i,e[0]=n(e[0],"cb-",s,null,!1),e[1]=n(e[1],"cb-",s,null,!1);const a=o.apply(this,e);return s.nextPromise=a,t.emit("propagate",[i,!0],a,!1,!1),a},i.prototype.then[oe.Jt]=o,t.on("executor-start",function(e){e[0]=n(e[0],"resolve-",this,null,!1),e[1]=n(e[1],"resolve-",this,null,!1)}),t.on("executor-err",function(e,t,r){e[1](r)}),t.on("cb-end",function(e,r,n){t.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),t.on("propagate",function(e,r,n){if(!this.getCtx||r){const r=this,n=e instanceof Promise?t.context(e):null;let i;this.getCtx=function(){return i||(i=n&&n!==r?"function"==typeof n.getCtx?n.getCtx():n:r,i)}}})}(),t}const et={},tt="setTimeout",rt="setInterval",nt="clearTimeout",it="-start",ot=[tt,"setImmediate",rt,nt,"clearImmediate"];function st(e){const t=function(e){return(e||ie.ee).get("timer")}(e);if(et[t.debugId]++)return t;et[t.debugId]=1;var r=(0,oe.YM)(t);return r.inPlace(y.gm,ot.slice(0,2),tt+"-"),r.inPlace(y.gm,ot.slice(2,3),rt+"-"),r.inPlace(y.gm,ot.slice(3),nt+"-"),t.on(rt+it,function(e,t,n){e[0]=r(e[0],"fn-",null,n)}),t.on(tt+it,function(e,t,n){this.method=n,this.timerDuration=isNaN(e[1])?0:+e[1],e[0]=r(e[0],"fn-",this,n)}),t}const at={};function ct(e){const t=function(e){return(e||ie.ee).get("mutation")}(e);if(!y.RI||at[t.debugId])return t;at[t.debugId]=!0;var r=(0,oe.YM)(t),n=y.gm.MutationObserver;return n&&(window.MutationObserver=function(e){return this instanceof n?new n(r(e,"fn-")):n.apply(this,arguments)},MutationObserver.prototype=n.prototype),t}const{TZ:ut,d3:dt,Kp:lt,$p:ft,wW:ht,e5:pt,tH:gt,uP:mt,rw:vt,Lc:bt}=qe;class yt extends E{static featureName=ut;constructor(e){if(super(e,ut),ze(e),!y.RI)return;try{this.removeOnAbort=new AbortController}catch(e){}let t,r=0;const n=this.ee.get("tracer"),o=Je(this.ee),s=Qe(this.ee),u=st(this.ee),d=ce(this.ee),l=this.ee.get("events"),f=me(this.ee),h=Pe(this.ee),p=ct(this.ee);function g(e,t){h.emit("newURL",[""+window.location,t])}function m(){r++,t=window.location.hash,this[mt]=(0,c.t)()}function v(){r--,window.location.hash!==t&&g(0,!0);var e=(0,c.t)();this[pt]=~~this[pt]+e-this[mt],this[bt]=e}function b(e,t){e.on(t,function(){this[t]=(0,c.t)()})}this.ee.on(mt,m),s.on(vt,m),o.on(vt,m),this.ee.on(bt,v),s.on(ht,v),o.on(ht,v),this.ee.on("fn-err",(...t)=>{t[2]?.__newrelic?.[e.agentIdentifier]||(0,a.p)("function-err",[...t],void 0,this.featureName,this.ee)}),this.ee.buffer([mt,bt,"xhr-resolved"],this.featureName),l.buffer([mt],this.featureName),u.buffer(["setTimeout"+lt,"clearTimeout"+dt,mt],this.featureName),d.buffer([mt,"new-xhr","send-xhr"+dt],this.featureName),f.buffer([gt+dt,gt+"-done",gt+ft+dt,gt+ft+lt],this.featureName),h.buffer(["newURL"],this.featureName),p.buffer([mt],this.featureName),s.buffer(["propagate",vt,ht,"executor-err","resolve"+dt],this.featureName),n.buffer([mt,"no-"+mt],this.featureName),o.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),b(f,gt+dt),b(f,gt+"-done"),b(o,"new-jsonp"),b(o,"jsonp-end"),b(o,"cb-start"),h.on("pushState-end",g),h.on("replaceState-end",g),window.addEventListener("hashchange",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",function(){g(0,r>1)},(0,I.jT)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,5592)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var wt=i(3333);class Rt extends E{static featureName=wt.TZ;constructor(e){super(e,wt.TZ);const t=[e.init.page_action.enabled,e.init.performance.capture_marks,e.init.performance.capture_measures,e.init.user_actions.enabled,e.init.performance.resources.enabled];var r;r=e,p(u.hG,(e,t)=>z(e,t,r),r),function(e){p(u.fF,(t,r)=>q(t,r,e),e)}(e),ke(e),X(e),function(e){p(u.V1,(t,r)=>Z(t,r,e),e)}(e);const o=e.init.feature_flags.includes("user_frustrations");let s;if(y.RI&&o&&(me(this.ee),ce(this.ee),s=Pe(this.ee)),y.RI){if(e.init.user_actions.enabled&&(wt.Zp.forEach(e=>(0,I.sp)(e,e=>(0,a.p)("ua",[e],void 0,this.featureName,this.ee),!0)),wt.qN.forEach(e=>{const t=(0,x.s)(e=>{(0,a.p)("ua",[e],void 0,this.featureName,this.ee)},500,{leading:!0});(0,I.sp)(e,t)}),o)){function c(t){const r=(0,ve.D)(t);return e.beacons.includes(r.hostname+":"+r.port)}function d(){s.emit("navChange")}y.gm.addEventListener("error",()=>{(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.ee.on("open-xhr-start",(e,t)=>{c(e[1])||t.addEventListener("readystatechange",()=>{2===t.readyState&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)})}),this.ee.on("fetch-start",e=>{e.length>=1&&!c(Re(e[0]))&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)}),s.on("pushState-end",d),s.on("replaceState-end",d),window.addEventListener("hashchange",d,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",d,(0,I.jT)(!0,this.removeOnAbort?.signal))}if(e.init.performance.resources.enabled&&y.gm.PerformanceObserver?.supportedEntryTypes.includes("resource")){new PerformanceObserver(e=>{e.getEntries().forEach(e=>{(0,a.p)("browserPerformance.resource",[e],void 0,this.featureName,this.ee)})}).observe({type:"resource",buffered:!0})}}try{this.removeOnAbort=new AbortController}catch(l){}this.abortHandler=()=>{this.removeOnAbort?.abort(),this.abortHandler=void 0},t.some(e=>e)?this.importAggregator(e,()=>i.e(478).then(i.bind(i,8019))):this.deregisterDrain()}}var xt=i(2646);const Tt=new Map;function Et(e,t,r,n){if("object"!=typeof t||!t||"string"!=typeof r||!r||"function"!=typeof t[r])return(0,l.R)(29);const i=function(e){return(e||ie.ee).get("logger")}(e),o=(0,oe.YM)(i),s=new xt.y(ie.P);s.level=n.level,s.customAttributes=n.customAttributes;const a=t[r]?.[oe.Jt]||t[r];return Tt.set(a,s),o.inPlace(t,[r],"wrap-logger-",()=>Tt.get(a)),i}var At=i(1910);class St extends E{static featureName=B.TZ;constructor(e){var t;super(e,B.TZ),t=e,p(u.$9,(e,r)=>G(e,r,t),t),function(e){p(u.Wb,(t,r,{customAttributes:n={},level:i=B.p_.INFO}={})=>{Et(e.ee,t,r,{customAttributes:n,level:i})},e)}(e),X(e);const r=this.ee;["log","error","warn","info","debug","trace"].forEach(e=>{(0,At.i)(y.gm.console[e]),Et(r,y.gm.console,e,{level:"log"===e?"info":e})}),this.ee.on("wrap-logger-end",function([e]){const{level:t,customAttributes:n}=this;(0,V.R)(r,e,n,t)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,5288)))}}new class extends r{constructor(e){var t;(super(),y.gm)?(this.features={},(0,O.bQ)(this.agentIdentifier,this),this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(_),this.runSoftNavOverSpa=[...this.desiredFeatures].some(e=>e.featureName===n.K7.softNav),(0,s.j)(this,e,e.loaderType||"agent"),t=this,p(u.cD,function(e,r,n=!1){if("string"==typeof e){if(["string","number","boolean"].includes(typeof r)||null===r)return g(t,e,r,u.cD,n);(0,l.R)(40,typeof r)}else(0,l.R)(39,typeof e)},t),function(e){p(u.Dl,function(t){if("string"==typeof t||null===t)return g(e,"enduser.id",t,u.Dl,!0);(0,l.R)(41,typeof t)},e)}(this),function(e){p(u.nb,function(t){if("string"==typeof t||null===t)return g(e,"application.version",t,u.nb,!1);(0,l.R)(42,typeof t)},e)}(this),function(e){p(u.d3,function(){e.ee.emit("manual-start-all")},e)}(this),function(e){p(u.Pv,function(t=!0){if("boolean"==typeof t){if((0,a.p)(u.Pl+u.Pv,[t],void 0,"session",e.ee),e.runtime.consented=t,t){const t=e.features.page_view_event;t.onAggregateImported.then(e=>{const r=t.featAggregate;e&&!r.sentRum&&r.sendRum()})}}else(0,l.R)(65,typeof t)},e)}(this),this.run()):(0,l.R)(21)}get config(){return{info:this.info,init:this.init,loader_config:this.loader_config,runtime:this.runtime}}get api(){return this}run(){try{const e=function(e){const t={};return o.forEach(r=>{t[r]=!!e[r]?.enabled}),t}(this.init),t=[...this.desiredFeatures];t.sort((e,t)=>n.P3[e.featureName]-n.P3[t.featureName]),t.forEach(t=>{if(!e[t.featureName]&&t.featureName!==n.K7.pageViewEvent)return;if(this.runSoftNavOverSpa&&t.featureName===n.K7.spa)return;if(!this.runSoftNavOverSpa&&t.featureName===n.K7.softNav)return;const r=function(e){switch(e){case n.K7.ajax:return[n.K7.jserrors];case n.K7.sessionTrace:return[n.K7.ajax,n.K7.pageViewEvent];case n.K7.sessionReplay:return[n.K7.sessionTrace];case n.K7.pageViewTiming:return[n.K7.pageViewEvent];default:return[]}}(t.featureName).filter(e=>!(e in this.features));r.length>0&&(0,l.R)(36,{targetFeature:t.featureName,missingDependencies:r}),this.features[t.featureName]=new t(this)})}catch(e){(0,l.R)(22,e);for(const e in this.features)this.features[e].abortHandler?.();const t=(0,O.Zm)();delete t.initializedAgents[this.agentIdentifier]?.features,delete this.sharedAggregator;return t.ee.get(this.agentIdentifier).abort(),!1}}}({features:[_e,_,j,We,Ve,k,J,Rt,St,Ze,yt],loaderType:"spa"})})()})();</script>
<link rel="icon" type="image/png" sizes="16x16" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png">
<meta name="apple-mobile-web-app-title" content="Frontiers | Articles">
<link rel="manifest" href="/manifest.json">
<link rel="canonical" href="https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/full">
<meta property="description" name="description" content="Hereditary (variant) transthyretin amyloidosis (ATTRv amyloidosis), which is caused by variants in the transthyretin (TTR) gene, leads to TTR amyloid deposit...">
<meta property="og:title" name="title" content="Frontiers | Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis">
<meta property="og:description" name="description" content="Hereditary (variant) transthyretin amyloidosis (ATTRv amyloidosis), which is caused by variants in the transthyretin (TTR) gene, leads to TTR amyloid deposit...">
<meta name="keywords" content="Amyloidosis,transthyretin,Extracellular vesicle,ATTRv amyloidosis,Atomic Force Microscope">
<meta property="og:site_name" name="site_name" content="Frontiers">
<meta property="og:image" name="image" content="https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g001.jpg">
<meta property="og:type" name="type" content="article">
<meta property="og:url" name="url" content="https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/full">
<meta name="twitter:card" content="summary_large_image">
<meta name="citation_volume" content="9">
<meta name="citation_journal_title" content="Frontiers in Molecular Biosciences">
<meta name="citation_publisher" content="Frontiers">
<meta name="citation_journal_abbrev" content="Front. Mol. Biosci.">
<meta name="citation_issn" content="2296-889X">
<meta name="citation_doi" content="10.3389/fmolb.2022.839917">
<meta name="citation_firstpage" content="839917">
<meta name="citation_language" content="English">
<meta name="citation_title" content="Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis">
<meta name="citation_keywords" content="Amyloidosis; transthyretin; Extracellular vesicle; ATTRv amyloidosis; Atomic Force Microscope">
<meta name="citation_abstract" content="Hereditary (variant) transthyretin amyloidosis (ATTRv amyloidosis), which is caused by variants in the transthyretin (TTR) gene, leads to TTR amyloid deposits in multiple organs and various symptoms such as limb ataxia, muscle weakness, and cardiac failure. Interaction between amyloid proteins and extracellular vesicles (EVs), which are secreted by various cells, is known to promote the clearance of the proteins, but it is unclear whether EVs are involved in the formation and deposition of TTR amyloid in ATTRv amyloidosis. To clarify the relationship between ATTRv amyloidosis and EVs, serum-derived EVs were analyzed. In this study, we showed that cell-derived EVs are involved in the formation of TTR amyloid deposits on the membrane of small EVs, as well as the deposition of TTR amyloid in cells. Human serum-derived small EVs also altered the degree of aggregation and deposition of TTR. Furthermore, the amount of TTR aggregates in serum-derived small EVs in patients with ATTRv amyloidosis was lower than that in healthy controls. These results indicate that EVs contribute to the metabolism of TTR amyloid, and suggest that TTR in serum-derived small EVs is a potential target for future ATTRv amyloidosis diagnosis and therapy.">
<meta name="citation_article_type" content="Original Research">
<meta name="citation_pdf_url" content="https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/pdf">
<meta name="citation_xml_url" content="https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/xml">
<meta name="citation_fulltext_world_readable" content="yes">
<meta name="citation_online_date" content="2022/02/22">
<meta name="citation_publication_date" content="2022/03/23">
<meta name="citation_author" content="Yamaguchi, Hiroki ">
<meta name="citation_author_institution" content="Department of Immunology, Japan">
<meta name="citation_author" content="Kawahara, Hironori ">
<meta name="citation_author_institution" content="Department of Immunology, Japan">
<meta name="citation_author" content="Kodera, Noriyuki ">
<meta name="citation_author_institution" content="WPI Nano Life Science Institute (NanoLSI), Japan">
<meta name="citation_author" content="Kumaki, Ayanori ">
<meta name="citation_author_institution" content="Department of Immunology, Japan">
<meta name="citation_author" content="Tada, Yasutake ">
<meta name="citation_author_institution" content="Department of Immunology, Japan">
<meta name="citation_author" content="Tang, Zixin ">
<meta name="citation_author_institution" content="Department of Immunology, Japan">
<meta name="citation_author" content="Sakai, Kenji ">
<meta name="citation_author_institution" content="Department of Neurology and Neurobiology of Aging, Japan">
<meta name="citation_author" content="Ono, Kenjiro ">
<meta name="citation_author_institution" content="Department of Neurology and Neurobiology of Aging, Japan">
<meta name="citation_author" content="Yamada, Masahito ">
<meta name="citation_author_institution" content="Department of Neurology and Neurobiology of Aging, Japan">
<meta name="citation_author" content="Hanayama, Rikinari ">
<meta name="citation_author_institution" content="Department of Immunology, Japan">
<meta name="dc.identifier" content="doi:10.3389/fmolb.2022.839917">
<script type="application/ld+json">{"@context":"https://schema.org","@type":"ScholarlyArticle","headline":"Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis","author":[{"@type":"Person","name":"Hiroki Yamaguchi","affiliation":["Department of Immunology, Japan","Department of Neurology and Neurobiology of Aging, Japan"]},{"@type":"Person","name":"Hironori Kawahara","affiliation":["Department of Immunology, Japan","WPI Nano Life Science Institute (NanoLSI), Japan"]},{"@type":"Person","name":"Noriyuki Kodera","affiliation":["WPI Nano Life Science Institute (NanoLSI), Japan"]},{"@type":"Person","name":"Ayanori Kumaki","affiliation":["Department of Immunology, Japan"]},{"@type":"Person","name":"Yasutake Tada","affiliation":["Department of Immunology, Japan","Department of Neurology and Neurobiology of Aging, Japan"]},{"@type":"Person","name":"Zixin Tang","affiliation":["Department of Immunology, Japan"]},{"@type":"Person","name":"Kenji Sakai","affiliation":["Department of Neurology and Neurobiology of Aging, Japan"]},{"@type":"Person","name":"Kenjiro Ono","affiliation":["Department of Neurology and Neurobiology of Aging, Japan"]},{"@type":"Person","name":"Masahito Yamada","affiliation":["Department of Neurology and Neurobiology of Aging, Japan","Department of Internal Medicine, Japan"]},{"@type":"Person","name":"Rikinari Hanayama","affiliation":["Department of Immunology, Japan","WPI Nano Life Science Institute (NanoLSI), Japan"]}],"datePublished":"2022-03-23","dateModified":"2025-11-25","publisher":{"@type":"Organization","name":"Frontiers"},"isPartOf":{"@type":"PublicationIssue","datePublished":"2022","isPartOf":{"@type":"PublicationVolume","volumeNumber":"9","isPartOf":{"@type":"Periodical","name":"Frontiers in Molecular Biosciences"}}},"citation":["https://doi.org/10.3389/fmolb.2022.839917"],"inLanguage":"en"}</script>
<script type="module" src="/ap-2024/_nuxt/v1IBIWh4.js" crossorigin></script>
<script id="unhead:payload" type="application/json">{"title":"Frontiers | Articles"}</script></head><body  class="body--v3"><div id="__nuxt"><!--[--><!----><div theme="orange"><nav class="Ibar"><div class="Ibar__main"><div class="Ibar__wrapper"><button class="Ibar__burger" aria-label="Open Menu" data-event="iBar-btn-openMenu"></button><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/molecular-biosciences" class="Ibar__journalName" data-event="iBar-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Molecular Biosciences</span></div></div></a><div class="Ibar__dropdown--aboutUs" parent-data-event="iBar"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=102&amp;specialtyid=0&amp;entitytype=2&amp;entityid=698" data-event="iBar-a-submit">Submit your research</a><div class="Ibar__spacer"></div><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><div><div class="Ibar__menu Ibar__menu--journal"><div class="Ibar__menu__header"><div class="Ibar__logo"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div></div><button class="Ibar__close" aria-label="Close Menu" data-event="iBarMenu-btn-closeMenu"></button></div><div class="Ibar__menu__wrapper"><div class="Ibar__menu__journal"><a href="//www.frontiersin.org/journals/molecular-biosciences" data-event="iBarMenu-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Molecular Biosciences</span></div></div></a><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/bioenergetics" data-event="iBarJournal-sections-a_id_3647">Bioenergetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/biological-modeling-and-simulation" data-event="iBarJournal-sections-a_id_777">Biological Modeling and Simulation</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/cellular-biochemistry" data-event="iBarJournal-sections-a_id_716">Cellular Biochemistry</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/genome-organization-and-dynamics" data-event="iBarJournal-sections-a_id_2297">Genome Organization and Dynamics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/glycoscience" data-event="iBarJournal-sections-a_id_2218">Glycoscience</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/lipids-membranes-and-membranous-organelles" data-event="iBarJournal-sections-a_id_2426">Lipids, Membranes and Membranous Organelles</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/metabolomics" data-event="iBarJournal-sections-a_id_736">Metabolomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/micronutrient-biology" data-event="iBarJournal-sections-a_id_3693">Micronutrient Biology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/molecular-biophysics" data-event="iBarJournal-sections-a_id_3064">Molecular Biophysics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/molecular-diagnostics-and-therapeutics" data-event="iBarJournal-sections-a_id_701">Molecular Diagnostics and Therapeutics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/molecular-evolution" data-event="iBarJournal-sections-a_id_2529">Molecular Evolution</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/molecular-recognition" data-event="iBarJournal-sections-a_id_1013">Molecular Recognition</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/nanobiotechnology" data-event="iBarJournal-sections-a_id_697">Nanobiotechnology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/protein-biochemistry-for-basic-and-applied-sciences" data-event="iBarJournal-sections-a_id_825">Protein Biochemistry for Basic and Applied Sciences</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/rna-networks-and-biology" data-event="iBarJournal-sections-a_id_699">RNA Networks and Biology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/structural-biology" data-event="iBarJournal-sections-a_id_767">Structural Biology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-biosciences/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-biosciences/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-biosciences/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div></div><div class="Ibar__dropdown--aboutUs" parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><!----><!----><!----><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=102&amp;specialtyid=0&amp;entitytype=2&amp;entityid=698" data-event="iBarMenu-a-submit">Submit your research</a></div></div></div><!--[--><div class="Ibar__journal Ibar__journal--main"><div class="Ibar__wrapper Ibar__wrapper--journal"><a href="//www.frontiersin.org/journals/molecular-biosciences" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Molecular Biosciences</span></div></div></a><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/bioenergetics" data-event="iBarJournal-sections-a_id_3647">Bioenergetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/biological-modeling-and-simulation" data-event="iBarJournal-sections-a_id_777">Biological Modeling and Simulation</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/cellular-biochemistry" data-event="iBarJournal-sections-a_id_716">Cellular Biochemistry</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/genome-organization-and-dynamics" data-event="iBarJournal-sections-a_id_2297">Genome Organization and Dynamics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/glycoscience" data-event="iBarJournal-sections-a_id_2218">Glycoscience</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/lipids-membranes-and-membranous-organelles" data-event="iBarJournal-sections-a_id_2426">Lipids, Membranes and Membranous Organelles</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/metabolomics" data-event="iBarJournal-sections-a_id_736">Metabolomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/micronutrient-biology" data-event="iBarJournal-sections-a_id_3693">Micronutrient Biology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/molecular-biophysics" data-event="iBarJournal-sections-a_id_3064">Molecular Biophysics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/molecular-diagnostics-and-therapeutics" data-event="iBarJournal-sections-a_id_701">Molecular Diagnostics and Therapeutics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/molecular-evolution" data-event="iBarJournal-sections-a_id_2529">Molecular Evolution</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/molecular-recognition" data-event="iBarJournal-sections-a_id_1013">Molecular Recognition</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/nanobiotechnology" data-event="iBarJournal-sections-a_id_697">Nanobiotechnology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/protein-biochemistry-for-basic-and-applied-sciences" data-event="iBarJournal-sections-a_id_825">Protein Biochemistry for Basic and Applied Sciences</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/rna-networks-and-biology" data-event="iBarJournal-sections-a_id_699">RNA Networks and Biology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/structural-biology" data-event="iBarJournal-sections-a_id_767">Structural Biology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-biosciences/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-biosciences/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-biosciences/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div></div></div><div class="Ibar__journal Ibar__journal--mix"><div class="Ibar__wrapper Ibar__wrapper--journal"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/molecular-biosciences" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Molecular Biosciences</span></div></div></a><div class="Ibar__spacer"></div><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/bioenergetics" data-event="iBarJournal-sections-a_id_3647">Bioenergetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/biological-modeling-and-simulation" data-event="iBarJournal-sections-a_id_777">Biological Modeling and Simulation</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/cellular-biochemistry" data-event="iBarJournal-sections-a_id_716">Cellular Biochemistry</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/genome-organization-and-dynamics" data-event="iBarJournal-sections-a_id_2297">Genome Organization and Dynamics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/glycoscience" data-event="iBarJournal-sections-a_id_2218">Glycoscience</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/lipids-membranes-and-membranous-organelles" data-event="iBarJournal-sections-a_id_2426">Lipids, Membranes and Membranous Organelles</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/metabolomics" data-event="iBarJournal-sections-a_id_736">Metabolomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/micronutrient-biology" data-event="iBarJournal-sections-a_id_3693">Micronutrient Biology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/molecular-biophysics" data-event="iBarJournal-sections-a_id_3064">Molecular Biophysics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/molecular-diagnostics-and-therapeutics" data-event="iBarJournal-sections-a_id_701">Molecular Diagnostics and Therapeutics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/molecular-evolution" data-event="iBarJournal-sections-a_id_2529">Molecular Evolution</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/molecular-recognition" data-event="iBarJournal-sections-a_id_1013">Molecular Recognition</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/nanobiotechnology" data-event="iBarJournal-sections-a_id_697">Nanobiotechnology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/protein-biochemistry-for-basic-and-applied-sciences" data-event="iBarJournal-sections-a_id_825">Protein Biochemistry for Basic and Applied Sciences</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/rna-networks-and-biology" data-event="iBarJournal-sections-a_id_699">RNA Networks and Biology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-biosciences/sections/structural-biology" data-event="iBarJournal-sections-a_id_767">Structural Biology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-biosciences/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-biosciences/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-biosciences/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-biosciences/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=102&amp;specialtyid=0&amp;entitytype=2&amp;entityid=698" data-event="iBarJournal-a-submit"><span>Submit</span><span>your research</span></a><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><!--]--></nav><div class="ArticlePage"><!--[--><div class="Layout Layout--withAside Layout--withIbarMix"><div class="Alert Alert--info Alert--noInfo ArticleTemplateBanner"><div class="Alert__icon"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" class="FeedbackIcon"><path fill="#fff" d="M10 10h28v28H10z"></path><path fill="var(--blue50)" d="M24 2.88a21.12 21.12 0 1 0 0 42.24 21.12 21.12 0 0 0 0-42.24ZM22.08 13.4a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v1.92a.96.96 0 0 1-.96.96h-1.92a.96.96 0 0 1-.96-.96V13.4Zm5.76 21.2a.96.96 0 0 1-.96.97h-5.76a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h.96v-7.68h-.96a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h3.84a.96.96 0 0 1 .96.96v10.56h.96a.96.96 0 0 1 .96.96v1.92Z"></path></svg></div><div class="Alert__main"><p class="Alert__message">Your new experience awaits. Try the new design now and help us make it even better</p><!--[--><button type="button" class="Button Button--outline Button--grey80 Button--small ArticleTemplateBanner__switchButton" data-event="btn-action"><span>Switch to the new experience</span></button><!--]--><!----></div><ol class="Alert__info"><!--[--><!--]--></ol></div><!----><main class="Layout__main"><!----><div class="ArticleDetails"><div class="ArticleLayoutHeader"><div class="ArticleLayoutHeader__info"><p class="ArticleLayoutHeader__info__title">ORIGINAL RESEARCH article</p><p class="ArticleLayoutHeader__info__journalDate"><span>Front. Mol. Biosci.</span><span>, 23 March 2022</span></p><p class="ArticleLayoutHeader__info__journalDate"> Sec. Cellular Biochemistry</p><p class="ArticleLayoutHeader__info__doiVolume"><span>Volume 9 - 2022 | </span><a class="ArticleLayoutHeader__info__doi" href="https://doi.org/10.3389/fmolb.2022.839917">https://doi.org/10.3389/fmolb.2022.839917</a></p><!----></div><!----><p class="ArticleLayoutHeader__isPartOfRT"><span class="ArticleLayoutHeader__isPartOfRT__label">This article is part of the Research Topic</span><span class="ArticleLayoutHeader__isPartOfRT__title">Extracellular Vesicles in CNS Diseases</span><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View all 5 articles" href="https://www.frontiersin.org/research-topics/21931/extracellular-vesicles-in-cns-diseases/magazine" target="_self" data-event="customLink-linkType-a_viewAll5Articles"><span>View all 5 articles</span></a></span></p></div><div class="ArticleDetails__main__content"><div class="ArticleDetails__main__content__main ArticleDetails__main__content__main--fullArticle"><div class="JournalAbstract"><div class="JournalAbstract__titleWrapper"><h1>Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis</h1><!----></div><!----></div><div class="JournalFullText"><div class="JournalAbstract"><a id="h1" name="h1"></a><div class="authors"><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Hiroki Yamaguchi," onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Hiroki Yamaguchi<sup>1,2</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/1605653" class="user-id-1605653"><img class="pr5" src="https://loop.frontiersin.org/images/profile/1605653/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Hironori Kawahara,&#xa;">Hironori Kawahara</a><sup>1,3</sup>&#x0002a;</span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/859455" class="user-id-859455"><img class="pr5" src="https://loop.frontiersin.org/images/profile/859455/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Noriyuki Kodera">Noriyuki Kodera</a><sup>3</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Ayanori Kumaki" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Ayanori Kumaki<sup>1</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Yasutake Tada," onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Yasutake Tada<sup>1,2</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Zixin Tang" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Zixin Tang<sup>1</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Kenji Sakai" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Kenji Sakai<sup>2</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/4982" class="user-id-4982"><img class="pr5" src="https://loop.frontiersin.org/images/profile/4982/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Kenjiro Ono">Kenjiro Ono</a><sup>2</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Masahito Yamada," onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Masahito Yamada<sup>2,4</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/1214000" class="user-id-1214000"><img class="pr5" src="https://loop.frontiersin.org/images/profile/1214000/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Rikinari Hanayama,&#xa;">Rikinari Hanayama</a><sup>1,3</sup>&#x0002a;</span></div><ul class="notes"><li><span><sup>1</sup></span>Department of Immunology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan</li><li><span><sup>2</sup></span>Department of Neurology and Neurobiology of Aging, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan</li><li><span><sup>3</sup></span>WPI Nano Life Science Institute (NanoLSI), Kanazawa University, Kanazawa, Japan</li><li><span><sup>4</sup></span>Department of Internal Medicine, Division of Neurology, Kudanzaka Hospital, Tokyo, Japan</li></ul><p class="mb15">Hereditary (variant) transthyretin amyloidosis (ATTRv amyloidosis), which is caused by variants in the transthyretin (TTR) gene, leads to TTR amyloid deposits in multiple organs and various symptoms such as limb ataxia, muscle weakness, and cardiac failure. Interaction between amyloid proteins and extracellular vesicles (EVs), which are secreted by various cells, is known to promote the clearance of the proteins, but it is unclear whether EVs are involved in the formation and deposition of TTR amyloid in ATTRv amyloidosis. To clarify the relationship between ATTRv amyloidosis and EVs, serum-derived EVs were analyzed. In this study, we showed that cell-derived EVs are involved in the formation of TTR amyloid deposits on the membrane of small EVs, as well as the deposition of TTR amyloid in cells. Human serum-derived small EVs also altered the degree of aggregation and deposition of TTR. Furthermore, the amount of TTR aggregates in serum-derived small EVs in patients with ATTRv amyloidosis was lower than that in healthy controls. These results indicate that EVs contribute to the metabolism of TTR amyloid, and suggest that TTR in serum-derived small EVs is a potential target for future ATTRv amyloidosis diagnosis and therapy.</p><div class="clear"></div></div><div class="JournalFullText"><a id="h2" name="h2"></a><h2>Introduction</h2><p class="mb15">Amyloidosis refers to a group of diseases in which insoluble proteins, called amyloids, are deposited in various organs, causing functional impairment (<a href="#B33">Picken, 2020</a>). Amyloid is formed by the misfolding and aggregation of soluble proteins. Once formed, amyloid takes on a fibrillar structure and is deposited outside the cell (<a href="#B40">Sipe and Cohen, 2000</a>; <a href="#B33">Picken, 2020</a>). The extracellular deposition of amyloid leads to destruction of normal tissue structure and cellular dysfunction (<a href="#B1">Agostinho et al., 2010</a>; <a href="#B27">Merlini et al., 2011</a>). Physical compression by amyloid deposition, oxidative stress, and abnormal mitochondrial function are thought to be the main mechanisms of cellular dysfunction (<a href="#B3">Ando et al., 1998</a>; <a href="#B6">Buxbaum and Linke, 2012</a>). A variety of soluble proteins, including amyloid-&#x003b2; (A&#x003b2;), &#x003b1;-synuclein (&#x003b1;-syn), transthyretin (TTR), &#x003b2;2-microglobulin (&#x003b2;2-MG), and serum amyloid A (SAA) are aggregated and deposited in the body, causing amyloidosis (<a href="#B33">Picken, 2020</a>). For example, A&#x003b2; and &#x003b1;-syn are predominantly deposited in the brain, A&#x003b2; aggregates are detected in patients with Alzheimer&#x02019;s disease and are called senile plaques (<a href="#B15">Hashimoto et al., 2020</a>), and Lewy bodies, formed by the aggregation of &#x003b1;-syn, are deposited in the brains of patients with Parkinson&#x02019;s disease and dementia with Lewy bodies (<a href="#B13">Gomperts, 2016</a>). These are examples of localized amyloidosis, in which amyloid deposits are confined to the central nervous system.</p><p class="mb15">In systemic amyloidosis, such as reactive AA amyloidosis and hereditary (variant) transthyretin amyloidosis (ATTRv amyloidosis), amyloid is deposited in multiple organs. Reactive AA amyloidosis, in which SAA is the amyloid precursor protein, is associated with secondary to chronic inflammatory diseases and infections (rheumatoid arthritis, systemic lupus erythematosus, tuberculosis, etc.). In hereditary ATTRv amyloidosis, TTR gene variant forms amyloid, which is deposited in multiple organs such as the peripheral nerves, gastrointestinal tract, heart, eyes, and kidneys (<a href="#B38">Sekijima et al., 2018</a>). TTR is mainly produced in the liver and exists as a tetramer in serum; however, the dissociation of tetramers into a monomers is the rate-limiting step in amyloid formation (<a href="#B38">Sekijima et al., 2018</a>). TTR tetramers composed of variant TTR are more likely to dissociate into monomers than those composed of wild-type TTR (<a href="#B38">Sekijima et al., 2018</a>; <a href="#B48">Yee et al., 2019</a>). The most common variant in the causative TTR gene is the p.Val50Met (Val30Met; V30M) variant, and the resulting mutated TTR is called V30M-TTR (<a href="#B48">Yee et al., 2019</a>). Acidic conditions also promote TTR amyloid formation <em>in vitro</em> (<a href="#B48">Yee et al., 2019</a>). Unlike A&#x003b2;, which is produced by neurons, TTR is not produced near the site of deposition of TTR aggregation or in the surrounding tissues. Furthermore, the mechanism of TTR aggregation and deposition in the body remains unknown.</p><p class="mb15">Extracellular vesicles (EVs) are small membrane vesicles secreted by various cell and tissue types (<a href="#B18">Kalluri and LeBleu, 2020</a>). EVs contain biological materials such as proteins, messenger RNA, and microRNA derived from the cells that produce them. Intercellular communication, such as the transport of pathogenic proteins, plays a major role in EVs, and the proteins and RNAs contained in EVs are useful biomarkers of several diseases (<a href="#B18">Kalluri and LeBleu, 2020</a>). Notably, the addition of Schwann cell-derived EVs or mesenchymal stem cell-derived EVs to mouse models of diabetic neuropathy or mice that were physically subjected to peripheral neuropathy promoted nerve repair (<a href="#B8">Dong et al., 2019</a>; <a href="#B10">Fan et al., 2021</a>). <em>In vitro</em>, Neuro2a mouse neuroblastoma (N2a) cell-derived EVs (N2a-EVs) promote A&#x003b2; aggregation in EVs. In addition, A&#x003b2; aggregated on N2a-EVs is easily taken up by microglia and degraded (<a href="#B49">Yuyama et al., 2012</a>). Furthermore, continuous injection of N2a-EVs into mouse models of Alzheimer&#x02019;s disease enhanced the phagocytosis of A&#x003b2; aggregates by microglia and reduced the amount of amyloid deposition in the brain (<a href="#B50">Yuyama et al., 2014</a>). Moreover, SAA and SAA oligomers present in plasma EVs also exhibit amyloid-enhancing-factor activity (<a href="#B44">Tasaki et al., 2010</a>). Human serum EVs (S-EVs) collected by ultracentrifugation contain TTR amyloid (<a href="#B45">Tong et al., 2017</a>); however, it remains unknown whether EVs contribute to TTR aggregation, deposition, or clearance in hereditary ATTRv amyloidosis. In this study, we show that TTR aggregation is enhanced on EV membranes and that EVs promote cell deposition accompanied by TTR aggregation, even under non-acidic conditions. Furthermore, we observe a decrease in TTR in serum-derived EVs in patients with hereditary ATTRv amyloidosis, indicating that EVs could play an active role in TTR tissue deposition.</p><a id="h3" name="h3"></a><h2>Materials and Methods</h2><h3 class="pt0">Purification of Serum Extracellular Vesicles</h3><p class="mb0">Six patients with ATTRv (V30M-TTR) amyloidosis and six healthy controls provided serum samples in this study. The patients included three males and three females, whereas the healthy individuals were six males. The age of the patients was 56&#x02013;75, and that of the healthy controls was 22&#x02013;40. Serum was collected from patients after diagnosis and before the start of treatment for ATTRv amyloidosis. The duration of illness was 3&#x02013;7&#x000a0;years at the time of blood sampling. All donors provided informed consent, and the study was approved by the Kanzawa University Ethics Committee Reference 2018&#x02013;238 (3,029).</p><p class="mb0">All serum samples were centrifuged at 3,000 &#x000d7;g for 10&#x000a0;min and 10,000 &#x000d7; g for 30&#x000a0;min at 4&#x000b0;C, followed by microfiltration with Millipore 0.22&#x000a0;&#x003bc;m filters. Filtrated serum (1&#x000a0;ml) was reacted with MagCapture Exosome Isolation Kit PS (MagCapture) (FUJIFILM Wako, Japan) according to the manual. After the overnight reaction, purified serum EVs were eluted with elution buffer and the EVs were saved (FUJIFILM Wako). Eluted serum EVs were stored at 4&#x000b0;C until further use. The concentration of serum EVs was measured using the Pierce BCA Protein Assay Kit (Thermo Scientific, United States) at 25&#x000b0;C. The number and size distribution of EV particles were measured <em>via</em> nanoparticle tracking analysis using a NanoSight LM10 instrument (software NTA 3.1; Malvern Panalytical, United Kingdom) after diluting the EVs 30&#x000a0;times with phosphate-buffered saline (PBS). The particle numbers per frame used were 70 particles/frame for recording of S-EVs in Raw mode.</p><h3 class="pt0">Purification of Cell Line-Derived Extracellular Vesicles</h3><p class="mb0">HepG2, HEK293T, and NIH3T3 cell lines was purified. Cells (2 &#x000d7; 10<sup>6</sup>) were spread on a 10&#x000a0;cm dish and incubated with Dulbecco&#x02019;s modified Eagle medium (DMEM) medium (FUJIFILM Wako) containing 10% fetal calf serum (FCS). EVs in the FCS were eliminated by 1,00,000 &#x000d7; g ultracentrifugation. Cell lines were cultured until they reached 90% confluence at 37&#x000b0;C with 5% CO<sub>2</sub>. Then, the culture medium was changed to fresh DMEM containing 2% FCS (2% FCS-DMEM) and incubated for 24&#x000a0;h. The collected conditioned culture media were centrifuged at 3,000 &#x000d7; g for 10&#x000a0;min and 10,000 &#x000d7; g for 30&#x000a0;min at 4&#x000b0;C, followed by microfiltration with Millipore 0.22&#x000a0;&#x003bc;m filters. Filtrated conditioned culture media were reacted with MagCapture, and cell line-derived EVs were eluted using the same procedure as that used for serum EVs. Measurement of collected EV solutions using the Pierce BCA Protein Assay Kit and NanoSight was performed according to the same procedure as that for serum. The particle numbers per frame used were 42, 50, or 39 particles/frame for recording of HepG2, HEK293T, and NIH3T3 cells in Raw mode, respectively.</p><h3 class="pt0">Purification of Recombinant Transthyretin</h3><p class="mb0">Protein purification was performed as described previously (<a href="#B20">Kawahara et al., 2008</a>). TTR (NM_000371.4) and V30M were amplified by PrimeSTAR GXL DNA polymerase (Takara, Japan) using primers (5&#x02032;- ggg&#x0200b;gcc&#x0200b;cct&#x0200b;ggg&#x0200b;atc&#x0200b;TGG&#x0200b;CCC&#x0200b;TAC&#x0200b;GGG&#x0200b;CAC&#x0200b;CGG&#x0200b;T-3&#x02032;; 5&#x02032;- gat&#x0200b;gcg&#x0200b;gcc&#x0200b;gct&#x0200b;cga&#x0200b;TCA&#x0200b;TTC&#x0200b;CTT&#x0200b;GGG&#x0200b;ATT&#x0200b;GGT&#x0200b;G-3&#x02032;) and subcloned pGEX6P1 using In-Fusion HD Cloning Kit (Takara). V30M mutation was generated by using an inverse PCR method (PrimeSTAR GXL) and primers (5&#x02032;-TGT&#x0200b;GGC&#x0200b;CaT&#x0200b;GCA&#x0200b;TGT&#x0200b;GTT&#x0200b;CAG&#x0200b;AAA&#x0200b;GG-3&#x02032;; 5&#x02032;- ACA&#x0200b;TGC&#x0200b;AtG&#x0200b;GCC&#x0200b;ACA&#x0200b;TTG&#x0200b;ATG&#x0200b;GCA&#x0200b;GG-3&#x02032;). <em>Escherichia coli</em> strain BL21 (DE3) pLysS (Biodynamics, DS260) was transfected with the plasmid pGEX6P1-GST-WT-TTR or pGEX6P1-GST-V30M-TTR. After overnight incubation in LB medium at 37&#x000b0;C, the culture medium was transferred into 100&#x02013;200&#x000a0;ml of LB medium and incubated at 37&#x000b0;C. At the time of OD600 &#x0003d; 0.5, Isopropyl &#x003b2;-D-1-thiogalactopyranoside (IPTG) was added to a final concentration of 0.1&#x000a0;mM and the medium was incubated for 5&#x000a0;h. Cultured <em>E. coli</em> was centrifuged, collected, suspended in PBS, and sonicated on ice. Triton-X 100 (Nacalai Tesque, Japan) was added to the final 0.1% and the solutions were centrifuged at 10,000 &#x000d7; g for 30&#x000a0;min at 4&#x000b0;C. The supernatant was then ultracentrifuged at 100,000 &#x000d7;g for 90&#x000a0;min at 4&#x000b0;C. The supernatant was mixed with Pierce Glutathione Agarose (Thermo Scientific) and rotated overnight at 4&#x000b0;C. Beads were then washed five times and 1&#x000a0;ml of PBS or FCS-free DMEM and 20&#x000a0;&#x003bc;l of Turbo3C protease (FUJIFILM Wako) was added; the mixture was then rotated for 24&#x000a0;h at 4&#x000b0;C. Then, the TTR solution was collected, followed by microfiltration with Millipore 0.22&#x000a0;&#x003bc;m filters. The concentration of filtered purified TTR solution was measured with Pierce 660&#x000a0;nm Protein Assay Reagent (Thermo Scientific) at 25&#x000b0;C, and the TTR solution was stored at 4&#x000b0;C until use.</p><h3 class="pt0">Western Blotting Analysis</h3><p class="mb0">The SDS-PAGE was performed under reducing condition according to previous study (<a href="#B43">Tangthavewattana et al., 2019</a>), and immunoblotting was performed as described previously (<a href="#B21">Kawahara et al., 2011</a>). Samples were boiled with sodium dodecyl sulfate sample buffer, denatured on 13% polyacrylamide gels, transferred onto a nitrocellulose membrane, and blocked in 4% skim milk in TBS-T (0.5% Triton-X 100 with TBS) for 30&#x000a0;min at room temperature then washed with TBS-T three times. The membrane was then incubated with primary antibodies overnight at 4&#x000b0;C. The membrane was washed three times with TBS-T and incubated with secondary antibodies overnight at 4&#x000b0;C. Both the primary and secondary antibodies were diluted 1,000 times with Can Get Signal 1 and Can Get Signal 2 (TOYOBO, Japan). Following TBS-T washing in triplicate, the membrane was enclosed with SuperSignal West Pico PLUS Chemiluminescent Substrate (Thermo Scientific) or ImmunoStar LD (FUJIFILM Wako). Chemiluminescence was detected using FUSION SYSTEM (Vilber Lourmat, France). The signal intensity of the bands was measured using Evolution Capt Version 18.04 (Vilber Lourmat). The primary antibodies used in this study were anti-prealbumin antibody (Abcam, ab-92469), Anti-CD9, monoclonal antibody (1&#x000a0;K) (FUJIFILM Wako, 014-27763), LEAF Purified anti-human CD63 antibody (BioLegend, 353014), anti-Alix antibody (Cell Signaling Technology, 2171), Anti-HSP70 antibody (BioLegend, 648002), Anti-CD81 antibody (BioLegend, 104902), and Purified Mouse Anti-Flotillin-2 antibody (BD Biosciences, 610384). The secondary antibodies were anti-rabbit IgG, HRP-linked antibody (Jackson Immuno Research Laboratories, 711-035-152), and anti-mouse IgG, HRP-linked antibody (Cell Signaling Technology, 7076P2).</p><h3 class="pt0">Thioflavin T Assay</h3><p class="mb0">The acidic buffer was 50&#x000a0;mM sodium acetate and 100&#x000a0;mM NaCl at pH 4.2, as described previously (<a href="#B35">Saito et al., 2005</a>). Cell line-derived EVs (50&#x000a0;&#x003bc;g/ml) and purified TTR in PBS (WT-TTR or V30M-TTR, 0.75&#x000a0;mg/ml) were mixed with the acidic buffer in a PCR tube. The final concentration of TTR was 0.1&#x000a0;mg/ml. The sample solutions were incubated at 37&#x000b0;C in a thermal cycler. The increase in aggregated TTR was evaluated by measuring the fluorescence intensity (FI) of ThT. The ThT solution (as described previously in <a href="#B35">Saito et al. (2005)</a> (5&#x000a0;&#x003bc;M ThT and 50&#x000a0;mM glycine-NaOH buffer, pH 9.0) and sample solutions were mixed at a ratio of 20:1. The mixture was poured into four wells of a Nunc Black polystyrene 96-well microplate (Thermo Scientific) with 200&#x000a0;&#x003bc;l per well. The FI value was recorded at 25&#x000b0;C within a few minutes of pouring. The measurement device was an Enspire Multimode Plate Reader (PerkinElmer, United States). The measurement timing was as follows: 0&#x000a0;h (immediately after mixing), 6, 12, 24, and 48&#x000a0;h. The wavelengths of the plate reader for excitation and emission were 450 and 482&#x000a0;nm, respectively.</p><h3 class="pt0">Biotinylation of Anti-Transthyretin Antibody</h3><p class="mb0">EZ-Link NHS-LC-LC-Biotin (Thermo Scientific) was diluted in 2&#x000a0;mM using dimethyl sulfoxide, and 6.7&#x000a0;&#x003bc;l of the diluted biotin solution was mixed with 200&#x000a0;&#x003bc;l of purified anti-transthyretin aggregated antibody (BioLegend, 848202). The mixture was then rotated at 4&#x000b0;C overnight. Then, the same amount of 100&#x000a0;mM glycine-PBS was added to inactivate the remaining biotin.</p><h3 class="pt0">Enzyme-Linked Immunosorbent Assay of Extracellular Vesicles (EV ELISA)</h3><p class="mb0">A PS Capture Exosome ELISA Kit (Streptavidin HRP) (FUJIFILM Wako, Japan) was used for semi-quantification of EVs. Cell line-derived EVs or serum were used as the samples. The samples were diluted to the desired ratio using the reaction buffer in the kit. Diluted samples were poured into three wells of the kit (100&#x000a0;&#x003bc;l per well) and incubated overnight with shaking at 4&#x000b0;C and 500&#x000a0;rpm. Subsequent procedures were performed according to the manufacturer&#x02019;s instructions. Control biotinylated anti-CD63 antibody in the kit or biotinylated anti-aggregated TTR antibody described in the previous section were used for the detection of proteins contained in the EVs. Absorbance spectra were obtained at 25&#x000b0;C using an Enspire Multimode plate reader (PerkinElmer), and the absorbance was measured at 450&#x000a0;nm (reference wavelength: 620&#x000a0;nm). According to the manual, the actual absorbance was obtained by subtracting the blank absorbance from the average absorbance at three points.</p><h3 class="pt0">Binding of EVs and Purified TTR in Neutral Conditions and Extracellular Vesicles Labeling</h3><p class="mb0">Each 30&#x000a0;&#x003bc;l of purified TTR in FCS-free DMEM (WT-TTR or V30M-TTR, 0.4&#x000a0;mg/ml) and cell line-derived EVs (40&#x000a0;&#x003bc;g/ml) were mixed in a PCR tube. The mixtures were incubated for 48&#x000a0;h at 37&#x000b0;C. Then, 15&#x000a0;&#x003bc;L of each sample was used for western blotting analysis, and the remaining samples were diluted 100 times with reaction buffer and used for EV ELISA. The experiment was also conducted in serum EVs using the same procedure. For PKH-labeled EVs, 293T-EVs (3&#x000a0;&#x003bc;g) was incubated with 4x PKH26 Dye solution (Sigma-Aldrich) for 15&#x000a0;min at room temperature according to the manual after both ultracentrifugation followed by MagCapture. PKH-labeled EVs was purified by Exosome Spin Columns (Thermo) by centrifuging at 750 &#x000d7; <em>g</em> for 2&#x000a0;min.</p><h3 class="pt0">Immunocytochemistry</h3><p class="mb0">Immunocytochemistry was performed as described previously (<a href="#B20">Kawahara et al., 2008</a>). V30M-TTR in FCS-free DMEM was aggregated in acidic buffer for 3&#x000a0;days, and TTR aggregates were diluted in FCS-free DMEM (final TTR concentration; 1.0&#x000a0;&#x003bc;g/ml). HEK293T cell was incubated with 10% FCS-DMEM (500&#x000a0;&#x003bc;l) on gelatin coated 12&#x000a0;mm coverslips until they reached 50% confluence at 37&#x000b0;C. Then, the culture medium was replaced with fresh 2% FCS-DMEM (500&#x000a0;&#x003bc;l) and 10&#x000a0;&#x003bc;l of diluted aggregated TTR was added, and the cells were incubated at 37&#x000b0;C for 30&#x000a0;h. After incubation, the cells were washed with TBS-T and fixed with 4% PFA for 15&#x000a0;min at room temperature. The cells were then washed, 2% bovine serum albumin (BSA) was added to TBS-T, and cells were incubated with shaking for 30&#x000a0;min at room temperature. Then, the cells were washed with TBS-T, and biotinylated anti-aggregated TTR antibody was diluted 1,000 times with 1% BSA in TBS-T and incubated overnight at 4&#x000b0;C. The cells were washed with TBS-T, Streptavidin-Cy3 (BioLegend, 405215) diluted 1,000 times with 2% BSA in TBS-T, and incubated overnight at 4&#x000b0;C with shading. After incubation, the cells were washed with TBS-T and incubated with VECTASHIELD Mounting Medium with DAPI (5&#x000a0;&#x003bc;g/ml) (VECTOR LABORATORIES, Unites states). Purified V30M-TTR in FCS-free DMEM was also used. HEK293T cell was cultured as described above until they reached 90% confluence. The culture medium was then replaced with fresh 2.5% FCS-DMEM (400&#x000a0;&#x003bc;l). Purified V30M-TTR in FCS-free DMEM (50&#x000a0;&#x003bc;l, 2.0&#x000a0;mg/ml) with 50&#x000a0;&#x003bc;l of serum EVs (70&#x000a0;ng/ml) or elution buffer (MagCapture, FUJIFILM Wako, Japan) were also spread on the cell lines, and cells were incubated at 37&#x000b0;C for 18&#x000a0;h. After incubation, the same procedure described above was performed to observe the fluorescence. For the uptake of 293T-EVs, HEK293T cell was cultured as described above until they reached 90% confluence. The culture medium was then replaced with fresh 2.5% FCS-DMEM (400&#x000a0;&#x003bc;l). Purified TTR or V30M-TTR in FCS-free DMEM (50&#x000a0;&#x003bc;l, 2.0&#x000a0;mg/ml) with 50&#x000a0;&#x003bc;l of PKH26-labeled 293T-EVs (70&#x000a0;ng/ml) or PKH26-labeled 293T-EVs alone were also spread on the cell lines, and cells were incubated at 37&#x000b0;C for 24&#x000a0;h. After incubation, the same procedure described above was performed to observe the fluorescence using anti-aggregated TTR antibody, anti-mouse IgG, Biotin-linked antibody (Jackson Immuno Research Laboratories, 715-065-150), and Streptavidin-FITC (BD Bioscience, 554060). They were captured by BZ-X710 (KEYENCE, Japan) or FV10-ASW (Olympus) and Quantitative analysis were performed using Hybrid Cell Count software according to the manual (Keyenece, BZ-H3C).</p><h3 class="pt0">High-Speed Atomic Force Microscopy</h3><p class="mb0">A laboratory-built high-speed atomic force microscope (HS-AFM) was used for the analysis, as described previously (<a href="#B2">Ando et al., 2013</a>). In brief, a glass sample stage (diameter, 2&#x000a0;mm; height, 2&#x000a0;mm) with a thin mica disc (1.5&#x000a0;mm diameter and &#x0223c;0.05&#x000a0;mm thickness) glued to the top by epoxy was attached onto the top of a Z-scanner using a drop of nail polish. A drop (2&#x000a0;&#x003bc;l) of the serum EV solution from the healthy control group (1.8 &#x000d7; 10<sup>9</sup> particles/ml) was deposited onto a freshly cleaved mica surface and left to sit for 3&#x000a0;min. This ensured that the S-EVs were nonspecifically immobilized on the mica surface. After rinsing the surface with either PBS buffer or acidic buffer (pH 4.0) of 20&#x000a0;&#x003bc;l, the sample stage was immersed in a liquid cell filled with either PBS buffer or acidic buffer (60&#x000a0;&#x003bc;l), and HS-AFM imaging was conducted in tapping mode. We used small cantilevers (BL-AC10DS-A2, Olympus, Tokyo) with a spring constant, resonant frequency in water, and quality factor in water of &#x0223c;0.1&#x000a0;N/m, &#x0223c;0.5 MHz, and &#x0223c;1.5, respectively. The probe tip was grown on the original tip end of the cantilever through electron beam deposition using ferrocene. The cantilever&#x02019;s free oscillation amplitude <em>A</em><sub>0</sub> and set-point amplitude <em>A</em><sub>s</sub> were set to &#x0223c;2&#x000a0;nm and &#x0223c;0.9 &#x000d7; <em>A</em><sub>0</sub>, respectively. In some experiments, purified V30M-TTR solution (5&#x000a0;&#x003bc;L) was injected into the observation buffer during HS-AFM imaging so that the final concentration of TTR was either 0.07&#x000a0;mg/ml or 0.25&#x000a0;mg/ml, as described previously (<a href="#B30">Nonaka et al., 2020</a>). Details of the HS-AFM imaging method are described elsewhere (<a href="#B46">Uchihashi et al., 2012</a>). Data analysis of HS-AFM images was performed as described previously (<a href="#B23">Kori et al., 2019</a>; <a href="#B22">Kodera et al., 2021</a>).</p><h3 class="pt0">Analysis of High-Speed Atomic Force Microscopy Images</h3><p class="mb0">For analysis, HS-AFM images were pretreated with a low-pass filter to remove spike noise and with a flatten filter to render the overall xy-plane flat using a laboratory-built software, as described before (<a href="#B29">Ngo et al., 2015</a>). The heights of S-EVs were measured semi-automatically using the following steps. First, the estimated highest point of a S-EV was selected manually. Second, the actual highest point was automatically determined by searching a 10 &#x000d7; 10 pixel area (typically 40 &#x000d7; 40&#x000a0;nm<sup>2</sup>) around the selected point.</p><p class="mb0">2D correlation coefficients were calculated between the HS-AFM images of the first frame and each of the frames within the region of interest (ROI) (i.e., the first frame is the reference) (<a href="#B23">Kori et al., 2019</a>). The ROIs were set as rectangles that enclosed the spherical-shaped S-EVs (typically 50 &#x000d7; 50&#x000a0;nm<sup>2</sup>). The 2D correlation coefficient was calculated frame-by-frame for each ROI. The 2D correlation coefficient <em>r</em> is defined as,</p><div class="equationImageholder"><math  id="equ1"><mrow><mi>r</mi><mo>&#x0003d;</mo><mfrac><mrow><msub><mstyle displaystyle="true"><mo>&#x02211;</mo></mstyle><mi>m</mi></msub><msub><mstyle displaystyle="true"><mo>&#x02211;</mo></mstyle><mi>n</mi></msub><mrow><mo>(</mo><msub><mi>H</mi><mrow><mi>m</mi><mi>n</mi></mrow></msub><mo>&#x02212;</mo><mover accent="true"><mi>H</mi><mo>&#x000af;</mo></mover><mo>)</mo></mrow><mrow><mo>(</mo><msub><mi>R</mi><mrow><mi>m</mi><mi>n</mi></mrow></msub><mo>&#x02212;</mo><mover accent="true"><mi>R</mi><mo>&#x000af;</mo></mover><mo>)</mo></mrow></mrow><mrow><msqrt><mrow><mrow><mo>(</mo><msub><mstyle displaystyle="true"><mo>&#x02211;</mo></mstyle><mi>m</mi></msub><msub><mstyle displaystyle="true"><mo>&#x02211;</mo></mstyle><mi>n</mi></msub><msup><mrow><mrow><mo>(</mo><mrow><msub><mi>H</mi><mrow><mi>m</mi><mi>n</mi></mrow></msub><mo>&#x02212;</mo><mover accent="true"><mi>H</mi><mo>&#x000af;</mo></mover></mrow><mo>)</mo></mrow></mrow><mn>2</mn></msup><mo>)</mo></mrow><mrow><mo>(</mo><msub><mstyle displaystyle="true"><mo>&#x02211;</mo></mstyle><mi>m</mi></msub><msub><mstyle displaystyle="true"><mo>&#x02211;</mo></mstyle><mi>n</mi></msub><msup><mrow><mrow><mo>(</mo><mrow><msub><mi>R</mi><mrow><mi>m</mi><mi>n</mi></mrow></msub><mo>&#x02212;</mo><mover accent="true"><mi>R</mi><mo>&#x000af;</mo></mover></mrow><mo>)</mo></mrow></mrow><mn>2</mn></msup><mo>)</mo></mrow></mrow></msqrt></mrow></mfrac></mrow></math><div class="clear"></div></div><p class="noindent">in which <em>H</em><sub>mn</sub> and <em>R</em><sub>mn</sub> are the heights at the pixel points (m, n) in the ROI to be analyzed and the ROI of the reference, respectively.</p><h3 class="pt0">Statistical Analysis</h3><p class="mb0">Statistical analysis was performed using GraphPad Prism 8.4.3. Statistical comparisons were performed as indicated in the figure legends. <em>p</em> values &#x02264;0.05 were considered to be statistically significant, and those not significant (n.s.) were indicated accordingly. Bar graphs are presented as the mean &#x000b1; standard error (S.E.). Two-sample tests were performed by Mann&#x02013;Whitney&#x02019;s U-test. Multiple comparisons were performed via one-way analysis of variance. No statistical methods were used to select <em>N</em> number.</p><a id="h4" name="h4"></a><h2>Results</h2><h3 class="pt0">Extracellular Vesicles Bind to Transthyretin and Promote Transthyretin Aggregation</h3><p class="mb0">The majority of TTR is produced as a secreted protein in the liver (<a href="#B38">Sekijima et al., 2018</a>); the presence of serum EVs containing TTR has also been reported (<a href="#B45">Tong et al., 2017</a>). To confirm whether HepG2 cells contained TTR, immunoblotting was performed using HepG2 culture supernatants. TTR was detected in HepG2-EVs (<a href="#F1">Figure 1A</a>). In HEK293T and NIH3T3 cells that did not produce TTR, TTR was not detected in either the supernatants or EVs (<a href="#F1">Figure 1B</a>). The particle size and distribution of EVs were similar among the three groups (<a href="#F1">Figure 1C</a>). A&#x003b2;, which is a major causative factor of Alzheimer&#x02019;s disease, binds to the surface proteins of Neuro2a cell-derived EVs and promotes A&#x003b2; aggregation on EVs (<a href="#B49">Yuyama et al., 2012</a>). To investigate whether TTR, a major causative factor of ATTR amyloidosis (which is the same type of amyloidosis as Alzheimer&#x02019;s disease), interacts with the EV membrane surface, we analyzed the interaction using purified TTR and EVs derived from HEK293T and NIH3T3 cells that do not produce TTR. HEK293T cell-derived EVs (HEK293T-EVs) or NIN3T3 cell-derived EVs (NIH3T3-EVs) were mixed with purified wild-type TTR (WT-TTR) or V30M-TTR then analyzed. First, immunoblotting was performed using samples that had been mixed with EVs or non-EVs and purified TTR or FCS-free DMEM, then allowed to stand at 37&#x000b0;C for 48&#x000a0;h. In the mixed sample of V30M-TTR and EVs, multiple bands were detected (<a href="#F2">Figure 2A</a>). This result suggests that mixing of V30M-TTR and EVs resulted in the aggregation of TTR (<a href="#F2">Figure 2A</a>). The mixed sample of NIH3T3-EVs and WT-TTR also showed slight banding. Multiple bands were not observed in the sample without EVs (<a href="#F2">Figure 2A</a>). Next, to confirm the co-localization of EVs with TTR aggregates, we performed EV ELISA using the same samples as for immunoblotting. An increase in absorbance was observed in the mixed samples of EVs and TTR, with the highest absorbance in the mixed samples of NIH3T3-EVs and V30M-TTR (<a href="#F2">Figures 2B,C</a>). The absorbance exhibited a minimal increase in the mixed samples of TTR and non-EVs. Under neutral conditions, EVs from TTR-non-producing cell lines bound to purified TTR and promoted TTR aggregation. In addition, NIH3T3-EVs showed a higher affinity for TTR than HEK293T-EVs.</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE 1</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g001.jpg" name="Figure1" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g001.jpg" alt="www.frontiersin.org" id="F1" loading="lazy">
  </picture>
</a><p><strong>FIGURE 1</strong>. HepG2-derived EVs contain TTR whereas HEK293T-derived EVs or NIH3T3-derived EVs do not. <strong>(A)</strong> TTR monomer was detected in western blotting analysis of the culture supernatant of HepG2 and HepG2-derived EVs. <strong>(B)</strong> TTR was not detected in western blotting analysis of the cell lysate and cell line-derived EVs in HEK293T and NIH3T3. 3T3 (NIH3T3), 293T (HEK293T). <strong>(C)</strong> Analysis of three cell line-derived EVs [HepG2 (black), HEK293T (red), and NIH3T3 (green)] by NanoSight (Raw mode). The diameter and distribution of cell line-derived EVs were similar among the cell lines. All EVs were 40&#x000a0;ng/ml before measurement and were diluted 30-fold with PBS immediately before analysis. Particle concentrations were as follows: HepG2 cell-derived (2.52 &#x000d7; 10<sup>10</sup> &#x000b1; 1.19 &#x000d7; 10<sup>9</sup>), HEK293T-derived (2.96 &#x000d7; 10<sup>10</sup> &#x000b1; 1.01 &#x000d7; 10<sup>9</sup>), and NIH3T3-derived EVs (2.23&#x000d7; 10<sup>10</sup> &#x000b1; 1.28 &#x000d7; 10<sup>9</sup>).</p></div><div class="clear"></div><div class="DottedLine"></div><div class="Imageheaders">FIGURE 2</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g002.jpg" name="Figure2" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g002.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g002.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g002.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g002.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g002.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g002.jpg" alt="www.frontiersin.org" id="F2" loading="lazy">
  </picture>
</a><p><strong>FIGURE 2</strong>. EVs are easily combined with purified V30M-TTR. <strong>(A)</strong> Mixture of NIH3T3-derived EVs, HEK293T-derived EVs or non-EVs, and purified TTR in non-shaking conditions for 48&#x000a0;h used for western blotting analysis. Ladder bands suggestive of aggregates were confirmed above the top of the running gel on V30-TTR and both EVs. <strong>(B)</strong> Remaining samples were diluted and used for EV ELISA. Binding of cell line-derived EVs to TTR was indicated by the increased absorbance in EV ELISA. NIH3T3-derived EVs were more likely to bind to TTR than HEK293T-derived EVs. N &#x0003d; 3, mean &#x000b1; S.E.; &#x0002a;&#x0002a;, <em>p</em> &#x0003c; 0.005; n.s., not significant, ANOVA with Tukey&#x02019;s post hoc test. <strong>(C)</strong> The same samples as the previous experiment were shaken at 500&#x000a0;rpm and used for EV ELISA. TTR-V30M with cell line-derived EVs showed higher absorbance than TTR-WT. N &#x0003d; 3, mean &#x000b1; S.E.; &#x0002a;&#x0002a;, <em>p</em> &#x0003c; 0.005; n.s., not significant, ANOVA with Tukey&#x02019;s post hoc test. <strong>(D)</strong> Increase of Thioflavin T (ThT) fluorescence intensity (FI) in a mixture of EVs and purified WT-TTR with acidic buffer observed by ThT assay. FI value decreased in the following order: TTR with NIH3T3-derived EVs, HEK293T-derived EVs, and elution buffer in both WT-TTR and V30M-TTR. N &#x0003d; 4, mean &#x000b1; S.E.; &#x0002a;, <em>p</em> &#x0003c; 0.05; &#x0002a;&#x0002a;, <em>p</em> &#x0003c; 0.005; ANOVA with Tukey&#x02019;s post hoc test. <strong>(E)</strong> Same experiment with V30M-TTR. FI value decreased in the same order as for WT-TTR. FI value of V30M-TTR was generally higher than that of WT-TTR. N &#x0003d; 4, mean &#x000b1; S.E.; &#x0002a;, <em>p</em> &#x0003c; 0.05; &#x0002a;&#x0002a;, <em>p</em> &#x0003c; 0.005; ANOVA with Tukey&#x02019;s post hoc test.</p></div><div class="clear"></div><div class="DottedLine"></div><p class="mb0">TTR aggregation is promoted under acidic conditions (<a href="#B7">Colon and Kelly, 1992</a>). EV-affected TTR aggregation was analyzed using the thioflavin T (ThT) assay. EVs or non-EVs, purified WT-TTR or V30M-TTR, and acidic buffer were mixed and evaluated (<a href="#F2">Figures 2D,E</a>). WT-TTR showed a significant increase in FI values in the presence of NIH3T3-derived EVs. V30M-TTR showed an increasing trend in FI values in the presence of both NIH3T3-derived and 293T-derived EVs, with 293T-derived EVs showing a significant increase in FI values at 12 and 24&#x000a0;h. Overall, the FI values of V30M-TTR were higher than those of WT-TTR. NIH3T3-EVs and V30M-TTR bound easily, even under acidic conditions, indicating that NIH3T3-EVs are likely to promote the aggregation of TTR.</p><h3 class="pt0">Serum Extracellular Vesicles Contain Transthyretin and Transthyretin Aggregates, and Serum Extracellular Vesicles Bind to Purified Transthyretin</h3><p class="mb0">Reportedly, S-EVs recovered by ultracentrifugation contain TTR aggregates (<a href="#B45">Tong et al., 2017</a>). However, these S-EVs also contain many impurities. Some methods have been used to purify S-EVs, including a two-step purification method using size exclusion chromatography in combination with the density gradient method (<a href="#B31">On&#x000f3;di et al., 2018</a>). We have reported that EVs can be easily purified by the MagCapture method to ensure their high purity (<a href="#B28">Nakai et al., 2016</a>). To investigate whether highly purified S-EVs also contain TTR and TTR aggregates, S-EVs from healthy individuals were collected by MagCapture and analyzed using the same procedure as that used for cell line-derived EVs. The particle size of S-EVs was analyzed using a nanoparticle meter, which revealed a similar particle size and distribution to those of cell line-derived EVs (<a href="#F1">Figures 1C</a>, <a href="#F3">3A</a>). TTR with multiple molecular weights was detected in the immunoblot of S-EVs, as well as a small amount of TTR aggregates in the high purity S-EV (<a href="#F3">Figure 3B</a>). As cultured cell-derived EVs promoted TTR aggregation, we performed a similar analysis with serum-derived EVs. S-EVs or non-EVs were mixed with purified TTR or TTR minus as controls. A ladder-like band was observed in the mixed sample of S-EVs and V30M-TTR, indicating that S-EVs promoted the aggregation of TTR (<a href="#F3">Figure 3C</a>). In addition, to investigate whether TTR aggregation occurred on the EV surface, EV ELISA was performed using the same samples as those used for immunoblotting. The absorbance increased in the mixed sample of TTR and S-EVs and was higher in V30M-TTR than in WT-TTR (<a href="#F3">Figure 3D</a>). However, the absorbance did not increase as much as when the cell line-derived EVs were mixed with purified TTR (<a href="#F2">Figures 2B</a>, <a href="#F3">3D</a>). These ELISA results indicated that V30M-TTR was more easily aggregated on the surface of the S-EVs.</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE 3</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g003.jpg" name="Figure3" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g003.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g003.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g003.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g003.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g003.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g003.jpg" alt="www.frontiersin.org" id="F3" loading="lazy">
  </picture>
</a><p><strong>FIGURE 3</strong>. EVs derived from human serum contain TTR, and purified TTR binds to the serum EVs. <strong>(A)</strong> Analysis of EVs derived from serum (S-EVs) by NanoSight (Raw mode). The particle concentration was 4.15 &#x000d7; 10<sup>10</sup> &#x000b1; 3.30 &#x000d7; 10<sup>9</sup>. <strong>(B)</strong> Multiple molecular weight TTR and TTR aggregates were detected in western blotting analysis of serum and S-EVs. <strong>(C)</strong> Mixture of S-EVs or Elution Buffer and purified TTR in static conditions for 48&#x000a0;h used for western blotting analysis. V30M-TTR with or without S-EVs exhibited ladder bands. <strong>(D)</strong> Remaining samples were used for EV ELISA. S-EVs with V30M-TTR showed the highest absorbance. S-EVs with WT-TTR also exhibited an increase in absorbance, whereas TTR without EVs showed little increase in absorbance. N &#x0003d; 3, mean &#x000b1; S.E.; &#x0002a;&#x0002a;, <em>p</em> &#x0003c; 0.005; n.s., not significant, ANOVA with Tukey&#x02019;s post hoc test. <strong>(E)</strong> S-EVs in PBS were imaged with HS-AFM. EV particles were observed fixed to the substrate. Particles were mainly smaller than those confirmed by Nanosight. <strong>(F)</strong> Change in S-EV particle height over time under five conditions. Height of serum EVs increased in a time-dependent and TTR-concentration-dependent manner. Acid buffer (Acid). All AFM movies were taken at 250&#x000a0;ms/frame. Scanning area was 100 &#x000d7; 100&#x000a0;nm<sup>2</sup> with 80 &#x000d7; 80 pixels. <strong>(G)</strong> Time course of 2D correlation coefficients of the surface of EVs under the above five conditions. The 2D correlation coefficient calculation has been described in the Materials and Methods &#x0201c;Analysis of HS-AFM Images&#x0201d; section in detail. The addition of TTR and an increase in TTR concentration reduced amplitude of the EV surface.</p></div><div class="clear"></div><div class="DottedLine"></div><p class="mb0">As it is difficult to distinguish between S-EVs and lipoprotein impurities by Nanoparticle Tracking Analysis (NTA), it is recommended to combine NTA with microscopic analysis (<a href="#B4">Bachurski et al., 2019</a>). Hence, HS-AFM was used to visually analyze the binding of S-EVs to purified TTR. S-EVs in PBS were fixed to the substrate and were flexibly fluctuated due to their presence in PBS (<a href="#SM1">Supplemental Figure S1</a>). S-EVs with a height of approximately 20&#x000a0;nm in the Z-axis were mainly observed by HS-AFM: The difference in the height of the S-EVs between Nanosight and HS-AFM was thought to be due to the fact that smaller particles diffuse faster and are preferentially anchored to the substrate, and that the core size of particles was small enough to be observed by HS-AFM, but was effectively estimated larger by the existence of molecules outside S-EVs in Nanosight (<a href="#F3">Figure 3E</a>). There have been reports of similar results, including one from our group (<a href="#B47">Woo et al., 2016</a>; <a href="#B25">Lim et al., 2020</a>, <a href="#B26">2021</a>). Furthermore, the detection limit of NTA is about 60&#x000a0;nm (<a href="#B4">Bachurski et al., 2019</a>), and HS-AFM can detect smaller S-EVs that cannot be detected by NTA. The peak particle size in the X&#x02013;Y axis was 8.2&#x000a0;nm (<a href="#F3">Figure 3E</a>). The binding of V30M-TTR to S-EVs was analyzed under acidic conditions. The height of the S-EVs immobilized on the substrate increased in a time-dependent manner and V30M-TTR-concentration-dependent manner (<a href="#F3">Figure 3F</a>). As the increase in the size of the EVs surface has resulted in a decrease in mobility and amplitude, the fluctuations were suppressed when S-EVs and V30M-TTR interacted with correlation coefficients: Notably, the surface mobility of EVs appeared to reduce upon addition of TTR. This was confirmed by the correlation coefficient analysis for the shapes of S-EVs. Thus, the increase in the height of the S-EVs has resulted in a decrease in the surface mobility of S-EVs (<a href="#F3">Figure 3G</a>). These data suggest that purified TTR binds to S-EVs and accumulated on EV membranes.</p><h3 class="pt0">Serum-Derived Extracellular Vesicles are Involved in Transthyretin Aggregation and the Deposition of Transthyretin Aggregates on Cells</h3><p class="mb0">TTR aggregates are deposited on the outside of cells in the stroma. To investigate whether V30M-TTR aggregates were capable of being deposited on the cell periphery, V30M-TTR aggregates, purified V30M-TTR, and S-EVs were added to the culture cells. First, to confirm the pattern of extracellularly deposited V30M-TTR aggregates, a certain amount of V30M-TTR aggregates was added to HEK293T cells. As a result of analysis using TTR aggregate antibodies, almost no deposition signal was detected in cells incubated with S-EVs purified by MagCaputre compared to those incubated with V30M-TTR aggregates (<a href="#F4">Figure 4A</a>). Next, we examined whether TTR was aggregated and deposited around the cells when purified V30M-TTR was added to the cell lines. Specifically, 0.22&#x000a0;&#x003bc;m of filtered purified V30M-TTR was added to HEK293T cells, and TTR aggregates deposited around the cells were detected by the same method, as shown in <a href="#F4">Figure 4A</a>. V30M-TTR aggregates were not detected in V30M-TTR alone to the same extent as in S-EVs (<a href="#F4">Figure 4A</a>). However, when V30M-TTR and S-EVs were simultaneously added, cellular deposition of TTR aggregates was more pronounced than that under other conditions (<a href="#F4">Figure 4B</a>). As PKH-labeled EVs is also likely to observe impurities other than EVs (<a href="#B42">Takov et al., 2017</a>), the analysis was performed using 293T-EVs purified and labeled by spin column after ultracentrifugation followed by MagCapture. V30M with 293T-EVs not only observed the presence of TTR aggregates but also increased EVs uptake (<a href="#F4">Figure 4C</a>). These data indicate that S-EVs promote cell deposition with aggregation of V30M-TTR.</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE 4</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g004.jpg" name="Figure4" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g004.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g004.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g004.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g004.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g004.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g004.jpg" alt="www.frontiersin.org" id="F4" loading="lazy">
  </picture>
</a><p><strong>FIGURE 4</strong>. EVs promote the cell deposition of V30M-TTR, and S-EVs change the degree of TTR aggregation and deposition of TTR aggregates on cell lines. <strong>(A)</strong> TTR aggregates spread on HEK293T. Deposited TTR aggregates were detected by the biotinylated TTR aggregate antibody as red fluorescence in immunocytochemistry. Bars: 100&#x000a0;&#x003bc;m. <strong>(B)</strong> Purified V30M-TTR monomer, V30M-TTR monomer with S-EVs, and S-EVs spread on HEK293T. HEK293T showed red fluorescence in only V30M-TTR with S-EVs in appearance. Bars: 100&#x000a0;&#x003bc;m. <strong>(C)</strong> Purified TTR monomer with 293T-EVs, V30M-TTR monomer with 293T-EVs, and 293T-EVs spread on HEK293T. PKH26-labeled 293T-EVs and purified TTR protein (WT or V30M) were mixed and incubated with 293T cells at 37&#x000b0;C for 24&#x000a0;h. The uptake efficiency of EVs was quantified by PKH (right panel), and TTR aggregates were quantified using anti-aggregated TTR antibody (right panel). TTR aggregates were observed only in the presence of V30M-TTR and EVs under this condition. HEK293T showed green fluorescence in only V30M-TTR with 293T-EVs in appearance. Red fluorescence is indicated PKH-labeled EVs that is purified by ultracentrifugation and Magcapture followed by Exosome Spin Columns. Bars: 40&#x000a0;&#x003bc;m. N &#x0003d; 10, mean &#x000b1; S.E.; &#x0002a;&#x0002a;, <em>p</em> &#x0003c; 0.001; n.s., not significant, ANOVA with Tukey&#x02019;s post hoc test.</p></div><div class="clear"></div><div class="DottedLine"></div><h3 class="pt0">Amount of EV Markers and TTR Aggregates in Serum EVs Differ Between Patients and Controls</h3><p class="mb0">In summary, our results showed that S-EVs contain TTR aggregates (<a href="#F3">Figure 3B</a>) and that TTR aggregation is an important process in the pathogenesis of ATTR amyloidosis. Here, we investigated whether there is a difference in the amount of TTR aggregates and EV markers in S-EVs between patients with hereditary ATTRv amyloidosis and the healthy controls. First, we analyzed TTR aggregates by immunoblotting analysis of the EVs of patients with ATTRv amyloidosis and healthy individuals (N &#x0003d; 6). A higher rate of TTR tetramer and TTR aggregates was observed in the healthy controls (<a href="#F5">Figure 5A</a>). CD9, a marker for EVs, had a high rate of low expression in healthy controls (<a href="#F5">Figure 5A</a>). Next, we performed EV ELISA to quantify the tendency of these TTR aggregates and EV markers. Patient and control serum samples were diluted 2-fold or 16-fold, and EV ELISA was performed using a fixed volume (100&#x000a0;&#x000b5;L) of diluted serum. The absorbance was measured, and the amounts of TTR aggregates and CD63 in the serum EVs were compared. The absorbance of TTR aggregates increased to some extent in the control group, but hardly increased in the patient group (<a href="#F5">Figure 5B</a>). The absorbance of CD63 increased in both groups but was significantly higher in the patient group than in the control group (<a href="#F5">Figure 5B</a>). The amount of TTR aggregates on S-EVs was significantly lower in the patient group than in the healthy group, and the number of EV markers was significantly higher in the patient group than in the healthy group. Taken together, as the uptake of EVs, which promote V30M-TTR aggregation, into cells was increased by the complex of V30M-TTR and EVs (<a href="#F4">Figures 4A&#x02013;C</a>), increased EVs levels in ATTRv amyloidosis could enhance tissue deposition of TTR aggregates, which follows a decrease of TTR aggregates in the serum of patients with ATTRv amyloidosis (<a href="#F5">Figure 5C</a>).</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE 5</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g005.jpg" name="Figure5" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g005.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g005.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g005.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g005.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g005.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g005.jpg" alt="www.frontiersin.org" id="F5" loading="lazy">
  </picture>
</a><p><strong>FIGURE 5</strong>. TTR in Serum-derived EVs is reduced in patients with ATTRv amyloidosis. <strong>(A)</strong> Western blotting analysis of S-EVs derived from patients and controls. TTR ladder bands were more obvious in the controls than in the patients. <strong>(B)</strong> EV ELISA using serum of controls and patients. Absorbance of TTR aggregates was significantly higher in the healthy controls than in the patients with ATTRv amyloidosis, whereas absorbance of CD63 was significantly higher in the patients than in the healthy controls. N &#x0003d; 6, mean &#x000b1; S.E.; &#x0002a;, <em>p</em> &#x0003c; 0.05; &#x0002a;&#x0002a;, <em>p</em> &#x0003c; 0.005, Mann&#x02013;Whitney U test. <strong>(C)</strong> A model of EV-mediated V30M-TTR cell deposition. TTR is mainly produced by the liver and secreted into the bloodstream, but the majority of patients with ATTRv amyloidosis produce TTR with the V30M mutation, which promotes aggregation of V30M-TTR on the membranes of Serum-derived EVs and facilitates deposition on cells and other surfaces, resulting in reduced TTR in Serum-derived EVs for patients with ATTRv amyloidosis. Increasing the amount of EVs in patients with ATTRv amyloidosis could further promote this deposition.</p></div><div class="clear"></div><div class="DottedLine"></div><a id="h5" name="h5"></a><h2>Discussion</h2><p class="mb15">In this study, we showed that TTR present in the blood was also present in serum-derived EVs, and that V30M-TTR aggregation is promoted at the surfaces of membranes such as serum-derived EVs. V30M-TTR aggregation is particularly enhanced in the majority of patients with ATTRv amyloidosis. We also showed that monomeric TTR-V30M promoted aggregation and increased cell deposition in the presence of EVs, even under non-acidic conditions. Compared to healthy subjects, patients with ATTRv amyloidosis showed decreased TTR aggregates and increased EV markers.</p><p class="mb15">In amyloidosis, the aggregation of the major causative protein is promoted on the surface of the EV membrane, which is assumed to alleviate the pathological conditions (<a href="#B49">Yuyama et al., 2012</a>; <a href="#B9">Falker et al., 2016</a>). TTR variant, as a major causative protein, causes TTR aggregation and deposition on specific tissues (<a href="#B5">Bezerra et al., 2020</a>). In this study, we showed <em>via</em> atomic force microscopy that TTR aggregation is promoted by EVs and that TTR multimerizes on the surface of EVs. TTR forms a strong tetramer in serum (<a href="#B19">Kanda et al., 1974</a>) and transports thyroxine and vitamin A through the binding region located in the central channel of the tetramer (<a href="#B36">Saponaro et al., 2020</a>). In ATTRv amyloidosis, variants such as V30M in TTR destabilize the tetrameric structure and facilitate aggregation (<a href="#B17">Saraiva, 1995</a>; <a href="#B39">Sekijima et al., 2005</a>). In this study, the ThT assay and <em>in vitro</em> aggregation assay showed that V30M, a major variant of ATTRv amyloidosis, markedly enhanced TTR aggregation, even in the presence of EVs. The <em>in vitro</em> aggregation of TTR is hindered under neutral conditions and promoted under acidic conditions (<a href="#B7">Colon and Kelly, 1992</a>). Interestingly, in the presence of EVs, TTR aggregation and cell deposition were promoted in this study, even under non-acidic conditions. The addition of purified V30M monomer alone did not cause TTR aggregation, as was observed for the addition of EVs alone as a control, suggesting that EVs did in fact induce TTR aggregation.</p><p class="mb15">In Alzheimer&#x02019;s disease, EVs remove A&#x003b2;, which is a toxic molecule in the brain (<a href="#B32">P&#x000e9;rez-Gonz&#x000e1;lez et al., 2020</a>). EV proteins accumulate in the brain plaque of patients with Alzheimer&#x02019;s disease, suggesting their strong involvement in the pathogenesis of this disease (<a href="#B34">Rajendran et al., 2006</a>). The enhanced cellular deposition of TTR aggregates by EVs indicates that the EV-mediated tissue deposition of TTR aggregates may be involved in ATTRv amyloidosis as well as Alzheimer&#x02019;s disease. In fact, the amount of EV markers in serum was significantly higher in patients with ATTRv amyloidosis than in healthy subjects. This suggests that EVs may be actively involved in ATTRv amyloidosis. However, although TTR can be transported throughout the body by the bloodstream, TTR aggregate deposits are found in specific tissues. Various membrane proteins are present on the surface of EV membranes, where they act on specific cells (<a href="#B16">Hoshino et al., 2015</a>). Therefore, it is possible that tissue-specific deposition of TTR amyloid is mediated by the EV pathway. A detailed analysis of TTR aggregation in the EV pathway will help further elucidate the pathogenesis of ATTRv amyloidosis.</p><p class="mb15">TTR has been implicated in dementia, whereby a lack of TTR can exacerbate cognitive impairment (<a href="#B41">Sousa et al., 2004</a>). With regard to Alzheimer&#x02019;s disease in amyloidosis with dementia, reduced TTR levels have been detected in both the cerebrospinal fluid and plasma of patients with Alzheimer&#x02019;s disease (<a href="#B14">Han et al., 2011</a>; <a href="#B36">Saponaro et al., 2020</a>) and in subjects with mild cognitive impairment, becoming more pronounced as the disease progresses. A&#x003b2;, which is the major causative protein of Alzheimer&#x02019;s disease, and TTR have also been analyzed molecularly. For example, TTR inhibits the primary and secondary nucleation of A&#x003b2; aggregation, restricting each the toxicity of A&#x003b2; oligomers and the proliferative ability of fibrils (<a href="#B11">Ghadami et al., 2020</a>; <a href="#B12">Gi&#x000e3;o et al., 2020</a>), as well as the proteolytic activity of A&#x003b2; (<a href="#B36">Saponaro et al., 2020</a>). In other words, TTR can bind to A&#x003b2; and inhibit A&#x003b2; aggregation and toxicity, suggesting a protecting role for TTR in Alzheimer&#x02019;s disease (<a href="#B37">Schwarzman et al., 1994</a>). As A&#x003b2; promotes aggregation at the surface of EV membranes (<a href="#B49">Yuyama et al., 2012</a>), it appears consistent with the phenomenon of TTR observed in this study. TTR is expressed in the choroid plexus in the brain (Sakai et al., 2017) in addition to the liver and A&#x003b2; is also expressed in EVs in serum across the brain blood barrier (<a href="#B24">Lim et al., 2019</a>), suggesting that A&#x003b2; and TTR can transfer fluidly through EVs. Thus, the targeting of A&#x003b2; degradation and A&#x003b2; aggregation inhibition in the brain <em>via</em> EVs and TTR could represent a new therapeutic candidate for Alzheimer&#x02019;s disease. Therefore, it is necessary to further analyze the relationship between TTR and A&#x003b2; in EVs derived from the brain, in addition to EVs derived from the liver and other blood sources.</p><a id="h6" name="h6"></a><h2>Data Availability Statement</h2><p class="mb15">The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.</p><a id="h7" name="h7"></a><h2>Ethics Statement</h2><p class="mb0">The studies involving human participants were reviewed and approved by the Kanzawa University Ethics Committee Reference. The patients/participants provided their written informed consent to participate in this study.</p><a id="h8" name="h8"></a><h2>Author Contributions</h2><p class="mb0">HY, HK, MY, and RH designed the experiments. HY, HK, NK, AK, YT, and ZT performed the experiments. HY, HK, NK, and RH analyzed the data. HY, HK, AK, YT, and RH drafted the manuscript. KS, KO, MY, and RH supervised the study.</p><a id="h9" name="h9"></a><h2>Funding</h2><p class="mb0">This work was supported by Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST) (No. JPMJCR18H4 to RH), Grants-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (No. 19K22578 to RH, No. 15K06710 to HK), and a NanoLSI Transdisciplinary Research Promotion Grant in FY 2018 (HY, HK, and NK).</p><a id="h10" name="h10"></a><h2>Conflict of Interest</h2><p class="mb0">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p><a id="h11" name="h11"></a><h2>Publisher&#x02019;s Note</h2><p class="mb15">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p><a id="h12" name="h12"></a><h2>Acknowledgments</h2><p class="mb03">We are grateful to Dr. S. Horike for technical advice (Research Center for Experimental Modeling of Human Disease, Kanazawa University); Dr. T. Ando for technical support of HS-AFM analysis (Kanazawa University).</p><a id="h13" name="h13"></a><h2>Supplementary Material</h2><p class="mb15" id="SM1">The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fmolb.2022.839917/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmolb.2022.839917/full&#x00023;supplementary-material</a></p><a id="h14" name="h14"></a><h2>References</h2><div class="References"><p class="ReferencesCopy1"><a name="B1" id="B1"></a>Agostinho, P., A. Cunha, R., and Oliveira, C. (2010). Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimers Disease. <em>Cpd</em> 16, 2766&#x02013;2778. doi:10.2174/138161210793176572</p><p class="ReferencesCopy2"><a href="https://doi.org/10.2174/138161210793176572">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Neuroinflammation,+Oxidative+Stress+and+the+Pathogenesis+of+Alzheimers+Disease&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B2" id="B2"></a>Ando, T., Uchihashi, T., and Kodera, N. (2013). High-speed AFM and Applications to Biomolecular Systems. <em>Annu. Rev. Biophys.</em> 42, 393&#x02013;414. doi:10.1146/annurev-biophys-083012-130324</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/23541159/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1146/annurev-biophys-083012-130324">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=High-speed+AFM+and+Applications+to+Biomolecular+Systems&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B3" id="B3"></a>Ando, Y., Suhr, O., and el-Salhy, M. (1998). Oxidative Stress and Amyloidosis. <em>Histol. Histopathol</em> 13, 845&#x02013;850. doi:10.14670/HH-13.845</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/9690141/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.14670/HH-13.845">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Oxidative+Stress+and+Amyloidosis&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B4" id="B4"></a>Bachurski, D., Schuldner, M., Nguyen, P.-H., Malz, A., Reiners, K. S., Grenzi, P. C., et al. (2019). Extracellular Vesicle Measurements with Nanoparticle Tracking Analysis - an Accuracy and Repeatability Comparison between NanoSight NS300 and ZetaView. <em>J. Extracellular Vesicles</em> 8, 1596016. doi:10.1080/20013078.2019.1596016</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30988894/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1080/20013078.2019.1596016">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Extracellular+Vesicle+Measurements+with+Nanoparticle+Tracking+Analysis+-+an+Accuracy+and+Repeatability+Comparison+between+NanoSight+NS300+and+ZetaView&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B5" id="B5"></a>Bezerra, F., Saraiva, M. J., and Almeida, M. R. (2020). Modulation of the Mechanisms Driving Transthyretin Amyloidosis. <em>Front. Mol. Neurosci.</em> 13, 592644. doi:10.3389/fnmol.2020.592644</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33362465/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3389/fnmol.2020.592644">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Modulation+of+the+Mechanisms+Driving+Transthyretin+Amyloidosis&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B6" id="B6"></a>Buxbaum, J. N., and Linke, R. P. (2012). A Molecular History of the Amyloidoses. <em>J. Mol. Biol.</em> 421, 142&#x02013;159. doi:10.1016/j.jmb.2012.01.024</p><p class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.jmb.2012.01.024">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=A+Molecular+History+of+the+Amyloidoses&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B7" id="B7"></a>Colon, W., and Kelly, J. W. (1992). Partial Denaturation of Transthyretin Is Sufficient for Amyloid Fibril Formation <em>In Vitro</em>. <em>Biochemistry</em> 31, 8654&#x02013;8660. doi:10.1021/bi00151a036</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/1390650/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1021/bi00151a036">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Partial+Denaturation+of+Transthyretin+Is+Sufficient+for+Amyloid+Fibril+Formation+In+Vitro&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B8" id="B8"></a>Dong, R., Liu, Y., Yang, Y., Wang, H., Xu, Y., and Zhang, Z. (2019). MSC-derived Exosomes-Based Therapy for Peripheral Nerve Injury: A Novel Therapeutic Strategy. <em>Biomed. Res. Int.</em> 2019, 1&#x02013;12. doi:10.1155/2019/6458237</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31531362/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1155/2019/6458237">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=MSC-derived+Exosomes-Based+Therapy+for+Peripheral+Nerve+Injury:+A+Novel+Therapeutic+Strategy&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B9" id="B9"></a>Falker, C., Hartmann, A., Guett, I., Dohler, F., Altmeppen, H., Betzel, C., et al. (2016). Exosomal Cellular Prion Protein Drives Fibrillization of Amyloid Beta and Counteracts Amyloid Beta-Mediated Neurotoxicity. <em>J. Neurochem.</em> 137, 88&#x02013;100. doi:10.1111/jnc.13514</p><p class="ReferencesCopy2"><a href="https://doi.org/10.1111/jnc.13514">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Exosomal+Cellular+Prion+Protein+Drives+Fibrillization+of+Amyloid+Beta+and+Counteracts+Amyloid+Beta-Mediated+Neurotoxicity&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B10" id="B10"></a>Fan, B., Chopp, M., Zhang, Z. G., and Liu, X. S. (2021). Treatment of Diabetic Peripheral Neuropathy with Engineered Mesenchymal Stromal Cell-Derived Exosomes Enriched with microRNA-146a Provide Amplified Therapeutic Efficacy. <em>Exp. Neurol.</em> 341, 113694. doi:10.1016/j.expneurol.2021.113694</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33727097/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.expneurol.2021.113694">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Treatment+of+Diabetic+Peripheral+Neuropathy+with+Engineered+Mesenchymal+Stromal+Cell-Derived+Exosomes+Enriched+with+microRNA-146a+Provide+Amplified+Therapeutic+Efficacy&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B11" id="B11"></a>Ghadami, S. A., Chia, S., Ruggeri, F. S., Meisl, G., Bemporad, F., Habchi, J., et al. (2020). Transthyretin Inhibits Primary and Secondary Nucleations of Amyloid-&#x003b2; Peptide Aggregation and Reduces the Toxicity of its Oligomers. <em>Biomacromolecules</em> 21, 1112&#x02013;1125. doi:10.1021/acs.biomac.9b01475</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32011129/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1021/acs.biomac.9b01475">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Transthyretin+Inhibits+Primary+and+Secondary+Nucleations+of+Amyloid-+Peptide+Aggregation+and+Reduces+the+Toxicity+of+its+Oligomers&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B12" id="B12"></a>Gi&#x000e3;o, T., Saavedra, J., Cotrina, E., Quintana, J., Llop, J., Arsequell, G., et al. (2020). Undiscovered Roles for Transthyretin: From a Transporter Protein to a New Therapeutic Target for Alzheimer&#x00027;s Disease. <em>Ijms</em> 21, 2075. doi:10.3390/ijms21062075</p><p class="ReferencesCopy2"><a href="https://doi.org/10.3390/ijms21062075">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Undiscovered+Roles+for+Transthyretin:+From+a+Transporter+Protein+to+a+New+Therapeutic+Target+for+Alzheimer's+Disease&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B13" id="B13"></a>Gomperts, S. N. (2016). Lewy Body Dementias. <em>CONTINUUM: Lifelong Learn. Neurol.</em> 22, 435&#x02013;463. doi:10.1212/CON.0000000000000309</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27042903/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1212/CON.0000000000000309">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Lewy+Body+Dementias&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B14" id="B14"></a>Han, S.-H., Jung, E. S., Sohn, J.-H., Hong, H. J., Hong, H. S., Kim, J. W., et al. (2011). Human Serum Transthyretin Levels Correlate Inversely with Alzheimer&#x00027;s Disease. <em>Jad</em> 25, 77&#x02013;84. doi:10.3233/JAD-2011-102145</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/21335655/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3233/JAD-2011-102145">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Human+Serum+Transthyretin+Levels+Correlate+Inversely+with+Alzheimer's+Disease&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B15" id="B15"></a>Hashimoto, T., Fujii, D., Naka, Y., Kashiwagi-Hakozaki, M., Matsuo, Y., Matsuura, Y., et al. (2020). Collagenous Alzheimer Amyloid Plaque Component Impacts on the Compaction of Amyloid-&#x003b2; Plaques. <em>Acta Neuropathol. Commun.</em> 8, 212. doi:10.1186/s40478-020-01075-5</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33287899/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1186/s40478-020-01075-5">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Collagenous+Alzheimer+Amyloid+Plaque+Component+Impacts+on+the+Compaction+of+Amyloid-+Plaques&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B16" id="B16"></a>Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., et al. (2015). Tumour Exosome Integrins Determine Organotropic Metastasis. <em>Nature</em> 527, 329&#x02013;335. doi:10.1038/nature15756</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26524530/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/nature15756">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Tumour+Exosome+Integrins+Determine+Organotropic+Metastasis&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B17" id="B17"></a>Jo&#x000e3;o, M., and Saraiva, M. (1995). Transthyretin Mutations in Health and Disease. <em>Hum. Mutat.</em> 5, 191&#x02013;196. doi:10.1002/humu.1380050302</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/7599630/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1002/humu.1380050302">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Transthyretin+Mutations+in+Health+and+Disease&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B18" id="B18"></a>Kalluri, R., and LeBleu, V. S. (2020). The Biology , Function , and Biomedical Applications of Exosomes. <em>Science</em> 367, eaau6977. doi:10.1126/science.aau6977</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32029601/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1126/science.aau6977">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+Biology+,+Function+,+and+Biomedical+Applications+of+Exosomes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B19" id="B19"></a>Kanda, Y., Goodman, D. S., Canfield, R. E., and Morgan, F. J. (1974). The Amino Acid Sequence of Human Plasma Prealbumin. <em>J. Biol. Chem.</em> 249, 6796&#x02013;6805. doi:10.1016/s0021-9258(19)42128-5</p><p class="ReferencesCopy2"><a href="https://doi.org/10.1016/s0021-9258(19)42128-5">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+Amino+Acid+Sequence+of+Human+Plasma+Prealbumin&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B20" id="B20"></a>Kawahara, H., Imai, T., Imataka, H., Tsujimoto, M., Matsumoto, K., and Okano, H. (2008). Neural RNA-Binding Protein Musashi1 Inhibits Translation Initiation by Competing with eIF4G for PABP. <em>J. Cell Biol.</em> 181, 639&#x02013;653. doi:10.1083/jcb.200708004</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/18490513/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1083/jcb.200708004">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Neural+RNA-Binding+Protein+Musashi1+Inhibits+Translation+Initiation+by+Competing+with+eIF4G+for+PABP&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B21" id="B21"></a>Kawahara, H., Okada, Y., Imai, T., Iwanami, A., Mischel, P. S., and Okano, H. (2011). Musashi1 Cooperates in Abnormal Cell Lineage Protein 28 (Lin28)-Mediated Let-7 Family microRNA Biogenesis in Early Neural Differentiation. <em>J. Biol. Chem.</em> 286, 16121&#x02013;16130. doi:10.1074/jbc.M110.199166</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/21378162/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1074/jbc.M110.199166">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Musashi1+Cooperates+in+Abnormal+Cell+Lineage+Protein+28+(Lin28)-Mediated+Let-7+Family+microRNA+Biogenesis+in+Early+Neural+Differentiation&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B22" id="B22"></a>Kodera, N., Abe, H., Nguyen, P. D. N., and Ono, S. (2021). Native Cyclase-Associated Protein and Actin from <em>Xenopus laevis</em> Oocytes Form a Unique 4:4 Complex with a Tripartite Structure. <em>J. Biol. Chem.</em> 296, 100649. doi:10.1016/j.jbc.2021.100649</p><p class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.jbc.2021.100649">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Native+Cyclase-Associated+Protein+and+Actin+from+Xenopus+laevis+Oocytes+Form+a+Unique+4:4+Complex+with+a+Tripartite+Structure&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B23" id="B23"></a>Kori, S., Ferry, L., Matano, S., Jimenji, T., Kodera, N., Tsusaka, T., et al. (2019). Structure of the UHRF1 Tandem Tudor Domain Bound to a Methylated Non-histone Protein, LIG1, Reveals Rules for Binding and Regulation. <em>Structure</em> 27, 485&#x02013;496. doi:10.1016/j.str.2018.11.012</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30639225/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.str.2018.11.012">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Structure+of+the+UHRF1+Tandem+Tudor+Domain+Bound+to+a+Methylated+Non-histone+Protein,+LIG1,+Reveals+Rules+for+Binding+and+Regulation&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B24" id="B24"></a>Lim, C. Z. J., Zhang, Y., Chen, Y., Zhao, H., Stephenson, M. C., Ho, N. R. Y., et al. (2019). Subtyping of Circulating Exosome-Bound Amyloid &#x003b2; Reflects Brain Plaque Deposition. <em>Nat. Commun.</em> 10, 1144. doi:10.1038/s41467-019-09030-2</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30850633/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/s41467-019-09030-2">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Subtyping+of+Circulating+Exosome-Bound+Amyloid++Reflects+Brain+Plaque+Deposition&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B25" id="B25"></a>Lim, K., Kodera, N., Wang, H., Mohamed, M. S., Hazawa, M., Kobayashi, A., et al. (2020). High-Speed AFM Reveals Molecular Dynamics of Human Influenza A Hemagglutinin and its Interaction with Exosomes. <em>Nano Lett.</em> 20, 6320&#x02013;6328. doi:10.1021/acs.nanolett.0c01755</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32787163/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1021/acs.nanolett.0c01755">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=High-Speed+AFM+Reveals+Molecular+Dynamics+of+Human+Influenza+A+Hemagglutinin+and+its+Interaction+with+Exosomes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B26" id="B26"></a>Lim, K., Nishide, G., Yoshida, T., Watanabe&#x02010;Nakayama, T., Kobayashi, A., Hazawa, M., et al. (2021). Millisecond Dynamic of SARS&#x02010;CoV&#x02010;2 Spike and its Interaction with ACE2 Receptor and Small Extracellular Vesicles. <em>J. Extracellular Vesicle</em> 10, e12170. doi:10.1002/jev2.12170</p><p class="ReferencesCopy2"><a href="https://doi.org/10.1002/jev2.12170">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Millisecond+Dynamic+of+SARSCoV2+Spike+and+its+Interaction+with+ACE2+Receptor+and+Small+Extracellular+Vesicles&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B27" id="B27"></a>Merlini, G., Seldin, D. C., and Gertz, M. A. (2011). Amyloidosis: Pathogenesis and New Therapeutic Options. <em>Jco</em> 29, 1924&#x02013;1933. doi:10.1200/JCO.2010.32.2271</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/21483018/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1200/JCO.2010.32.2271">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Amyloidosis:+Pathogenesis+and+New+Therapeutic+Options&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B28" id="B28"></a>Nakai, W., Yoshida, T., Diez, D., Miyatake, Y., Nishibu, T., Imawaka, N., et al. (2016). A Novel Affinity-Based Method for the Isolation of Highly Purified Extracellular Vesicles. <em>Sci. Rep.</em> 6, 33935. doi:10.1038/srep33935</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27659060/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/srep33935">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=A+Novel+Affinity-Based+Method+for+the+Isolation+of+Highly+Purified+Extracellular+Vesicles&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B29" id="B29"></a>Ngo, K. X., Kodera, N., Katayama, E., Ando, T., and Uyeda, T. Q. (2015). Cofilin-induced Unidirectional Cooperative Conformational Changes in Actin Filaments Revealed by High-Speed Atomic Force Microscopy. <em>Elife</em> 4. doi:10.7554/eLife.04806</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25642645/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.7554/eLife.04806">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Cofilin-induced+Unidirectional+Cooperative+Conformational+Changes+in+Actin+Filaments+Revealed+by+High-Speed+Atomic+Force+Microscopy&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B30" id="B30"></a>Nonaka, S., Salim, E., Kamiya, K., Hori, A., Nainu, F., Asri, R. M., et al. (2020). Molecular and Functional Analysis of Pore-Forming Toxin Monalysin from Entomopathogenic Bacterium Pseudomonas Entomophila. <em>Front. Immunol.</em> 11, 520. doi:10.3389/fimmu.2020.00520</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32292407/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3389/fimmu.2020.00520">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Molecular+and+Functional+Analysis+of+Pore-Forming+Toxin+Monalysin+from+Entomopathogenic+Bacterium+Pseudomonas+Entomophila&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B31" id="B31"></a>On&#x000f3;di, Z., Pelyhe, C., Ter&#x000e9;zia Nagy, C., Brenner, G. B., Alm&#x000e1;si, L., Kittel, &#x000c1;., et al. (2018). Isolation of High-Purity Extracellular Vesicles by the Combination of Iodixanol Density Gradient Ultracentrifugation and Bind-Elute Chromatography from Blood Plasma. <em>Front. Physiol.</em> 9, 1479. doi:10.3389/fphys.2018.01479</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30405435/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3389/fphys.2018.01479">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Isolation+of+High-Purity+Extracellular+Vesicles+by+the+Combination+of+Iodixanol+Density+Gradient+Ultracentrifugation+and+Bind-Elute+Chromatography+from+Blood+Plasma&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B32" id="B32"></a>P&#x000e9;rez&#x02010;Gonz&#x000e1;lez, R., Kim, Y., Miller, C., Pacheco&#x02010;Quinto, J., Eckman, E. A., and Levy, E. (2020). Extracellular Vesicles: where the Amyloid Precursor Protein Carboxyl&#x02010;terminal Fragments Accumulate and Amyloid&#x02010;&#x003b2; Oligomerizes. <em>FASEB j.</em> 34, 12922&#x02013;12931. doi:10.1096/fj.202000823R</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32772431/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1096/fj.202000823R">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Extracellular+Vesicles:+where+the+Amyloid+Precursor+Protein+Carboxylterminal+Fragments+Accumulate+and+Amyloid+Oligomerizes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B33" id="B33"></a>Picken, M. M. (2020). The Pathology of Amyloidosis in Classification: A Review. <em>Acta Haematol.</em> 143, 322&#x02013;334. doi:10.1159/000506696</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32392555/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1159/000506696">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+Pathology+of+Amyloidosis+in+Classification:+A+Review&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B34" id="B34"></a>Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., et al. (2006). Alzheimer&#x00027;s Disease Beta-Amyloid Peptides Are Released in Association with Exosomes. <em>Proc. Natl. Acad. Sci.</em> 103, 11172&#x02013;11177. doi:10.1073/pnas.0603838103</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/16837572/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1073/pnas.0603838103">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Alzheimer's+Disease+Beta-Amyloid+Peptides+Are+Released+in+Association+with+Exosomes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B35" id="B35"></a>Saito, S., Ando, Y., Nakamura, M., Ueda, M., Kim, J., Ishima, Y., et al. (2005). Effect of Nitric Oxide in Amyloid Fibril Formation on Transthyretin-Related Amyloidosis. <em>Biochemistry</em> 44, 11122&#x02013;11129. doi:10.1021/bi050327i</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/16101296/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1021/bi050327i">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Effect+of+Nitric+Oxide+in+Amyloid+Fibril+Formation+on+Transthyretin-Related+Amyloidosis&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B36" id="B36"></a>Saponaro, F., Kim, J. H., and Chiellini, G. (2020). Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer&#x00027;s Disease? <em>Ijms</em> 21, 8672. doi:10.3390/ijms21228672</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33212973/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3390/ijms21228672">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Transthyretin+Stabilization:+An+Emerging+Strategy+for+the+Treatment+of+Alzheimer's+Disease?&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B37" id="B37"></a>Schwarzman, A. L., Gregori, L., Vitek, M. P., Lyubski, S., Strittmatter, W. J., Enghilde, J. J., et al. (1994). Transthyretin Sequesters Amyloid Beta Protein and Prevents Amyloid Formation. <em>Proc. Natl. Acad. Sci.</em> 91, 8368&#x02013;8372. doi:10.1073/pnas.91.18.8368</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/8078889/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1073/pnas.91.18.8368">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Transthyretin+Sequesters+Amyloid+Beta+Protein+and+Prevents+Amyloid+Formation&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B38" id="B38"></a>Sekijima, Y., Ueda, M., Koike, H., Misawa, S., Ishii, T., and Ando, Y. (2018). Diagnosis and Management of Transthyretin Familial Amyloid Polyneuropathy in Japan: Red-Flag Symptom Clusters and Treatment Algorithm. <em>Orphanet J. Rare Dis.</em> 13, 6. doi:10.1186/s13023-017-0726-x</p><p class="ReferencesCopy2"><a href="https://doi.org/10.1186/s13023-017-0726-x">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Diagnosis+and+Management+of+Transthyretin+Familial+Amyloid+Polyneuropathy+in+Japan:+Red-Flag+Symptom+Clusters+and+Treatment+Algorithm&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B39" id="B39"></a>Sekijima, Y., Wiseman, R. L., Matteson, J., Hammarstr&#x000f6;m, P., Miller, S. R., Sawkar, A. R., et al. (2005). The Biological and Chemical Basis for Tissue-Selective Amyloid Disease. <em>Cell</em> 121, 73&#x02013;85. doi:10.1016/j.cell.2005.01.018</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/15820680/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.cell.2005.01.018">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+Biological+and+Chemical+Basis+for+Tissue-Selective+Amyloid+Disease&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B40" id="B40"></a>Sipe, J. D., and Cohen, A. S. (2000). Review: History of the Amyloid Fibril. <em>J. Struct. Biol.</em> 130, 88&#x02013;98. doi:10.1006/jsbi.2000.4221</p><p class="ReferencesCopy2"><a href="https://doi.org/10.1006/jsbi.2000.4221">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Review:+History+of+the+Amyloid+Fibril&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B41" id="B41"></a>Sousa, J. C., Grandela, C., Fern&#x000e1;ndez-Ruiz, J., de Miguel, R., de Sousa, L., Magalh&#x000e3;es, A. I., et al. (2004). Transthyretin Is Involved in Depression-like Behaviour and Exploratory Activity. <em>J. Neurochem.</em> 88, 1052&#x02013;1058. doi:10.1046/j.1471-4159.2003.02309.x</p><p class="ReferencesCopy2"><a href="https://doi.org/10.1046/j.1471-4159.2003.02309.x">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Transthyretin+Is+Involved+in+Depression-like+Behaviour+and+Exploratory+Activity&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B42" id="B42"></a>Takov, K., Yellon, D. M., and Davidson, S. M. (2017). Confounding Factors in Vesicle Uptake Studies Using Fluorescent Lipophilic Membrane Dyes. <em>J. Extracellular Vesicles</em> 6, 1388731. doi:10.1080/20013078.2017.1388731</p><p class="ReferencesCopy2"><a href="https://doi.org/10.1080/20013078.2017.1388731">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Confounding+Factors+in+Vesicle+Uptake+Studies+Using+Fluorescent+Lipophilic+Membrane+Dyes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B43" id="B43"></a>Tangthavewattana, S., Leelawatwattana, L., and Prapunpoj, P. (2019). The Hydrophobic C&#x02010;terminal Sequence of Transthyretin Affects its Catalytic Kinetics towards Amidated Neuropeptide Y. <em>FEBS Open Bio</em> 9, 594&#x02013;604. doi:10.1002/2211-5463.12604</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30984535/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1002/2211-5463.12604">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+Hydrophobic+Cterminal+Sequence+of+Transthyretin+Affects+its+Catalytic+Kinetics+towards+Amidated+Neuropeptide+Y&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B44" id="B44"></a>Tasaki, M., Ueda, M., Ochiai, S., Tanabe, Y., Murata, S., Misumi, Y., et al. (2010). Transmission of Circulating Cell-free AA Amyloid Oligomers in Exosomes Vectors via a Prion-like Mechanism. <em>Biochem. Biophysical Res. Commun.</em> 400, 559&#x02013;562. doi:10.1016/j.bbrc.2010.08.101</p><p class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.bbrc.2010.08.101">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Transmission+of+Circulating+Cell-free+AA+Amyloid+Oligomers+in+Exosomes+Vectors+via+a+Prion-like+Mechanism&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B45" id="B45"></a>Tong, M., Cheng, S.-B., Chen, Q., DeSousa, J., Stone, P. R., James, J. L., et al. (2017). Aggregated Transthyretin Is Specifically Packaged into Placental Nano-Vesicles in Preeclampsia. <em>Sci. Rep.</em> 7, 6694. doi:10.1038/s41598-017-07017-x</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28751735/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/s41598-017-07017-x">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Aggregated+Transthyretin+Is+Specifically+Packaged+into+Placental+Nano-Vesicles+in+Preeclampsia&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B46" id="B46"></a>Uchihashi, T., Kodera, N., and Ando, T. (2012). Guide to Video Recording of Structure Dynamics and Dynamic Processes of Proteins by High-Speed Atomic Force Microscopy. <em>Nat. Protoc.</em> 7, 1193&#x02013;1206. doi:10.1038/nprot.2012.047</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/22635111/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/nprot.2012.047">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Guide+to+Video+Recording+of+Structure+Dynamics+and+Dynamic+Processes+of+Proteins+by+High-Speed+Atomic+Force+Microscopy&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B47" id="B47"></a>Woo, J., Sharma, S., and Gimzewski, J. (2016). The Role of Isolation Methods on a Nanoscale Surface Structure and its Effect on the Size of Exosomes. <em>J. Circulating Biomarkers</em> 5, 11. doi:10.5772/64148</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28936259/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.5772/64148">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+Role+of+Isolation+Methods+on+a+Nanoscale+Surface+Structure+and+its+Effect+on+the+Size+of+Exosomes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B48" id="B48"></a>Yee, A. W., Aldeghi, M., Blakeley, M. P., Ostermann, A., Mas, P. J., Moulin, M., et al. (2019). A Molecular Mechanism for Transthyretin Amyloidogenesis. <em>Nat. Commun.</em> 10, 925. doi:10.1038/s41467-019-08609-z</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30804345/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/s41467-019-08609-z">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=A+Molecular+Mechanism+for+Transthyretin+Amyloidogenesis&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B49" id="B49"></a>Yuyama, K., Sun, H., Mitsutake, S., and Igarashi, Y. (2012). Sphingolipid-modulated Exosome Secretion Promotes Clearance of Amyloid-&#x003b2; by Microglia. <em>J. Biol. Chem.</em> 287, 10977&#x02013;10989. doi:10.1074/jbc.M111.324616</p><p class="ReferencesCopy2"><a href="https://doi.org/10.1074/jbc.M111.324616">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Sphingolipid-modulated+Exosome+Secretion+Promotes+Clearance+of+Amyloid-+by+Microglia&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B50" id="B50"></a>Yuyama, K., Sun, H., Sakai, S., Mitsutake, S., Okada, M., Tahara, H., et al. (2014). Decreased Amyloid-&#x003b2; Pathologies by Intracerebral Loading of Glycosphingolipid-Enriched Exosomes in Alzheimer Model Mice. <em>J. Biol. Chem.</em> 289, 24488&#x02013;24498. doi:10.1074/jbc.M114.577213</p><p class="ReferencesCopy2"><a href="https://doi.org/10.1074/jbc.M114.577213">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Decreased+Amyloid-+Pathologies+by+Intracerebral+Loading+of+Glycosphingolipid-Enriched+Exosomes+in+Alzheimer+Model+Mice&amp;btnG=">Google Scholar</a></p></div></div><div class="thinLineM20"></div><div class="AbstractSummary"><p><span>Keywords:</span> amyloidosis, transthyretin, extracellular vesicle, ATTRv amyloidosis, atomic force microscope</p><p><span>Citation:</span> Yamaguchi H, Kawahara H, Kodera N, Kumaki A, Tada Y, Tang Z, Sakai K, Ono K, Yamada M and Hanayama R (2022) Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis. <em>Front. Mol. Biosci.</em> 9:839917. doi: 10.3389/fmolb.2022.839917</p><p id="timestamps"><span>Received:</span> 20 December 2021; <span>Accepted:</span> 22 February 2022;<br><span>Published:</span> 23 March 2022.</p><div><p>Edited by:</p> <a href="https://loop.frontiersin.org/people/822476/overview">Chiara Porro</a>, University of Foggia, Italy</div><div><p>Reviewed by:</p> <a href="https://loop.frontiersin.org/people/104701/overview">Mauro Manno</a>, National Research Council (CNR), Italy<br><a href="https://loop.frontiersin.org/people/1193304/overview">Gefei Chen</a>, Karolinska Institutet (KI), Sweden</div><p><span>Copyright</span> &#x000a9; 2022 Yamaguchi, Kawahara, Kodera, Kumaki, Tada, Tang, Sakai, Ono, Yamada and Hanayama. This is an open-access article distributed under the terms of the <a rel="license" href="http://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License (CC BY).</a> The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p><p><span>&#x0002a;Correspondence:</span> Hironori Kawahara, <a id="encmail">a2F3YWhhcmFAbWVkLmthbmF6YXdhLXUuYWMuanA=</a>; Rikinari Hanayama, <a id="encmail">aGFuYXlhbWFAbWVkLmthbmF6YXdhLXUuYWMuanA=</a></p><div class="clear"></div></div></div></div><p class="AbstractSummary__disclaimer"><span>Disclaimer: </span> All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. </p></div></div><!----></main><aside class="Layout__aside"><div class="ArticleDetails__wrapper"><div class="ArticleDetails__aside"><div class="ArticleDetails__aside__responsiveButtons"><div class="ActionsDropDown" id="FloatingButtonsEl"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--icon ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fmolb.2022.839917" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="ArticleDetails__aside__responsiveButtons__items"><span></span><div class="ArticleDetailsShare__responsive"><button class="ArticleDetailsShare__trigger" aria-label="Open share options"></button><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div></div><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeIconButton ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><!----></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Export citation</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div></div></div><div class="TotalViews"><div class="TotalViews__data"><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">5,3K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Total views</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">1,4K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Downloads</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">7</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Citations</div></div></div><div class="ImpactMetricsInfoPopover"><button aria-label="Open impact metrics info" class="ImpactMetricsInfoPopover__button"></button><div class="ImpactMetricsInfoPopover__tooltip"><button aria-label="Close impact metrics info" class="ImpactMetricsInfoPopover__tooltip__closeButton"></button><div class="ImpactMetricsInfoPopover__tooltip__text"> Citation numbers are available from Dimensions </div></div></div></div><div class="TotalViews__viewImpactLink"><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View article impact" href="http://loop-impact.frontiersin.org/impact/article/839917#totalviews/views" target="_blank" data-event="customLink-link-a_viewArticleImpact"><span>View article impact</span></a></span></div><div class="TotalViews__altmetric"><div data-badge-popover="bottom" data-badge-type="donut" data-doi="10.3389/fmolb.2022.839917" data-condensed="true" data-link-target="new" class="altmetric-embed"></div><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View altmetric score" href="https://www.altmetric.com/details/doi/10.3389/fmolb.2022.839917" target="_blank" data-event="customLink-link-a_viewAltmetricScore"><span>View altmetric score</span></a></span></div></div><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Edited by</div><!--[--><a href="https://loop.frontiersin.org/people/822476/overview" data-event="editorInfo-a-chiaraPorro" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">C</span><span class="notranslate">P</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Chiara  Porro</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">University of Foggia, Italy</div></div></a><!--]--></div></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Reviewed by</div><!--[--><a href="https://loop.frontiersin.org/people/104701/overview" data-event="editorInfo-a-mauroManno" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">M</span><span class="notranslate">M</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Mauro  Manno</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">National Research Council (CNR), Italy</div></div></a><a href="https://loop.frontiersin.org/people/1193304/overview" data-event="editorInfo-a-gefeiChen" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">G</span><span class="notranslate">C</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Gefei  Chen</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">Karolinska Institutet (KI), Sweden</div></div></a><!--]--></div></div><div class="ArticleDetailsGlossary ArticleDetailsGlossary--open"><button class="ArticleDetailsGlossary__header"><div class="ArticleDetailsGlossary__header__title">Table of contents</div><div class="ArticleDetailsGlossary__header__arrow"></div></button><div class="ArticleDetailsGlossary__content"><ul class="flyoutJournal"><li><a href="#h1">Abstract</a></li><li><a href="#h2">Introduction</a></li><li><a href="#h3">Materials and Methods</a></li><li><a href="#h4">Results</a></li><li><a href="#h5">Discussion</a></li><li><a href="#h6">Data Availability Statement</a></li><li><a href="#h7">Ethics Statement</a></li><li><a href="#h8">Author Contributions</a></li><li><a href="#h9">Funding</a></li><li><a href="#h10">Conflict of Interest</a></li><li><a href="#h11">Publisher&#x02019;s Note</a></li><li><a href="#h12">Acknowledgments</a></li><li><a href="#h13">Supplementary Material</a></li><li><a href="#h14">References</a></li></ul></div></div><span></span><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeOutline ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Export citation</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="CheckForUpdates"><button data-target="crossmark" class="CheckForUpdates__link" data-event="checkForUpdates-btn-openModal"><img class="CheckForUpdates__link__img" src="/ap-2024/images/crossmark.svg" alt="Crossmark icon"><div class="CheckForUpdates__link__text">Check for updates</div></button></div><div class="AnnouncementCard"><p class="AnnouncementCard__title">Frontiers&#39; impact</p><article class="CardA"><div class="CardA__wrapper CardA__wrapper--vertical"><figure class="FrontiersImage CardA__img"><picture class="FrontiersImage"><!--[--><source srcset="https://images-provider.frontiersin.org/api/ipx/w=440&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 563px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=320x400&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1024px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=268x280&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1441px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><!--]--><img src="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" class="is-inside-mask" alt loading="eager"></picture><!----></figure><div class="CardA__info"><!--[--><h2 class="CardA__title">Articles published with Frontiers have received 12 million total citations</h2><p class="CardA__text">Your research is the real superpower - learn how we maximise its impact through our leading community journals</p><br><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--small Link--icon Link--chevronRight Link--right" aria-label="Explore our impact metrics" href="https://www.frontiersin.org/about/impact" target="_self" data-event="customLink-linkType-a_exploreOurImpactMe"><span>Explore our impact metrics</span></a></span><!--]--></div></div></article></div><!----><!----></div><div><div class="Modal Modal--noFooter"><button aria-label="Close modal" class="Modal__overlay" data-event="modal-overlay-close"></button><div class="Modal__container"><div class="Modal__header"><p class="Modal__title">Supplementary Material</p><button aria-label="Close modal" class="Modal__close" data-event="modal-button-close"></button></div><div class="Modal__body"><!--[--><div class="SupplementalData"><ul class="SupplementalData__list"><!--[--><!--]--></ul></div><!--]--><!----></div><!----><!----></div></div></div><div><div class="FloatingButtons"><!----><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--iconDownload ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Download</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fmolb.2022.839917" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><!----></div></div></div></aside></div><div class=""><!----></div><!--]--></div><!----><footer class="Footer"><div class="Footer__wrapper"><div class="Footer__sections"><ul class="Accordion"><!--[--><!--[--><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Guidelines</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/guidelines/author-guidelines" target="_self" data-event="footer-block_0-a_authorGuidelines">Author guidelines</a></li><li><a href="https://www.frontiersin.org/for-authors/author-services" target="_self" data-event="footer-block_0-a_servicesForAuthors">Services for authors</a></li><li><a href="https://www.frontiersin.org/guidelines/policies-and-publication-ethics" target="_self" data-event="footer-block_0-a_policiesAndPublicationE">Policies and publication ethics</a></li><li><a href="https://www.frontiersin.org/guidelines/editor-guidelines" target="_self" data-event="footer-block_0-a_editorGuidelines">Editor guidelines</a></li><li><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="footer-block_0-a_feePolicy">Fee policy</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Explore</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/articles" target="_self" data-event="footer-block_1-a_articles">Articles</a></li><li><a href="https://www.frontiersin.org/research-topics" target="_self" data-event="footer-block_1-a_researchTopics">Research Topics </a></li><li><a href="https://www.frontiersin.org/journals" target="_self" data-event="footer-block_1-a_journals">Journals</a></li><li><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="footer-block_1-a_howWePublish">How we publish</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Outreach</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://forum.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForum">Frontiers Forum </a></li><li><a href="https://policylabs.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersPolicyLabs">Frontiers Policy Labs </a></li><li><a href="https://kids.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForYoungMinds">Frontiers for Young Minds</a></li><li><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="footer-block_2-a_frontiersPlanetPrize">Frontiers Planet Prize</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Connect</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://helpcenter.frontiersin.org" target="_blank" data-event="footer-block_3-a_helpCenter">Help center</a></li><li><a href="https://subscription-management.frontiersin.org/emails/preferences#block0" target="_blank" data-event="footer-block_3-a_emailsAndAlerts">Emails and alerts </a></li><li><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="footer-block_3-a_contactUs">Contact us </a></li><li><a href="https://www.frontiersin.org/submission/submit" target="_self" data-event="footer-block_3-a_submit">Submit</a></li><li><a href="https://careers.frontiersin.org/" target="_blank" data-event="footer-block_3-a_careerOpportunities">Career opportunities</a></li><!--]--></ul><!--]--></div></li><!--]--><!--]--></ul><div class="Footer__socialLinks"><div class="Footer__socialLinks__title">Follow us</div><!--[--><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--facebook Link--right" aria-label="Frontiers Facebook" href="https://www.facebook.com/Frontiersin" target="_blank" data-event="footer-facebook-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--twitter Link--right" aria-label="Frontiers Twitter" href="https://twitter.com/frontiersin" target="_blank" data-event="footer-twitter-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--linkedin Link--right" aria-label="Frontiers LinkedIn" href="https://www.linkedin.com/company/frontiers" target="_blank" data-event="footer-linkedIn-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--instagram Link--right" aria-label="Frontiers Instagram" href="https://www.instagram.com/frontiersin_" target="_blank" data-event="footer-instagram-a_true"><span></span></a></span><!--]--></div></div><div class="Footer__copyright"><div><span> 2025 Frontiers Media SA. All rights reserved.</span></div><div><a href="https://www.frontiersin.org/legal/privacy-policy" target="_blank">Privacy policy</a><span>|</span><a href="https://www.frontiersin.org/legal/terms-and-conditions" target="_blank">Terms and conditions</a></div></div></div></footer><div class="SnackbarWrapper"><div class="SnackbarManager"><!--[--><!--]--></div></div></div><noscript><iframe
            src="https://tag-manager.frontiersin.org/ns.html?id=GTM-M322FV2&gtm_auth=owVbWxfaJr21yQv1fe1cAQ&gtm_preview=env-1&gtm_cookies_win=x"
            height="0"
            width="0"
            style="display: none; visibility: hidden">
          </iframe></noscript><!--]--></div><div id="teleports"></div><script type="application/json" id="__NUXT_DATA__" data-ssr="true">[["ShallowReactive",1],{"data":2,"state":4,"once":10,"_errors":11,"serverRendered":13,"path":14,"pinia":15},["ShallowReactive",3],{},["Reactive",5],{"$ssite-config":6},{"env":7,"name":8,"url":9},"production","Frontiers articles","https://article-pages-2024.frontiersin.org/",["Set"],["ShallowReactive",12],{},true,"/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/full",["Reactive",16],{"main":17,"user":535,"article":536,"articleHub":859,"mainHeader":863},{"ibar":18,"footer":252,"newsletterComponent":-1,"snackbarItem":334,"toggleShowSnackbar":335,"contentfulJournal":336,"graphJournal":436,"settingsFeaturesSwitchers":440,"templateToggleBanner":441,"tenantConfig":500},{"tenantLogo":19,"journalLogo":19,"aboutUs":20,"submitUrl":113,"showSubmitButton":13,"journal":114,"sectionTerm":183,"aboutJournal":184,"mainLinks":233,"journalLinks":240,"helpCenterLink":249},"",[21,38,47,71,87],{"title":22,"links":23},"Who we are",[24,29,32,35],{"text":25,"url":26,"target":27,"ariaLabel":28},"Mission and values","https://www.frontiersin.org/about/mission","_self",null,{"text":30,"url":31,"target":27,"ariaLabel":28},"History","https://www.frontiersin.org/about/history",{"text":33,"url":34,"target":27,"ariaLabel":28},"Leadership","https://www.frontiersin.org/about/leadership",{"text":36,"url":37,"target":27,"ariaLabel":28},"Awards","https://www.frontiersin.org/about/awards",{"title":39,"links":40},"Impact and progress",[41,44],{"text":42,"url":43,"target":27,"ariaLabel":28},"Frontiers' impact","https://www.frontiersin.org/about/impact",{"text":45,"url":46,"target":27,"ariaLabel":28},"Our annual reports","https://www.frontiersin.org/about/annual-reports",{"title":48,"links":49},"Publishing model",[50,53,56,59,62,65,68],{"text":51,"url":52,"target":27,"ariaLabel":28},"How we publish","https://www.frontiersin.org/about/how-we-publish",{"text":54,"url":55,"target":27,"ariaLabel":28},"Open access","https://www.frontiersin.org/about/open-access",{"text":57,"url":58,"target":27,"ariaLabel":28},"Peer review","https://www.frontiersin.org/about/peer-review",{"text":60,"url":61,"target":27,"ariaLabel":28},"Research integrity","https://www.frontiersin.org/about/research-integrity",{"text":63,"url":64,"target":27,"ariaLabel":28},"Research Topics","https://www.frontiersin.org/about/research-topics",{"text":66,"url":67,"target":27,"ariaLabel":28},"FAIR Data Management","https://www.frontiersin.org/about/fair-data-management",{"text":69,"url":70,"target":27,"ariaLabel":28},"Fee policy","https://www.frontiersin.org/about/fee-policy",{"title":72,"links":73},"Services",[74,78,81,84],{"text":75,"url":76,"target":77,"ariaLabel":28},"Societies","https://publishingpartnerships.frontiersin.org/","_blank",{"text":79,"url":80,"target":27,"ariaLabel":28},"National consortia","https://www.frontiersin.org/open-access-agreements/consortia",{"text":82,"url":83,"target":27,"ariaLabel":28},"Institutional partnerships","https://www.frontiersin.org/about/open-access-agreements",{"text":85,"url":86,"target":27,"ariaLabel":28},"Collaborators","https://www.frontiersin.org/about/collaborators",{"title":88,"links":89},"More from Frontiers",[90,94,97,101,105,109],{"text":91,"url":92,"target":77,"ariaLabel":93},"Frontiers Forum","https://forum.frontiersin.org/","this link will take you to the Frontiers Forum website",{"text":95,"url":96,"target":27,"ariaLabel":28},"Frontiers Planet Prize","https://www.frontiersin.org/about/frontiers-planet-prize",{"text":98,"url":99,"target":77,"ariaLabel":100},"Press office","https://pressoffice.frontiersin.org/","this link will take you to the Frontiers press office website",{"text":102,"url":103,"target":27,"ariaLabel":104},"Sustainability","https://www.frontiersin.org/about/sustainability","link to information about Frontiers' sustainability",{"text":106,"url":107,"target":77,"ariaLabel":108},"Career opportunities","https://careers.frontiersin.org/","this link will take you to the Frontiers careers website",{"text":110,"url":111,"target":27,"ariaLabel":112},"Contact us","https://www.frontiersin.org/about/contact","this link will take you to the help pages to contact our support team","https://www.frontiersin.org/submission/submit?domainid=1&fieldid=102&specialtyid=0&entitytype=2&entityid=698",{"id":115,"name":116,"slug":117,"sections":118},698,"Frontiers in Molecular Biosciences","molecular-biosciences",[119,123,127,131,135,139,143,147,151,155,159,163,167,171,175,179],{"id":120,"name":121,"slug":122},3647,"Bioenergetics","bioenergetics",{"id":124,"name":125,"slug":126},777,"Biological Modeling and Simulation","biological-modeling-and-simulation",{"id":128,"name":129,"slug":130},716,"Cellular Biochemistry","cellular-biochemistry",{"id":132,"name":133,"slug":134},2297,"Genome Organization and Dynamics","genome-organization-and-dynamics",{"id":136,"name":137,"slug":138},2218,"Glycoscience","glycoscience",{"id":140,"name":141,"slug":142},2426,"Lipids, Membranes and Membranous Organelles","lipids-membranes-and-membranous-organelles",{"id":144,"name":145,"slug":146},736,"Metabolomics","metabolomics",{"id":148,"name":149,"slug":150},3693,"Micronutrient Biology","micronutrient-biology",{"id":152,"name":153,"slug":154},3064,"Molecular Biophysics","molecular-biophysics",{"id":156,"name":157,"slug":158},701,"Molecular Diagnostics and Therapeutics","molecular-diagnostics-and-therapeutics",{"id":160,"name":161,"slug":162},2529,"Molecular Evolution","molecular-evolution",{"id":164,"name":165,"slug":166},1013,"Molecular Recognition","molecular-recognition",{"id":168,"name":169,"slug":170},697,"Nanobiotechnology","nanobiotechnology",{"id":172,"name":173,"slug":174},825,"Protein Biochemistry for Basic and Applied Sciences","protein-biochemistry-for-basic-and-applied-sciences",{"id":176,"name":177,"slug":178},699,"RNA Networks and Biology","rna-networks-and-biology",{"id":180,"name":181,"slug":182},767,"Structural Biology","structural-biology","Sections",[185,209],{"title":186,"links":187},"Scope",[188,191,194,197,200,203,206],{"text":189,"url":190,"target":27,"ariaLabel":28},"Field chief editors","https://www.frontiersin.org/journals/molecular-biosciences/about#about-editors",{"text":192,"url":193,"target":27,"ariaLabel":28},"Mission & scope","https://www.frontiersin.org/journals/molecular-biosciences/about#about-scope",{"text":195,"url":196,"target":27,"ariaLabel":28},"Facts","https://www.frontiersin.org/journals/molecular-biosciences/about#about-facts",{"text":198,"url":199,"target":27,"ariaLabel":28},"Journal sections","https://www.frontiersin.org/journals/molecular-biosciences/about#about-submission",{"text":201,"url":202,"target":27,"ariaLabel":28},"Open access statement","https://www.frontiersin.org/journals/molecular-biosciences/about#about-open",{"text":204,"url":205,"target":27,"ariaLabel":28},"Copyright statement","https://www.frontiersin.org/journals/molecular-biosciences/about#copyright-statement",{"text":207,"url":208,"target":27,"ariaLabel":28},"Quality","https://www.frontiersin.org/journals/molecular-biosciences/about#about-quality",{"title":210,"links":211},"For authors",[212,215,218,221,224,227,230],{"text":213,"url":214,"target":27,"ariaLabel":28},"Why submit?","https://www.frontiersin.org/journals/molecular-biosciences/for-authors/why-submit",{"text":216,"url":217,"target":27,"ariaLabel":28},"Article types","https://www.frontiersin.org/journals/molecular-biosciences/for-authors/article-types",{"text":219,"url":220,"target":27,"ariaLabel":28},"Author guidelines","https://www.frontiersin.org/journals/molecular-biosciences/for-authors/author-guidelines",{"text":222,"url":223,"target":27,"ariaLabel":28},"Editor guidelines","https://www.frontiersin.org/journals/molecular-biosciences/for-authors/editor-guidelines",{"text":225,"url":226,"target":27,"ariaLabel":28},"Publishing fees","https://www.frontiersin.org/journals/molecular-biosciences/for-authors/publishing-fees",{"text":228,"url":229,"target":27,"ariaLabel":28},"Submission checklist","https://www.frontiersin.org/journals/molecular-biosciences/for-authors/submission-checklist",{"text":231,"url":232,"target":27,"ariaLabel":28},"Contact editorial office","https://www.frontiersin.org/journals/molecular-biosciences/for-authors/contact-editorial-office",[234,237],{"text":235,"url":236,"target":27,"ariaLabel":28},"All journals","https://www.frontiersin.org/journals",{"text":238,"url":239,"target":27,"ariaLabel":28},"All articles","https://www.frontiersin.org/articles",[241,244,246],{"text":242,"url":243,"target":27,"ariaLabel":28},"Articles","articles",{"text":63,"url":245,"target":27,"ariaLabel":28},"research-topics",{"text":247,"url":248,"target":27,"ariaLabel":28},"Editorial board","editors",{"text":250,"url":251,"target":77,"ariaLabel":250},"Help center","https://helpcenter.frontiersin.org",{"blocks":253,"socialLinks":307,"copyright":331,"termsAndConditionsUrl":332,"privacyPolicyUrl":333},[254,268,278,292],{"title":255,"links":256},"Guidelines",[257,259,262,265,267],{"text":219,"url":258,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/author-guidelines",{"text":260,"url":261,"target":27,"ariaLabel":28},"Services for authors","https://www.frontiersin.org/for-authors/author-services",{"text":263,"url":264,"target":27,"ariaLabel":28},"Policies and publication ethics","https://www.frontiersin.org/guidelines/policies-and-publication-ethics",{"text":222,"url":266,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/editor-guidelines",{"text":69,"url":70,"target":27,"ariaLabel":28},{"title":269,"links":270},"Explore",[271,272,275,277],{"text":242,"url":239,"target":27,"ariaLabel":28},{"text":273,"url":274,"target":27,"ariaLabel":28},"Research Topics ","https://www.frontiersin.org/research-topics",{"text":276,"url":236,"target":27,"ariaLabel":28},"Journals",{"text":51,"url":52,"target":27,"ariaLabel":28},{"title":279,"links":280},"Outreach",[281,284,287,291],{"text":282,"url":92,"target":77,"ariaLabel":283},"Frontiers Forum ","Frontiers Forum website",{"text":285,"url":286,"target":77,"ariaLabel":28},"Frontiers Policy Labs ","https://policylabs.frontiersin.org/",{"text":288,"url":289,"target":77,"ariaLabel":290},"Frontiers for Young Minds","https://kids.frontiersin.org/","Frontiers for Young Minds journal",{"text":95,"url":96,"target":27,"ariaLabel":28},{"title":293,"links":294},"Connect",[295,296,300,303,306],{"text":250,"url":251,"target":77,"ariaLabel":250},{"text":297,"url":298,"target":77,"ariaLabel":299},"Emails and alerts ","https://subscription-management.frontiersin.org/emails/preferences#block0","Subscribe to Frontiers emails",{"text":301,"url":111,"target":27,"ariaLabel":302},"Contact us ","Subscribe to newsletter",{"text":304,"url":305,"target":27,"ariaLabel":28},"Submit","https://www.frontiersin.org/submission/submit",{"text":106,"url":107,"target":77,"ariaLabel":28},[308,316,321,326],{"link":309,"type":312,"color":313,"icon":314,"size":315,"hiddenText":13},{"text":310,"url":311,"target":77,"ariaLabel":310},"Frontiers Facebook","https://www.facebook.com/Frontiersin","Link","Grey","Facebook","Medium",{"link":317,"type":312,"color":313,"icon":320,"size":315,"hiddenText":13},{"text":318,"url":319,"target":77,"ariaLabel":28},"Frontiers Twitter","https://twitter.com/frontiersin","Twitter",{"link":322,"type":312,"color":313,"icon":325,"size":315,"hiddenText":13},{"text":323,"url":324,"target":77,"ariaLabel":28},"Frontiers LinkedIn","https://www.linkedin.com/company/frontiers","LinkedIn",{"link":327,"type":312,"color":313,"icon":330,"size":315,"hiddenText":13},{"text":328,"url":329,"target":77,"ariaLabel":28},"Frontiers Instagram","https://www.instagram.com/frontiersin_","Instagram","Frontiers Media SA. All rights reserved.","https://www.frontiersin.org/legal/terms-and-conditions","https://www.frontiersin.org/legal/privacy-policy",{},false,{"__typename":337,"identifier":115,"name":116,"slug":117,"banner":338,"description":429,"mission":430,"palette":431,"impactFactor":432,"citeScore":433,"citations":434,"showTagline":28,"twitter":435},"Journal",[339],{"id":340,"src":341,"name":342,"tags":343,"type":388,"width":389,"height":390,"idHash":391,"archive":392,"brandId":393,"limited":392,"fileSize":394,"isPublic":395,"original":396,"copyright":19,"extension":397,"thumbnails":399,"dateCreated":407,"description":408,"orientation":409,"userCreated":410,"watermarked":392,"dateModified":407,"datePublished":411,"ecsArchiveFiles":412,"propertyOptions":413,"property_Channel":418,"property_Sub-Type":420,"property_Asset_Type":422,"activeOriginalFocusPoint":424,"property_Office_Department":427},"4A5D8893-D608-48FF-ABC5878D4E4E347C","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/4A5D8893-D608-48FF-ABC5878D4E4E347C/webimage-214CE6BC-8903-4E21-A60D0EC9E6518A31.png","FMOLB_Main Visual_Orange_Website",[344,345,346,347,348,349,350,351,352,353,354,355,356,357,358,359,360,361,362,363,364,365,366,367,368,369,370,371,372,373,374,375,376,377,378,379,380,381,382,383,384,385,386,387],"catalyst","dna","arrangement","changes","monomers","function","molecular","molecule","complex","peptides","chain","isomers","molecules","amino","biotechnology","enzymes","modification","genes","enzyme","atoms","genome","biology","compound","sequence","polymers","bond","formula","helix","nucleotide","organic","structural","material","proteins","3d illustration","acid","acids","synthetic","protein","folding","ribonucleic","structure","bonding","peptide","biochemistry","image",9000,4447,"789f98199e2c12e6",0,"22C10171-81B3-4DA6-99342F272A32E8BB",18859013,1,"https://brand.frontiersin.org/m/789f98199e2c12e6/original/FMOLB_Main-Visual_Orange_Website.jpg",[398],"jpg",{"mini":400,"thul":401,"webimage":341,"Guidelines":402,"WebsiteJpg_XL":403,"WebsiteWebP_L":404,"WebsiteWebP_M":405,"WebsiteWebP_XL":406},"https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/4A5D8893-D608-48FF-ABC5878D4E4E347C/mini-36032C88-E5DB-47BB-8CC142EC6A8FA2E2.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/4A5D8893-D608-48FF-ABC5878D4E4E347C/thul-65BBE0DC-DC85-4E25-A68C7F7FD739B00E.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/4A5D8893-D608-48FF-ABC5878D4E4E347C/6224F3DC-E923-42CC-891365CC5EED0185/Guidelines-FMOLB_Main Visual_Orange_Website.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/4A5D8893-D608-48FF-ABC5878D4E4E347C/6224F3DC-E923-42CC-891365CC5EED0185/WebsiteJpg_XL-FMOLB_Main Visual_Orange_Website.jpg","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/4A5D8893-D608-48FF-ABC5878D4E4E347C/6224F3DC-E923-42CC-891365CC5EED0185/WebsiteWebP_L-FMOLB_Main Visual_Orange_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/4A5D8893-D608-48FF-ABC5878D4E4E347C/6224F3DC-E923-42CC-891365CC5EED0185/WebsiteWebP_M-FMOLB_Main Visual_Orange_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/4A5D8893-D608-48FF-ABC5878D4E4E347C/6224F3DC-E923-42CC-891365CC5EED0185/WebsiteWebP_XL-FMOLB_Main Visual_Orange_Website.webp","2022-06-27T10:00:09Z","Chain of amino acid or bio molecules called protein - 3d illustration; Shutterstock ID 1938095488; purchase_order: Main Visual; job: ; client: ; other:","landscape","Caroline Sutter","2022-06-27T09:27:09Z",[],[414,415,416,417],"414FB2D4-2283-43FD-BE14E534ECA67928","6C18119B-14BD-4951-B437696F4357BD33","7C692885-DB25-4858-B1FB4FF47B241E9B","D88C0047-EC30-4506-A7DF28A4D765E1CF",[419],"frontiersin_org",[421],"Main_Visual",[423],"Photography",{"x":425,"y":426},4500,2224,[428],"Publishing","Focuses on the molecular mechanisms underpinning and regulating biological processes in organisms across all branches of life.","\u003Cp>Frontiers in Molecular Biosciences is a multidisciplinary journal focusing on understanding biological processes at the molecular level. It is currently indexed in the BIOSIS, SciFinder, Web of Science, Embase, DOAJ, SCIE, Scopus, and PubMed Central (PMC), among others.\u003C/p>\n\n\u003Cp>The journal is led by Field Chief Editor Prof Cecilia Giulivi(University of California, Davis, US). The journal welcomes submissions in all areas of molecular bioscience research that illustrate the molecular mechanisms regulating the basic and applied metabolism of proteins, nucleic acids, carbohydrates, lipids, and metabolites in health and disease states, including aging, pharmacological interventions, and genetic and acquired diseases, among others.\u003C/p>\n\n\u003Cp>Topics of interest include:\u003C/p>\n\u003Cul>\n  \u003Cli>biological modeling and simulation\u003C/li>\n  \u003Cli>cellular biochemistry\u003C/li>\n  \u003Cli>genome organization and dynamics\u003C/li>\n  \u003Cli>glycoscience\u003C/li>\n  \u003Cli>lipids, membranes and, membranous organelles\u003C/li>\n  \u003Cli>metabolomics\u003C/li>\n  \u003Cli>molecular biophysics\u003C/li>\n  \u003Cli>molecular diagnostics and therapeutics\u003C/li>\n  \u003Cli>molecular evolution\u003C/li>\n  \u003Cli>molecular recognition\u003C/li>\n  \u003Cli>nanobiotechnology\u003C/li>\n  \u003Cli>protein biochemistry for basic, and applied sciences\u003C/li>\n  \u003Cli>RNA networks and biology\u003C/li>\n  \u003Cli>structural biology.\u003C/li>\n\u003C/ul>\n\n\u003Cp>The Journal encompasses several empirical disciplines, including structural biology, enzymology, biochemistry, molecular biology, and biophysics. In addition to presenting novel discoveries, methodologies, and practical applications, Frontiers in Molecular Biosciences encourages the submission of testable hypotheses to inspire diverse perspectives and foster scientific discourse. Integrating in silico, in vitro, and in vivo approaches is particularly interesting.\u003C/p>\n\n\u003Cp>Please note that this journal does not publish manuscripts solely focused on clinical oncology, cancer epidemiology, or cancer prognosis that lack a clear molecular mechanisms perspective within the biosciences. Likewise, studies that offer only descriptive accounts and do not provide mechanistic insights into the molecular underpinnings of biological processes fall outside the journal's scope.\u003C/p>\n\n\u003Cp>Frontiers journals require that manuscripts primarily comprising computational studies of public data, must include appropriate validation. Please refer to the \u003Ca href=\"https://www.frontiersin.org/guidelines/policies-and-publication-ethics#standards-for-research-methodology:~:text=complaints%20and%20allegations.-,Standards%20for%20research%20methodology,-Experiments\">Frontiers Standards for research methodology policy\u003C/a>, for more information. Manuscripts not adhering to these standards will not be considered.\u003Cp>\n\n\u003Cp>Frontiers in Molecular Biosciences is dedicated to advancing molecular bioscience research by disseminating scientific knowledge to researchers and the general public, thus facilitating future breakthroughs in scientific understanding.\u003C/p>","orange","5 .0","4.8","86463","@FrontMolBioSci",{"id":115,"name":116,"slug":117,"abbreviation":437,"isOnline":13,"isOpenForSubmissions":13,"citeScore":438,"impactFactor":439},"fmolb",8.8,4,{"displayTitlePillLabels":13,"displayRelatedArticlesBox":13,"showEditors":13,"showReviewers":13,"showLoopImpactLink":13,"enableFigshare":335},{"isPublic":13,"allowCompanyUsers":335,"whiteListEmails":442,"enableAllJournals":13,"whiteListJournals":464},[443,444,445,446,447,448,449,450,451,448,452,453,454,455,456,457,458,459,460,461,462,463],"Y2FybG9zLmxvcmNhQGZyb250aWVyc2luLm9yZw==","ZGFuaWVsLmx1ekBmcm9udGllcnNpbi5vcmc=","bGF1cmEudGVuYUBmcm9udGllcnNpbi5vcmc=","cmFmYWVsLnJpYW5jaG9AZnJvbnRpZXJzaW4ub3Jn","amFtZXMuc21hbGxib25lQGZyb250aWVyc2luLm9yZw==","ZnJhbi5tb3Jlbm9AZnJvbnRpZXJzaW4ub3Jn","c2FtdWVsLmZlcm5hbmRlekBmcm9udGllcnNpbi5vcmc=","YmFyYmFyYS5jYXJjYW5naXVAZnJvbnRpZXJzaW4ub3Jn","aXZhbi5zYW50YW1hcmlhQGZyb250aWVyc2luLm9yZw==","aHVlLnRyYW5AZnJvbnRpZXJzaW4ub3Jn","Z29uY2Fsby52YXJnYXNAZnJvbnRpZXJzaW4ub3Jn","bHVjaWUuc2VubkBmcm9udGllcnNpbi5vcmc=","bG9ybi5mcmFzZXJAZnJvbnRpZXJzaW4ub3Jn","ZWxzYS5jYXJyb25AZnJvbnRpZXJzaW4ub3Jn","bWFhcnRlbi52YW5kaWpja0Bmcm9udGllcnNpbi5vcmc=","YmluZGh1LmtyaXNobmFuQGZyb250aWVyc2luLm9yZw==","bWF0dGhldy5hdHR3YXRlcnNAZnJvbnRpZXJzaW4ub3Jn","Z2l1bGlhLnZhbHNlY2NoaUBmcm9udGllcnNpbi5vcmc=","ZmFiaWFuLmRlbGxhbW9ydGVAZnJvbnRpZXJzaW4ub3Jn","dmlqYXlhbi5wcEBwaXRzb2x1dGlvbnMuY29t","Z3VpbGxhdW1lLnNldXJhdEBmcm9udGllcnNpbi5vcmc=",[465,466,467,468,469,470,395,471,472,473,474,475,476,477,478,479,480,481,482,483,484,485,486,487,488,489,490,115,491,492,493,494,495,496,497,498,499],2232,1729,2357,2456,2176,2333,1843,602,106,616,310,657,3123,1468,2137,628,1566,2726,2086,1490,451,141,1335,2655,1238,604,1547,176,1440,403,1239,755,2136,609,1534,{"spaceId":395,"name":395,"availableJournalPages":501,"announcement":505},[243,248,245,502,503,504],"volumes","about","community-reviewers",{"__typename":506,"sys":507,"preHeader":42,"title":509,"description":510,"image":511,"link":533},"Announcement",{"id":508},"5ITtnTtQgAzPPGH6rX0AlM","Articles published with Frontiers have received 12 million total citations","Your research is the real superpower - learn how we maximise its impact through our leading community journals",[512],{"archive":392,"brandId":393,"copyright":28,"dateCreated":513,"dateModified":514,"datePublished":515,"description":28,"extension":516,"fileSize":518,"height":519,"id":520,"isPublic":392,"limited":392,"name":521,"orientation":409,"original":28,"thumbnails":522,"type":388,"watermarked":392,"width":529,"videoPreviewURLs":530,"tags":531,"textMetaproperties":532,"src":523},"2025-06-18T12:58:01Z","2025-06-18T14:15:34Z","2025-06-18T12:57:32Z",[517],"png",1365026,920,"7C5269C4-3C83-4591-951A74D15B95DAEA","Impact metrics banner for article pages",{"webimage":523,"thul":524,"mini":525,"WebsiteWebP_L":526,"WebsiteWebP_M":527,"Guidelines":528},"https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/thul-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/mini-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_L/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_M/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/Guidelines/Impact-metrics-banner-for-article-pages.png",1600,[],[],[],{"text":534,"url":43,"target":27,"ariaLabel":28},"Explore our impact metrics",{"loggedUserInfo":-1},{"currentArticle":537,"isPreviewPage":335,"hasSupplementalData":335,"showCrossmarkWidget":13,"articleTemplate":710,"currentArticlePageMetaInfo":711,"xmlParsedArticleContent":-1,"xmlParsingError":-1},{"id":538,"doi":539,"title":540,"acceptanceDate":541,"receptionDate":542,"publicationDate":543,"lastModifiedDate":544,"isPublished":13,"abstract":545,"researchTopic":546,"articleType":552,"stage":555,"keywords":557,"authors":563,"editors":638,"reviewers":648,"journal":666,"section":673,"impactMetrics":675,"volume":679,"articleVolume":680,"relatedArticles":681,"isPublishedV2":335,"contents":682,"files":685},839917,"10.3389/fmolb.2022.839917","Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis",["Date","2022-02-22T12:19:04.000Z"],["Date","2021-12-20T13:55:10.000Z"],["Date","2022-03-23T00:00:00.000Z"],["Date","2025-11-25T04:09:05.885Z"],"Hereditary (variant) transthyretin amyloidosis (ATTRv amyloidosis), which is caused by variants in the transthyretin (TTR) gene, leads to TTR amyloid deposits in multiple organs and various symptoms such as limb ataxia, muscle weakness, and cardiac failure. Interaction between amyloid proteins and extracellular vesicles (EVs), which are secreted by various cells, is known to promote the clearance of the proteins, but it is unclear whether EVs are involved in the formation and deposition of TTR amyloid in ATTRv amyloidosis. To clarify the relationship between ATTRv amyloidosis and EVs, serum-derived EVs were analyzed. In this study, we showed that cell-derived EVs are involved in the formation of TTR amyloid deposits on the membrane of small EVs, as well as the deposition of TTR amyloid in cells. Human serum-derived small EVs also altered the degree of aggregation and deposition of TTR. Furthermore, the amount of TTR aggregates in serum-derived small EVs in patients with ATTRv amyloidosis was lower than that in healthy controls. These results indicate that EVs contribute to the metabolism of TTR amyloid, and suggest that TTR in serum-derived small EVs is a potential target for future ATTRv amyloidosis diagnosis and therapy.",{"id":547,"title":548,"articlesCount":549,"isMagazinePage":13,"slug":550,"isOpenForSubmission":335,"views":551},21931,"Extracellular Vesicles in CNS Diseases",5,"extracellular-vesicles-in-cns-diseases",27158,{"id":553,"name":554},24,"Original Research",{"id":556,"name":19},18,[558,559,560,561,562],"Amyloidosis","transthyretin","Extracellular vesicle","ATTRv amyloidosis","Atomic Force Microscope",[564,574,583,590,596,603,609,615,622,630],{"id":392,"firstName":565,"middleName":19,"lastName":566,"givenNames":567,"isCorresponding":335,"isProfilePublic":335,"userId":392,"email":-1,"affiliations":568},"Hiroki","Yamaguchi","Hiroki ",[569,572],{"organizationName":570,"countryName":571,"cityName":19,"stateName":19,"zipCode":19},"Department of Immunology","Japan",{"organizationName":573,"countryName":571,"cityName":19,"stateName":19,"zipCode":19},"Department of Neurology and Neurobiology of Aging",{"id":575,"firstName":576,"middleName":19,"lastName":577,"givenNames":578,"isCorresponding":335,"isProfilePublic":13,"userId":575,"email":-1,"affiliations":579},1605653,"Hironori","Kawahara","Hironori ",[580,581],{"organizationName":570,"countryName":571,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":582,"countryName":571,"cityName":19,"stateName":19,"zipCode":19},"WPI Nano Life Science Institute (NanoLSI)",{"id":584,"firstName":585,"middleName":19,"lastName":586,"givenNames":587,"isCorresponding":335,"isProfilePublic":13,"userId":584,"email":-1,"affiliations":588},859455,"Noriyuki","Kodera","Noriyuki ",[589],{"organizationName":582,"countryName":571,"cityName":19,"stateName":19,"zipCode":19},{"id":392,"firstName":591,"middleName":19,"lastName":592,"givenNames":593,"isCorresponding":335,"isProfilePublic":335,"userId":392,"email":-1,"affiliations":594},"Ayanori","Kumaki","Ayanori ",[595],{"organizationName":570,"countryName":571,"cityName":19,"stateName":19,"zipCode":19},{"id":392,"firstName":597,"middleName":19,"lastName":598,"givenNames":599,"isCorresponding":335,"isProfilePublic":335,"userId":392,"email":-1,"affiliations":600},"Yasutake","Tada","Yasutake ",[601,602],{"organizationName":570,"countryName":571,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":573,"countryName":571,"cityName":19,"stateName":19,"zipCode":19},{"id":392,"firstName":604,"middleName":19,"lastName":605,"givenNames":606,"isCorresponding":335,"isProfilePublic":335,"userId":392,"email":-1,"affiliations":607},"Zixin","Tang","Zixin ",[608],{"organizationName":570,"countryName":571,"cityName":19,"stateName":19,"zipCode":19},{"id":392,"firstName":610,"middleName":19,"lastName":611,"givenNames":612,"isCorresponding":335,"isProfilePublic":335,"userId":392,"email":-1,"affiliations":613},"Kenji","Sakai","Kenji ",[614],{"organizationName":573,"countryName":571,"cityName":19,"stateName":19,"zipCode":19},{"id":616,"firstName":617,"middleName":19,"lastName":618,"givenNames":619,"isCorresponding":335,"isProfilePublic":13,"userId":616,"email":-1,"affiliations":620},4982,"Kenjiro","Ono","Kenjiro ",[621],{"organizationName":573,"countryName":571,"cityName":19,"stateName":19,"zipCode":19},{"id":392,"firstName":623,"middleName":19,"lastName":624,"givenNames":625,"isCorresponding":335,"isProfilePublic":335,"userId":392,"email":-1,"affiliations":626},"Masahito","Yamada","Masahito ",[627,628],{"organizationName":573,"countryName":571,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":629,"countryName":571,"cityName":19,"stateName":19,"zipCode":19},"Department of Internal Medicine",{"id":631,"firstName":632,"middleName":19,"lastName":633,"givenNames":634,"isCorresponding":335,"isProfilePublic":13,"userId":631,"email":-1,"affiliations":635},1214000,"Rikinari","Hanayama","Rikinari ",[636,637],{"organizationName":570,"countryName":571,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":582,"countryName":571,"cityName":19,"stateName":19,"zipCode":19},[639],{"id":640,"firstName":641,"middleName":19,"lastName":642,"givenNames":643,"isCorresponding":335,"isProfilePublic":13,"userId":640,"email":-1,"affiliations":644},822476,"Chiara","Porro","Chiara ",[645],{"organizationName":646,"countryName":647,"cityName":19,"stateName":19,"zipCode":19},"University of Foggia","Italy",[649,657],{"id":650,"firstName":651,"middleName":19,"lastName":652,"givenNames":653,"isCorresponding":335,"isProfilePublic":13,"userId":650,"email":-1,"affiliations":654},104701,"Mauro","Manno","Mauro ",[655],{"organizationName":656,"countryName":647,"cityName":19,"stateName":19,"zipCode":19},"National Research Council (CNR)",{"id":658,"firstName":659,"middleName":19,"lastName":660,"givenNames":661,"isCorresponding":335,"isProfilePublic":13,"userId":658,"email":-1,"affiliations":662},1193304,"Gefei","Chen","Gefei ",[663],{"organizationName":664,"countryName":665,"cityName":19,"stateName":19,"zipCode":19},"Karolinska Institutet (KI)","Sweden",{"id":115,"slug":117,"name":116,"shortName":667,"electronicISSN":668,"field":669,"specialtyId":28,"journalSectionPaths":671},"Front. Mol. Biosci.","2296-889X",{"id":670,"domainId":395},102,[672],{"section":673},{"id":128,"name":129,"slug":130,"specialtyId":674},1502,{"views":676,"downloads":677,"citations":678},5348,1421,7,9,"Volume 9 - 2022",[],{"titleHtml":540,"fullTextHtml":683,"menuHtml":684},"\u003Cdiv class=\"JournalAbstract\">\u003Ca id=\"h1\" name=\"h1\">\u003C/a>\u003Cdiv class=\"authors\">\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Hiroki Yamaguchi,\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Hiroki Yamaguchi\u003Csup>1,2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/1605653\" class=\"user-id-1605653\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/1605653/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Hironori Kawahara,&#xa;\">Hironori Kawahara\u003C/a>\u003Csup>1,3\u003C/sup>&#x0002a;\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/859455\" class=\"user-id-859455\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/859455/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Noriyuki Kodera\">Noriyuki Kodera\u003C/a>\u003Csup>3\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Ayanori Kumaki\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Ayanori Kumaki\u003Csup>1\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Yasutake Tada,\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Yasutake Tada\u003Csup>1,2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Zixin Tang\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Zixin Tang\u003Csup>1\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Kenji Sakai\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Kenji Sakai\u003Csup>2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/4982\" class=\"user-id-4982\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/4982/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Kenjiro Ono\">Kenjiro Ono\u003C/a>\u003Csup>2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Masahito Yamada,\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Masahito Yamada\u003Csup>2,4\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/1214000\" class=\"user-id-1214000\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/1214000/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Rikinari Hanayama,&#xa;\">Rikinari Hanayama\u003C/a>\u003Csup>1,3\u003C/sup>&#x0002a;\u003C/span>\u003C/div>\u003Cul class=\"notes\">\u003Cli>\u003Cspan>\u003Csup>1\u003C/sup>\u003C/span>Department of Immunology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan\u003C/li>\u003Cli>\u003Cspan>\u003Csup>2\u003C/sup>\u003C/span>Department of Neurology and Neurobiology of Aging, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan\u003C/li>\u003Cli>\u003Cspan>\u003Csup>3\u003C/sup>\u003C/span>WPI Nano Life Science Institute (NanoLSI), Kanazawa University, Kanazawa, Japan\u003C/li>\u003Cli>\u003Cspan>\u003Csup>4\u003C/sup>\u003C/span>Department of Internal Medicine, Division of Neurology, Kudanzaka Hospital, Tokyo, Japan\u003C/li>\u003C/ul>\u003Cp class=\"mb15\">Hereditary (variant) transthyretin amyloidosis (ATTRv amyloidosis), which is caused by variants in the transthyretin (TTR) gene, leads to TTR amyloid deposits in multiple organs and various symptoms such as limb ataxia, muscle weakness, and cardiac failure. Interaction between amyloid proteins and extracellular vesicles (EVs), which are secreted by various cells, is known to promote the clearance of the proteins, but it is unclear whether EVs are involved in the formation and deposition of TTR amyloid in ATTRv amyloidosis. To clarify the relationship between ATTRv amyloidosis and EVs, serum-derived EVs were analyzed. In this study, we showed that cell-derived EVs are involved in the formation of TTR amyloid deposits on the membrane of small EVs, as well as the deposition of TTR amyloid in cells. Human serum-derived small EVs also altered the degree of aggregation and deposition of TTR. Furthermore, the amount of TTR aggregates in serum-derived small EVs in patients with ATTRv amyloidosis was lower than that in healthy controls. These results indicate that EVs contribute to the metabolism of TTR amyloid, and suggest that TTR in serum-derived small EVs is a potential target for future ATTRv amyloidosis diagnosis and therapy.\u003C/p>\u003Cdiv class=\"clear\">\u003C/div>\u003C/div>\u003Cdiv class=\"JournalFullText\">\u003Ca id=\"h2\" name=\"h2\">\u003C/a>\u003Ch2>Introduction\u003C/h2>\u003Cp class=\"mb15\">Amyloidosis refers to a group of diseases in which insoluble proteins, called amyloids, are deposited in various organs, causing functional impairment (\u003Ca href=\"#B33\">Picken, 2020\u003C/a>). Amyloid is formed by the misfolding and aggregation of soluble proteins. Once formed, amyloid takes on a fibrillar structure and is deposited outside the cell (\u003Ca href=\"#B40\">Sipe and Cohen, 2000\u003C/a>; \u003Ca href=\"#B33\">Picken, 2020\u003C/a>). The extracellular deposition of amyloid leads to destruction of normal tissue structure and cellular dysfunction (\u003Ca href=\"#B1\">Agostinho et al., 2010\u003C/a>; \u003Ca href=\"#B27\">Merlini et al., 2011\u003C/a>). Physical compression by amyloid deposition, oxidative stress, and abnormal mitochondrial function are thought to be the main mechanisms of cellular dysfunction (\u003Ca href=\"#B3\">Ando et al., 1998\u003C/a>; \u003Ca href=\"#B6\">Buxbaum and Linke, 2012\u003C/a>). A variety of soluble proteins, including amyloid-&#x003b2; (A&#x003b2;), &#x003b1;-synuclein (&#x003b1;-syn), transthyretin (TTR), &#x003b2;2-microglobulin (&#x003b2;2-MG), and serum amyloid A (SAA) are aggregated and deposited in the body, causing amyloidosis (\u003Ca href=\"#B33\">Picken, 2020\u003C/a>). For example, A&#x003b2; and &#x003b1;-syn are predominantly deposited in the brain, A&#x003b2; aggregates are detected in patients with Alzheimer&#x02019;s disease and are called senile plaques (\u003Ca href=\"#B15\">Hashimoto et al., 2020\u003C/a>), and Lewy bodies, formed by the aggregation of &#x003b1;-syn, are deposited in the brains of patients with Parkinson&#x02019;s disease and dementia with Lewy bodies (\u003Ca href=\"#B13\">Gomperts, 2016\u003C/a>). These are examples of localized amyloidosis, in which amyloid deposits are confined to the central nervous system.\u003C/p>\u003Cp class=\"mb15\">In systemic amyloidosis, such as reactive AA amyloidosis and hereditary (variant) transthyretin amyloidosis (ATTRv amyloidosis), amyloid is deposited in multiple organs. Reactive AA amyloidosis, in which SAA is the amyloid precursor protein, is associated with secondary to chronic inflammatory diseases and infections (rheumatoid arthritis, systemic lupus erythematosus, tuberculosis, etc.). In hereditary ATTRv amyloidosis, TTR gene variant forms amyloid, which is deposited in multiple organs such as the peripheral nerves, gastrointestinal tract, heart, eyes, and kidneys (\u003Ca href=\"#B38\">Sekijima et al., 2018\u003C/a>). TTR is mainly produced in the liver and exists as a tetramer in serum; however, the dissociation of tetramers into a monomers is the rate-limiting step in amyloid formation (\u003Ca href=\"#B38\">Sekijima et al., 2018\u003C/a>). TTR tetramers composed of variant TTR are more likely to dissociate into monomers than those composed of wild-type TTR (\u003Ca href=\"#B38\">Sekijima et al., 2018\u003C/a>; \u003Ca href=\"#B48\">Yee et al., 2019\u003C/a>). The most common variant in the causative TTR gene is the p.Val50Met (Val30Met; V30M) variant, and the resulting mutated TTR is called V30M-TTR (\u003Ca href=\"#B48\">Yee et al., 2019\u003C/a>). Acidic conditions also promote TTR amyloid formation \u003Cem>in vitro\u003C/em> (\u003Ca href=\"#B48\">Yee et al., 2019\u003C/a>). Unlike A&#x003b2;, which is produced by neurons, TTR is not produced near the site of deposition of TTR aggregation or in the surrounding tissues. Furthermore, the mechanism of TTR aggregation and deposition in the body remains unknown.\u003C/p>\u003Cp class=\"mb15\">Extracellular vesicles (EVs) are small membrane vesicles secreted by various cell and tissue types (\u003Ca href=\"#B18\">Kalluri and LeBleu, 2020\u003C/a>). EVs contain biological materials such as proteins, messenger RNA, and microRNA derived from the cells that produce them. Intercellular communication, such as the transport of pathogenic proteins, plays a major role in EVs, and the proteins and RNAs contained in EVs are useful biomarkers of several diseases (\u003Ca href=\"#B18\">Kalluri and LeBleu, 2020\u003C/a>). Notably, the addition of Schwann cell-derived EVs or mesenchymal stem cell-derived EVs to mouse models of diabetic neuropathy or mice that were physically subjected to peripheral neuropathy promoted nerve repair (\u003Ca href=\"#B8\">Dong et al., 2019\u003C/a>; \u003Ca href=\"#B10\">Fan et al., 2021\u003C/a>). \u003Cem>In vitro\u003C/em>, Neuro2a mouse neuroblastoma (N2a) cell-derived EVs (N2a-EVs) promote A&#x003b2; aggregation in EVs. In addition, A&#x003b2; aggregated on N2a-EVs is easily taken up by microglia and degraded (\u003Ca href=\"#B49\">Yuyama et al., 2012\u003C/a>). Furthermore, continuous injection of N2a-EVs into mouse models of Alzheimer&#x02019;s disease enhanced the phagocytosis of A&#x003b2; aggregates by microglia and reduced the amount of amyloid deposition in the brain (\u003Ca href=\"#B50\">Yuyama et al., 2014\u003C/a>). Moreover, SAA and SAA oligomers present in plasma EVs also exhibit amyloid-enhancing-factor activity (\u003Ca href=\"#B44\">Tasaki et al., 2010\u003C/a>). Human serum EVs (S-EVs) collected by ultracentrifugation contain TTR amyloid (\u003Ca href=\"#B45\">Tong et al., 2017\u003C/a>); however, it remains unknown whether EVs contribute to TTR aggregation, deposition, or clearance in hereditary ATTRv amyloidosis. In this study, we show that TTR aggregation is enhanced on EV membranes and that EVs promote cell deposition accompanied by TTR aggregation, even under non-acidic conditions. Furthermore, we observe a decrease in TTR in serum-derived EVs in patients with hereditary ATTRv amyloidosis, indicating that EVs could play an active role in TTR tissue deposition.\u003C/p>\u003Ca id=\"h3\" name=\"h3\">\u003C/a>\u003Ch2>Materials and Methods\u003C/h2>\u003Ch3 class=\"pt0\">Purification of Serum Extracellular Vesicles\u003C/h3>\u003Cp class=\"mb0\">Six patients with ATTRv (V30M-TTR) amyloidosis and six healthy controls provided serum samples in this study. The patients included three males and three females, whereas the healthy individuals were six males. The age of the patients was 56&#x02013;75, and that of the healthy controls was 22&#x02013;40. Serum was collected from patients after diagnosis and before the start of treatment for ATTRv amyloidosis. The duration of illness was 3&#x02013;7&#x000a0;years at the time of blood sampling. All donors provided informed consent, and the study was approved by the Kanzawa University Ethics Committee Reference 2018&#x02013;238 (3,029).\u003C/p>\u003Cp class=\"mb0\">All serum samples were centrifuged at 3,000 &#x000d7;g for 10&#x000a0;min and 10,000 &#x000d7; g for 30&#x000a0;min at 4&#x000b0;C, followed by microfiltration with Millipore 0.22&#x000a0;&#x003bc;m filters. Filtrated serum (1&#x000a0;ml) was reacted with MagCapture Exosome Isolation Kit PS (MagCapture) (FUJIFILM Wako, Japan) according to the manual. After the overnight reaction, purified serum EVs were eluted with elution buffer and the EVs were saved (FUJIFILM Wako). Eluted serum EVs were stored at 4&#x000b0;C until further use. The concentration of serum EVs was measured using the Pierce BCA Protein Assay Kit (Thermo Scientific, United States) at 25&#x000b0;C. The number and size distribution of EV particles were measured \u003Cem>via\u003C/em> nanoparticle tracking analysis using a NanoSight LM10 instrument (software NTA 3.1; Malvern Panalytical, United Kingdom) after diluting the EVs 30&#x000a0;times with phosphate-buffered saline (PBS). The particle numbers per frame used were 70 particles/frame for recording of S-EVs in Raw mode.\u003C/p>\u003Ch3 class=\"pt0\">Purification of Cell Line-Derived Extracellular Vesicles\u003C/h3>\u003Cp class=\"mb0\">HepG2, HEK293T, and NIH3T3 cell lines was purified. Cells (2 &#x000d7; 10\u003Csup>6\u003C/sup>) were spread on a 10&#x000a0;cm dish and incubated with Dulbecco&#x02019;s modified Eagle medium (DMEM) medium (FUJIFILM Wako) containing 10% fetal calf serum (FCS). EVs in the FCS were eliminated by 1,00,000 &#x000d7; g ultracentrifugation. Cell lines were cultured until they reached 90% confluence at 37&#x000b0;C with 5% CO\u003Csub>2\u003C/sub>. Then, the culture medium was changed to fresh DMEM containing 2% FCS (2% FCS-DMEM) and incubated for 24&#x000a0;h. The collected conditioned culture media were centrifuged at 3,000 &#x000d7; g for 10&#x000a0;min and 10,000 &#x000d7; g for 30&#x000a0;min at 4&#x000b0;C, followed by microfiltration with Millipore 0.22&#x000a0;&#x003bc;m filters. Filtrated conditioned culture media were reacted with MagCapture, and cell line-derived EVs were eluted using the same procedure as that used for serum EVs. Measurement of collected EV solutions using the Pierce BCA Protein Assay Kit and NanoSight was performed according to the same procedure as that for serum. The particle numbers per frame used were 42, 50, or 39 particles/frame for recording of HepG2, HEK293T, and NIH3T3 cells in Raw mode, respectively.\u003C/p>\u003Ch3 class=\"pt0\">Purification of Recombinant Transthyretin\u003C/h3>\u003Cp class=\"mb0\">Protein purification was performed as described previously (\u003Ca href=\"#B20\">Kawahara et al., 2008\u003C/a>). TTR (NM_000371.4) and V30M were amplified by PrimeSTAR GXL DNA polymerase (Takara, Japan) using primers (5&#x02032;- ggg&#x0200b;gcc&#x0200b;cct&#x0200b;ggg&#x0200b;atc&#x0200b;TGG&#x0200b;CCC&#x0200b;TAC&#x0200b;GGG&#x0200b;CAC&#x0200b;CGG&#x0200b;T-3&#x02032;; 5&#x02032;- gat&#x0200b;gcg&#x0200b;gcc&#x0200b;gct&#x0200b;cga&#x0200b;TCA&#x0200b;TTC&#x0200b;CTT&#x0200b;GGG&#x0200b;ATT&#x0200b;GGT&#x0200b;G-3&#x02032;) and subcloned pGEX6P1 using In-Fusion HD Cloning Kit (Takara). V30M mutation was generated by using an inverse PCR method (PrimeSTAR GXL) and primers (5&#x02032;-TGT&#x0200b;GGC&#x0200b;CaT&#x0200b;GCA&#x0200b;TGT&#x0200b;GTT&#x0200b;CAG&#x0200b;AAA&#x0200b;GG-3&#x02032;; 5&#x02032;- ACA&#x0200b;TGC&#x0200b;AtG&#x0200b;GCC&#x0200b;ACA&#x0200b;TTG&#x0200b;ATG&#x0200b;GCA&#x0200b;GG-3&#x02032;). \u003Cem>Escherichia coli\u003C/em> strain BL21 (DE3) pLysS (Biodynamics, DS260) was transfected with the plasmid pGEX6P1-GST-WT-TTR or pGEX6P1-GST-V30M-TTR. After overnight incubation in LB medium at 37&#x000b0;C, the culture medium was transferred into 100&#x02013;200&#x000a0;ml of LB medium and incubated at 37&#x000b0;C. At the time of OD600 &#x0003d; 0.5, Isopropyl &#x003b2;-D-1-thiogalactopyranoside (IPTG) was added to a final concentration of 0.1&#x000a0;mM and the medium was incubated for 5&#x000a0;h. Cultured \u003Cem>E. coli\u003C/em> was centrifuged, collected, suspended in PBS, and sonicated on ice. Triton-X 100 (Nacalai Tesque, Japan) was added to the final 0.1% and the solutions were centrifuged at 10,000 &#x000d7; g for 30&#x000a0;min at 4&#x000b0;C. The supernatant was then ultracentrifuged at 100,000 &#x000d7;g for 90&#x000a0;min at 4&#x000b0;C. The supernatant was mixed with Pierce Glutathione Agarose (Thermo Scientific) and rotated overnight at 4&#x000b0;C. Beads were then washed five times and 1&#x000a0;ml of PBS or FCS-free DMEM and 20&#x000a0;&#x003bc;l of Turbo3C protease (FUJIFILM Wako) was added; the mixture was then rotated for 24&#x000a0;h at 4&#x000b0;C. Then, the TTR solution was collected, followed by microfiltration with Millipore 0.22&#x000a0;&#x003bc;m filters. The concentration of filtered purified TTR solution was measured with Pierce 660&#x000a0;nm Protein Assay Reagent (Thermo Scientific) at 25&#x000b0;C, and the TTR solution was stored at 4&#x000b0;C until use.\u003C/p>\u003Ch3 class=\"pt0\">Western Blotting Analysis\u003C/h3>\u003Cp class=\"mb0\">The SDS-PAGE was performed under reducing condition according to previous study (\u003Ca href=\"#B43\">Tangthavewattana et al., 2019\u003C/a>), and immunoblotting was performed as described previously (\u003Ca href=\"#B21\">Kawahara et al., 2011\u003C/a>). Samples were boiled with sodium dodecyl sulfate sample buffer, denatured on 13% polyacrylamide gels, transferred onto a nitrocellulose membrane, and blocked in 4% skim milk in TBS-T (0.5% Triton-X 100 with TBS) for 30&#x000a0;min at room temperature then washed with TBS-T three times. The membrane was then incubated with primary antibodies overnight at 4&#x000b0;C. The membrane was washed three times with TBS-T and incubated with secondary antibodies overnight at 4&#x000b0;C. Both the primary and secondary antibodies were diluted 1,000 times with Can Get Signal 1 and Can Get Signal 2 (TOYOBO, Japan). Following TBS-T washing in triplicate, the membrane was enclosed with SuperSignal West Pico PLUS Chemiluminescent Substrate (Thermo Scientific) or ImmunoStar LD (FUJIFILM Wako). Chemiluminescence was detected using FUSION SYSTEM (Vilber Lourmat, France). The signal intensity of the bands was measured using Evolution Capt Version 18.04 (Vilber Lourmat). The primary antibodies used in this study were anti-prealbumin antibody (Abcam, ab-92469), Anti-CD9, monoclonal antibody (1&#x000a0;K) (FUJIFILM Wako, 014-27763), LEAF Purified anti-human CD63 antibody (BioLegend, 353014), anti-Alix antibody (Cell Signaling Technology, 2171), Anti-HSP70 antibody (BioLegend, 648002), Anti-CD81 antibody (BioLegend, 104902), and Purified Mouse Anti-Flotillin-2 antibody (BD Biosciences, 610384). The secondary antibodies were anti-rabbit IgG, HRP-linked antibody (Jackson Immuno Research Laboratories, 711-035-152), and anti-mouse IgG, HRP-linked antibody (Cell Signaling Technology, 7076P2).\u003C/p>\u003Ch3 class=\"pt0\">Thioflavin T Assay\u003C/h3>\u003Cp class=\"mb0\">The acidic buffer was 50&#x000a0;mM sodium acetate and 100&#x000a0;mM NaCl at pH 4.2, as described previously (\u003Ca href=\"#B35\">Saito et al., 2005\u003C/a>). Cell line-derived EVs (50&#x000a0;&#x003bc;g/ml) and purified TTR in PBS (WT-TTR or V30M-TTR, 0.75&#x000a0;mg/ml) were mixed with the acidic buffer in a PCR tube. The final concentration of TTR was 0.1&#x000a0;mg/ml. The sample solutions were incubated at 37&#x000b0;C in a thermal cycler. The increase in aggregated TTR was evaluated by measuring the fluorescence intensity (FI) of ThT. The ThT solution (as described previously in \u003Ca href=\"#B35\">Saito et al. (2005)\u003C/a> (5&#x000a0;&#x003bc;M ThT and 50&#x000a0;mM glycine-NaOH buffer, pH 9.0) and sample solutions were mixed at a ratio of 20:1. The mixture was poured into four wells of a Nunc Black polystyrene 96-well microplate (Thermo Scientific) with 200&#x000a0;&#x003bc;l per well. The FI value was recorded at 25&#x000b0;C within a few minutes of pouring. The measurement device was an Enspire Multimode Plate Reader (PerkinElmer, United States). The measurement timing was as follows: 0&#x000a0;h (immediately after mixing), 6, 12, 24, and 48&#x000a0;h. The wavelengths of the plate reader for excitation and emission were 450 and 482&#x000a0;nm, respectively.\u003C/p>\u003Ch3 class=\"pt0\">Biotinylation of Anti-Transthyretin Antibody\u003C/h3>\u003Cp class=\"mb0\">EZ-Link NHS-LC-LC-Biotin (Thermo Scientific) was diluted in 2&#x000a0;mM using dimethyl sulfoxide, and 6.7&#x000a0;&#x003bc;l of the diluted biotin solution was mixed with 200&#x000a0;&#x003bc;l of purified anti-transthyretin aggregated antibody (BioLegend, 848202). The mixture was then rotated at 4&#x000b0;C overnight. Then, the same amount of 100&#x000a0;mM glycine-PBS was added to inactivate the remaining biotin.\u003C/p>\u003Ch3 class=\"pt0\">Enzyme-Linked Immunosorbent Assay of Extracellular Vesicles (EV ELISA)\u003C/h3>\u003Cp class=\"mb0\">A PS Capture Exosome ELISA Kit (Streptavidin HRP) (FUJIFILM Wako, Japan) was used for semi-quantification of EVs. Cell line-derived EVs or serum were used as the samples. The samples were diluted to the desired ratio using the reaction buffer in the kit. Diluted samples were poured into three wells of the kit (100&#x000a0;&#x003bc;l per well) and incubated overnight with shaking at 4&#x000b0;C and 500&#x000a0;rpm. Subsequent procedures were performed according to the manufacturer&#x02019;s instructions. Control biotinylated anti-CD63 antibody in the kit or biotinylated anti-aggregated TTR antibody described in the previous section were used for the detection of proteins contained in the EVs. Absorbance spectra were obtained at 25&#x000b0;C using an Enspire Multimode plate reader (PerkinElmer), and the absorbance was measured at 450&#x000a0;nm (reference wavelength: 620&#x000a0;nm). According to the manual, the actual absorbance was obtained by subtracting the blank absorbance from the average absorbance at three points.\u003C/p>\u003Ch3 class=\"pt0\">Binding of EVs and Purified TTR in Neutral Conditions and Extracellular Vesicles Labeling\u003C/h3>\u003Cp class=\"mb0\">Each 30&#x000a0;&#x003bc;l of purified TTR in FCS-free DMEM (WT-TTR or V30M-TTR, 0.4&#x000a0;mg/ml) and cell line-derived EVs (40&#x000a0;&#x003bc;g/ml) were mixed in a PCR tube. The mixtures were incubated for 48&#x000a0;h at 37&#x000b0;C. Then, 15&#x000a0;&#x003bc;L of each sample was used for western blotting analysis, and the remaining samples were diluted 100 times with reaction buffer and used for EV ELISA. The experiment was also conducted in serum EVs using the same procedure. For PKH-labeled EVs, 293T-EVs (3&#x000a0;&#x003bc;g) was incubated with 4x PKH26 Dye solution (Sigma-Aldrich) for 15&#x000a0;min at room temperature according to the manual after both ultracentrifugation followed by MagCapture. PKH-labeled EVs was purified by Exosome Spin Columns (Thermo) by centrifuging at 750 &#x000d7; \u003Cem>g\u003C/em> for 2&#x000a0;min.\u003C/p>\u003Ch3 class=\"pt0\">Immunocytochemistry\u003C/h3>\u003Cp class=\"mb0\">Immunocytochemistry was performed as described previously (\u003Ca href=\"#B20\">Kawahara et al., 2008\u003C/a>). V30M-TTR in FCS-free DMEM was aggregated in acidic buffer for 3&#x000a0;days, and TTR aggregates were diluted in FCS-free DMEM (final TTR concentration; 1.0&#x000a0;&#x003bc;g/ml). HEK293T cell was incubated with 10% FCS-DMEM (500&#x000a0;&#x003bc;l) on gelatin coated 12&#x000a0;mm coverslips until they reached 50% confluence at 37&#x000b0;C. Then, the culture medium was replaced with fresh 2% FCS-DMEM (500&#x000a0;&#x003bc;l) and 10&#x000a0;&#x003bc;l of diluted aggregated TTR was added, and the cells were incubated at 37&#x000b0;C for 30&#x000a0;h. After incubation, the cells were washed with TBS-T and fixed with 4% PFA for 15&#x000a0;min at room temperature. The cells were then washed, 2% bovine serum albumin (BSA) was added to TBS-T, and cells were incubated with shaking for 30&#x000a0;min at room temperature. Then, the cells were washed with TBS-T, and biotinylated anti-aggregated TTR antibody was diluted 1,000 times with 1% BSA in TBS-T and incubated overnight at 4&#x000b0;C. The cells were washed with TBS-T, Streptavidin-Cy3 (BioLegend, 405215) diluted 1,000 times with 2% BSA in TBS-T, and incubated overnight at 4&#x000b0;C with shading. After incubation, the cells were washed with TBS-T and incubated with VECTASHIELD Mounting Medium with DAPI (5&#x000a0;&#x003bc;g/ml) (VECTOR LABORATORIES, Unites states). Purified V30M-TTR in FCS-free DMEM was also used. HEK293T cell was cultured as described above until they reached 90% confluence. The culture medium was then replaced with fresh 2.5% FCS-DMEM (400&#x000a0;&#x003bc;l). Purified V30M-TTR in FCS-free DMEM (50&#x000a0;&#x003bc;l, 2.0&#x000a0;mg/ml) with 50&#x000a0;&#x003bc;l of serum EVs (70&#x000a0;ng/ml) or elution buffer (MagCapture, FUJIFILM Wako, Japan) were also spread on the cell lines, and cells were incubated at 37&#x000b0;C for 18&#x000a0;h. After incubation, the same procedure described above was performed to observe the fluorescence. For the uptake of 293T-EVs, HEK293T cell was cultured as described above until they reached 90% confluence. The culture medium was then replaced with fresh 2.5% FCS-DMEM (400&#x000a0;&#x003bc;l). Purified TTR or V30M-TTR in FCS-free DMEM (50&#x000a0;&#x003bc;l, 2.0&#x000a0;mg/ml) with 50&#x000a0;&#x003bc;l of PKH26-labeled 293T-EVs (70&#x000a0;ng/ml) or PKH26-labeled 293T-EVs alone were also spread on the cell lines, and cells were incubated at 37&#x000b0;C for 24&#x000a0;h. After incubation, the same procedure described above was performed to observe the fluorescence using anti-aggregated TTR antibody, anti-mouse IgG, Biotin-linked antibody (Jackson Immuno Research Laboratories, 715-065-150), and Streptavidin-FITC (BD Bioscience, 554060). They were captured by BZ-X710 (KEYENCE, Japan) or FV10-ASW (Olympus) and Quantitative analysis were performed using Hybrid Cell Count software according to the manual (Keyenece, BZ-H3C).\u003C/p>\u003Ch3 class=\"pt0\">High-Speed Atomic Force Microscopy\u003C/h3>\u003Cp class=\"mb0\">A laboratory-built high-speed atomic force microscope (HS-AFM) was used for the analysis, as described previously (\u003Ca href=\"#B2\">Ando et al., 2013\u003C/a>). In brief, a glass sample stage (diameter, 2&#x000a0;mm; height, 2&#x000a0;mm) with a thin mica disc (1.5&#x000a0;mm diameter and &#x0223c;0.05&#x000a0;mm thickness) glued to the top by epoxy was attached onto the top of a Z-scanner using a drop of nail polish. A drop (2&#x000a0;&#x003bc;l) of the serum EV solution from the healthy control group (1.8 &#x000d7; 10\u003Csup>9\u003C/sup> particles/ml) was deposited onto a freshly cleaved mica surface and left to sit for 3&#x000a0;min. This ensured that the S-EVs were nonspecifically immobilized on the mica surface. After rinsing the surface with either PBS buffer or acidic buffer (pH 4.0) of 20&#x000a0;&#x003bc;l, the sample stage was immersed in a liquid cell filled with either PBS buffer or acidic buffer (60&#x000a0;&#x003bc;l), and HS-AFM imaging was conducted in tapping mode. We used small cantilevers (BL-AC10DS-A2, Olympus, Tokyo) with a spring constant, resonant frequency in water, and quality factor in water of &#x0223c;0.1&#x000a0;N/m, &#x0223c;0.5 MHz, and &#x0223c;1.5, respectively. The probe tip was grown on the original tip end of the cantilever through electron beam deposition using ferrocene. The cantilever&#x02019;s free oscillation amplitude \u003Cem>A\u003C/em>\u003Csub>0\u003C/sub> and set-point amplitude \u003Cem>A\u003C/em>\u003Csub>s\u003C/sub> were set to &#x0223c;2&#x000a0;nm and &#x0223c;0.9 &#x000d7; \u003Cem>A\u003C/em>\u003Csub>0\u003C/sub>, respectively. In some experiments, purified V30M-TTR solution (5&#x000a0;&#x003bc;L) was injected into the observation buffer during HS-AFM imaging so that the final concentration of TTR was either 0.07&#x000a0;mg/ml or 0.25&#x000a0;mg/ml, as described previously (\u003Ca href=\"#B30\">Nonaka et al., 2020\u003C/a>). Details of the HS-AFM imaging method are described elsewhere (\u003Ca href=\"#B46\">Uchihashi et al., 2012\u003C/a>). Data analysis of HS-AFM images was performed as described previously (\u003Ca href=\"#B23\">Kori et al., 2019\u003C/a>; \u003Ca href=\"#B22\">Kodera et al., 2021\u003C/a>).\u003C/p>\u003Ch3 class=\"pt0\">Analysis of High-Speed Atomic Force Microscopy Images\u003C/h3>\u003Cp class=\"mb0\">For analysis, HS-AFM images were pretreated with a low-pass filter to remove spike noise and with a flatten filter to render the overall xy-plane flat using a laboratory-built software, as described before (\u003Ca href=\"#B29\">Ngo et al., 2015\u003C/a>). The heights of S-EVs were measured semi-automatically using the following steps. First, the estimated highest point of a S-EV was selected manually. Second, the actual highest point was automatically determined by searching a 10 &#x000d7; 10 pixel area (typically 40 &#x000d7; 40&#x000a0;nm\u003Csup>2\u003C/sup>) around the selected point.\u003C/p>\u003Cp class=\"mb0\">2D correlation coefficients were calculated between the HS-AFM images of the first frame and each of the frames within the region of interest (ROI) (i.e., the first frame is the reference) (\u003Ca href=\"#B23\">Kori et al., 2019\u003C/a>). The ROIs were set as rectangles that enclosed the spherical-shaped S-EVs (typically 50 &#x000d7; 50&#x000a0;nm\u003Csup>2\u003C/sup>). The 2D correlation coefficient was calculated frame-by-frame for each ROI. The 2D correlation coefficient \u003Cem>r\u003C/em> is defined as,\u003C/p>\u003Cdiv class=\"equationImageholder\">\u003Cmath  id=\"equ1\">\u003Cmrow>\u003Cmi>r\u003C/mi>\u003Cmo>&#x0003d;\u003C/mo>\u003Cmfrac>\u003Cmrow>\u003Cmsub>\u003Cmstyle displaystyle=\"true\">\u003Cmo>&#x02211;\u003C/mo>\u003C/mstyle>\u003Cmi>m\u003C/mi>\u003C/msub>\u003Cmsub>\u003Cmstyle displaystyle=\"true\">\u003Cmo>&#x02211;\u003C/mo>\u003C/mstyle>\u003Cmi>n\u003C/mi>\u003C/msub>\u003Cmrow>\u003Cmo>(\u003C/mo>\u003Cmsub>\u003Cmi>H\u003C/mi>\u003Cmrow>\u003Cmi>m\u003C/mi>\u003Cmi>n\u003C/mi>\u003C/mrow>\u003C/msub>\u003Cmo>&#x02212;\u003C/mo>\u003Cmover accent=\"true\">\u003Cmi>H\u003C/mi>\u003Cmo>&#x000af;\u003C/mo>\u003C/mover>\u003Cmo>)\u003C/mo>\u003C/mrow>\u003Cmrow>\u003Cmo>(\u003C/mo>\u003Cmsub>\u003Cmi>R\u003C/mi>\u003Cmrow>\u003Cmi>m\u003C/mi>\u003Cmi>n\u003C/mi>\u003C/mrow>\u003C/msub>\u003Cmo>&#x02212;\u003C/mo>\u003Cmover accent=\"true\">\u003Cmi>R\u003C/mi>\u003Cmo>&#x000af;\u003C/mo>\u003C/mover>\u003Cmo>)\u003C/mo>\u003C/mrow>\u003C/mrow>\u003Cmrow>\u003Cmsqrt>\u003Cmrow>\u003Cmrow>\u003Cmo>(\u003C/mo>\u003Cmsub>\u003Cmstyle displaystyle=\"true\">\u003Cmo>&#x02211;\u003C/mo>\u003C/mstyle>\u003Cmi>m\u003C/mi>\u003C/msub>\u003Cmsub>\u003Cmstyle displaystyle=\"true\">\u003Cmo>&#x02211;\u003C/mo>\u003C/mstyle>\u003Cmi>n\u003C/mi>\u003C/msub>\u003Cmsup>\u003Cmrow>\u003Cmrow>\u003Cmo>(\u003C/mo>\u003Cmrow>\u003Cmsub>\u003Cmi>H\u003C/mi>\u003Cmrow>\u003Cmi>m\u003C/mi>\u003Cmi>n\u003C/mi>\u003C/mrow>\u003C/msub>\u003Cmo>&#x02212;\u003C/mo>\u003Cmover accent=\"true\">\u003Cmi>H\u003C/mi>\u003Cmo>&#x000af;\u003C/mo>\u003C/mover>\u003C/mrow>\u003Cmo>)\u003C/mo>\u003C/mrow>\u003C/mrow>\u003Cmn>2\u003C/mn>\u003C/msup>\u003Cmo>)\u003C/mo>\u003C/mrow>\u003Cmrow>\u003Cmo>(\u003C/mo>\u003Cmsub>\u003Cmstyle displaystyle=\"true\">\u003Cmo>&#x02211;\u003C/mo>\u003C/mstyle>\u003Cmi>m\u003C/mi>\u003C/msub>\u003Cmsub>\u003Cmstyle displaystyle=\"true\">\u003Cmo>&#x02211;\u003C/mo>\u003C/mstyle>\u003Cmi>n\u003C/mi>\u003C/msub>\u003Cmsup>\u003Cmrow>\u003Cmrow>\u003Cmo>(\u003C/mo>\u003Cmrow>\u003Cmsub>\u003Cmi>R\u003C/mi>\u003Cmrow>\u003Cmi>m\u003C/mi>\u003Cmi>n\u003C/mi>\u003C/mrow>\u003C/msub>\u003Cmo>&#x02212;\u003C/mo>\u003Cmover accent=\"true\">\u003Cmi>R\u003C/mi>\u003Cmo>&#x000af;\u003C/mo>\u003C/mover>\u003C/mrow>\u003Cmo>)\u003C/mo>\u003C/mrow>\u003C/mrow>\u003Cmn>2\u003C/mn>\u003C/msup>\u003Cmo>)\u003C/mo>\u003C/mrow>\u003C/mrow>\u003C/msqrt>\u003C/mrow>\u003C/mfrac>\u003C/mrow>\u003C/math>\u003Cdiv class=\"clear\">\u003C/div>\u003C/div>\u003Cp class=\"noindent\">in which \u003Cem>H\u003C/em>\u003Csub>mn\u003C/sub> and \u003Cem>R\u003C/em>\u003Csub>mn\u003C/sub> are the heights at the pixel points (m, n) in the ROI to be analyzed and the ROI of the reference, respectively.\u003C/p>\u003Ch3 class=\"pt0\">Statistical Analysis\u003C/h3>\u003Cp class=\"mb0\">Statistical analysis was performed using GraphPad Prism 8.4.3. Statistical comparisons were performed as indicated in the figure legends. \u003Cem>p\u003C/em> values &#x02264;0.05 were considered to be statistically significant, and those not significant (n.s.) were indicated accordingly. Bar graphs are presented as the mean &#x000b1; standard error (S.E.). Two-sample tests were performed by Mann&#x02013;Whitney&#x02019;s U-test. Multiple comparisons were performed via one-way analysis of variance. No statistical methods were used to select \u003Cem>N\u003C/em> number.\u003C/p>\u003Ca id=\"h4\" name=\"h4\">\u003C/a>\u003Ch2>Results\u003C/h2>\u003Ch3 class=\"pt0\">Extracellular Vesicles Bind to Transthyretin and Promote Transthyretin Aggregation\u003C/h3>\u003Cp class=\"mb0\">The majority of TTR is produced as a secreted protein in the liver (\u003Ca href=\"#B38\">Sekijima et al., 2018\u003C/a>); the presence of serum EVs containing TTR has also been reported (\u003Ca href=\"#B45\">Tong et al., 2017\u003C/a>). To confirm whether HepG2 cells contained TTR, immunoblotting was performed using HepG2 culture supernatants. TTR was detected in HepG2-EVs (\u003Ca href=\"#F1\">Figure 1A\u003C/a>). In HEK293T and NIH3T3 cells that did not produce TTR, TTR was not detected in either the supernatants or EVs (\u003Ca href=\"#F1\">Figure 1B\u003C/a>). The particle size and distribution of EVs were similar among the three groups (\u003Ca href=\"#F1\">Figure 1C\u003C/a>). A&#x003b2;, which is a major causative factor of Alzheimer&#x02019;s disease, binds to the surface proteins of Neuro2a cell-derived EVs and promotes A&#x003b2; aggregation on EVs (\u003Ca href=\"#B49\">Yuyama et al., 2012\u003C/a>). To investigate whether TTR, a major causative factor of ATTR amyloidosis (which is the same type of amyloidosis as Alzheimer&#x02019;s disease), interacts with the EV membrane surface, we analyzed the interaction using purified TTR and EVs derived from HEK293T and NIH3T3 cells that do not produce TTR. HEK293T cell-derived EVs (HEK293T-EVs) or NIN3T3 cell-derived EVs (NIH3T3-EVs) were mixed with purified wild-type TTR (WT-TTR) or V30M-TTR then analyzed. First, immunoblotting was performed using samples that had been mixed with EVs or non-EVs and purified TTR or FCS-free DMEM, then allowed to stand at 37&#x000b0;C for 48&#x000a0;h. In the mixed sample of V30M-TTR and EVs, multiple bands were detected (\u003Ca href=\"#F2\">Figure 2A\u003C/a>). This result suggests that mixing of V30M-TTR and EVs resulted in the aggregation of TTR (\u003Ca href=\"#F2\">Figure 2A\u003C/a>). The mixed sample of NIH3T3-EVs and WT-TTR also showed slight banding. Multiple bands were not observed in the sample without EVs (\u003Ca href=\"#F2\">Figure 2A\u003C/a>). Next, to confirm the co-localization of EVs with TTR aggregates, we performed EV ELISA using the same samples as for immunoblotting. An increase in absorbance was observed in the mixed samples of EVs and TTR, with the highest absorbance in the mixed samples of NIH3T3-EVs and V30M-TTR (\u003Ca href=\"#F2\">Figures 2B,C\u003C/a>). The absorbance exhibited a minimal increase in the mixed samples of TTR and non-EVs. Under neutral conditions, EVs from TTR-non-producing cell lines bound to purified TTR and promoted TTR aggregation. In addition, NIH3T3-EVs showed a higher affinity for TTR than HEK293T-EVs.\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">FIGURE 1\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g001.jpg\" name=\"Figure1\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g001.jpg\" alt=\"www.frontiersin.org\" id=\"F1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cstrong>FIGURE 1\u003C/strong>. HepG2-derived EVs contain TTR whereas HEK293T-derived EVs or NIH3T3-derived EVs do not. \u003Cstrong>(A)\u003C/strong> TTR monomer was detected in western blotting analysis of the culture supernatant of HepG2 and HepG2-derived EVs. \u003Cstrong>(B)\u003C/strong> TTR was not detected in western blotting analysis of the cell lysate and cell line-derived EVs in HEK293T and NIH3T3. 3T3 (NIH3T3), 293T (HEK293T). \u003Cstrong>(C)\u003C/strong> Analysis of three cell line-derived EVs [HepG2 (black), HEK293T (red), and NIH3T3 (green)] by NanoSight (Raw mode). The diameter and distribution of cell line-derived EVs were similar among the cell lines. All EVs were 40&#x000a0;ng/ml before measurement and were diluted 30-fold with PBS immediately before analysis. Particle concentrations were as follows: HepG2 cell-derived (2.52 &#x000d7; 10\u003Csup>10\u003C/sup> &#x000b1; 1.19 &#x000d7; 10\u003Csup>9\u003C/sup>), HEK293T-derived (2.96 &#x000d7; 10\u003Csup>10\u003C/sup> &#x000b1; 1.01 &#x000d7; 10\u003Csup>9\u003C/sup>), and NIH3T3-derived EVs (2.23&#x000d7; 10\u003Csup>10\u003C/sup> &#x000b1; 1.28 &#x000d7; 10\u003Csup>9\u003C/sup>).\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">FIGURE 2\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g002.jpg\" name=\"Figure2\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g002.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g002.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g002.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g002.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g002.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g002.jpg\" alt=\"www.frontiersin.org\" id=\"F2\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cstrong>FIGURE 2\u003C/strong>. EVs are easily combined with purified V30M-TTR. \u003Cstrong>(A)\u003C/strong> Mixture of NIH3T3-derived EVs, HEK293T-derived EVs or non-EVs, and purified TTR in non-shaking conditions for 48&#x000a0;h used for western blotting analysis. Ladder bands suggestive of aggregates were confirmed above the top of the running gel on V30-TTR and both EVs. \u003Cstrong>(B)\u003C/strong> Remaining samples were diluted and used for EV ELISA. Binding of cell line-derived EVs to TTR was indicated by the increased absorbance in EV ELISA. NIH3T3-derived EVs were more likely to bind to TTR than HEK293T-derived EVs. N &#x0003d; 3, mean &#x000b1; S.E.; &#x0002a;&#x0002a;, \u003Cem>p\u003C/em> &#x0003c; 0.005; n.s., not significant, ANOVA with Tukey&#x02019;s post hoc test. \u003Cstrong>(C)\u003C/strong> The same samples as the previous experiment were shaken at 500&#x000a0;rpm and used for EV ELISA. TTR-V30M with cell line-derived EVs showed higher absorbance than TTR-WT. N &#x0003d; 3, mean &#x000b1; S.E.; &#x0002a;&#x0002a;, \u003Cem>p\u003C/em> &#x0003c; 0.005; n.s., not significant, ANOVA with Tukey&#x02019;s post hoc test. \u003Cstrong>(D)\u003C/strong> Increase of Thioflavin T (ThT) fluorescence intensity (FI) in a mixture of EVs and purified WT-TTR with acidic buffer observed by ThT assay. FI value decreased in the following order: TTR with NIH3T3-derived EVs, HEK293T-derived EVs, and elution buffer in both WT-TTR and V30M-TTR. N &#x0003d; 4, mean &#x000b1; S.E.; &#x0002a;, \u003Cem>p\u003C/em> &#x0003c; 0.05; &#x0002a;&#x0002a;, \u003Cem>p\u003C/em> &#x0003c; 0.005; ANOVA with Tukey&#x02019;s post hoc test. \u003Cstrong>(E)\u003C/strong> Same experiment with V30M-TTR. FI value decreased in the same order as for WT-TTR. FI value of V30M-TTR was generally higher than that of WT-TTR. N &#x0003d; 4, mean &#x000b1; S.E.; &#x0002a;, \u003Cem>p\u003C/em> &#x0003c; 0.05; &#x0002a;&#x0002a;, \u003Cem>p\u003C/em> &#x0003c; 0.005; ANOVA with Tukey&#x02019;s post hoc test.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cp class=\"mb0\">TTR aggregation is promoted under acidic conditions (\u003Ca href=\"#B7\">Colon and Kelly, 1992\u003C/a>). EV-affected TTR aggregation was analyzed using the thioflavin T (ThT) assay. EVs or non-EVs, purified WT-TTR or V30M-TTR, and acidic buffer were mixed and evaluated (\u003Ca href=\"#F2\">Figures 2D,E\u003C/a>). WT-TTR showed a significant increase in FI values in the presence of NIH3T3-derived EVs. V30M-TTR showed an increasing trend in FI values in the presence of both NIH3T3-derived and 293T-derived EVs, with 293T-derived EVs showing a significant increase in FI values at 12 and 24&#x000a0;h. Overall, the FI values of V30M-TTR were higher than those of WT-TTR. NIH3T3-EVs and V30M-TTR bound easily, even under acidic conditions, indicating that NIH3T3-EVs are likely to promote the aggregation of TTR.\u003C/p>\u003Ch3 class=\"pt0\">Serum Extracellular Vesicles Contain Transthyretin and Transthyretin Aggregates, and Serum Extracellular Vesicles Bind to Purified Transthyretin\u003C/h3>\u003Cp class=\"mb0\">Reportedly, S-EVs recovered by ultracentrifugation contain TTR aggregates (\u003Ca href=\"#B45\">Tong et al., 2017\u003C/a>). However, these S-EVs also contain many impurities. Some methods have been used to purify S-EVs, including a two-step purification method using size exclusion chromatography in combination with the density gradient method (\u003Ca href=\"#B31\">On&#x000f3;di et al., 2018\u003C/a>). We have reported that EVs can be easily purified by the MagCapture method to ensure their high purity (\u003Ca href=\"#B28\">Nakai et al., 2016\u003C/a>). To investigate whether highly purified S-EVs also contain TTR and TTR aggregates, S-EVs from healthy individuals were collected by MagCapture and analyzed using the same procedure as that used for cell line-derived EVs. The particle size of S-EVs was analyzed using a nanoparticle meter, which revealed a similar particle size and distribution to those of cell line-derived EVs (\u003Ca href=\"#F1\">Figures 1C\u003C/a>, \u003Ca href=\"#F3\">3A\u003C/a>). TTR with multiple molecular weights was detected in the immunoblot of S-EVs, as well as a small amount of TTR aggregates in the high purity S-EV (\u003Ca href=\"#F3\">Figure 3B\u003C/a>). As cultured cell-derived EVs promoted TTR aggregation, we performed a similar analysis with serum-derived EVs. S-EVs or non-EVs were mixed with purified TTR or TTR minus as controls. A ladder-like band was observed in the mixed sample of S-EVs and V30M-TTR, indicating that S-EVs promoted the aggregation of TTR (\u003Ca href=\"#F3\">Figure 3C\u003C/a>). In addition, to investigate whether TTR aggregation occurred on the EV surface, EV ELISA was performed using the same samples as those used for immunoblotting. The absorbance increased in the mixed sample of TTR and S-EVs and was higher in V30M-TTR than in WT-TTR (\u003Ca href=\"#F3\">Figure 3D\u003C/a>). However, the absorbance did not increase as much as when the cell line-derived EVs were mixed with purified TTR (\u003Ca href=\"#F2\">Figures 2B\u003C/a>, \u003Ca href=\"#F3\">3D\u003C/a>). These ELISA results indicated that V30M-TTR was more easily aggregated on the surface of the S-EVs.\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">FIGURE 3\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g003.jpg\" name=\"Figure3\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g003.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g003.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g003.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g003.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g003.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g003.jpg\" alt=\"www.frontiersin.org\" id=\"F3\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cstrong>FIGURE 3\u003C/strong>. EVs derived from human serum contain TTR, and purified TTR binds to the serum EVs. \u003Cstrong>(A)\u003C/strong> Analysis of EVs derived from serum (S-EVs) by NanoSight (Raw mode). The particle concentration was 4.15 &#x000d7; 10\u003Csup>10\u003C/sup> &#x000b1; 3.30 &#x000d7; 10\u003Csup>9\u003C/sup>. \u003Cstrong>(B)\u003C/strong> Multiple molecular weight TTR and TTR aggregates were detected in western blotting analysis of serum and S-EVs. \u003Cstrong>(C)\u003C/strong> Mixture of S-EVs or Elution Buffer and purified TTR in static conditions for 48&#x000a0;h used for western blotting analysis. V30M-TTR with or without S-EVs exhibited ladder bands. \u003Cstrong>(D)\u003C/strong> Remaining samples were used for EV ELISA. S-EVs with V30M-TTR showed the highest absorbance. S-EVs with WT-TTR also exhibited an increase in absorbance, whereas TTR without EVs showed little increase in absorbance. N &#x0003d; 3, mean &#x000b1; S.E.; &#x0002a;&#x0002a;, \u003Cem>p\u003C/em> &#x0003c; 0.005; n.s., not significant, ANOVA with Tukey&#x02019;s post hoc test. \u003Cstrong>(E)\u003C/strong> S-EVs in PBS were imaged with HS-AFM. EV particles were observed fixed to the substrate. Particles were mainly smaller than those confirmed by Nanosight. \u003Cstrong>(F)\u003C/strong> Change in S-EV particle height over time under five conditions. Height of serum EVs increased in a time-dependent and TTR-concentration-dependent manner. Acid buffer (Acid). All AFM movies were taken at 250&#x000a0;ms/frame. Scanning area was 100 &#x000d7; 100&#x000a0;nm\u003Csup>2\u003C/sup> with 80 &#x000d7; 80 pixels. \u003Cstrong>(G)\u003C/strong> Time course of 2D correlation coefficients of the surface of EVs under the above five conditions. The 2D correlation coefficient calculation has been described in the Materials and Methods &#x0201c;Analysis of HS-AFM Images&#x0201d; section in detail. The addition of TTR and an increase in TTR concentration reduced amplitude of the EV surface.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cp class=\"mb0\">As it is difficult to distinguish between S-EVs and lipoprotein impurities by Nanoparticle Tracking Analysis (NTA), it is recommended to combine NTA with microscopic analysis (\u003Ca href=\"#B4\">Bachurski et al., 2019\u003C/a>). Hence, HS-AFM was used to visually analyze the binding of S-EVs to purified TTR. S-EVs in PBS were fixed to the substrate and were flexibly fluctuated due to their presence in PBS (\u003Ca href=\"#SM1\">Supplemental Figure S1\u003C/a>). S-EVs with a height of approximately 20&#x000a0;nm in the Z-axis were mainly observed by HS-AFM: The difference in the height of the S-EVs between Nanosight and HS-AFM was thought to be due to the fact that smaller particles diffuse faster and are preferentially anchored to the substrate, and that the core size of particles was small enough to be observed by HS-AFM, but was effectively estimated larger by the existence of molecules outside S-EVs in Nanosight (\u003Ca href=\"#F3\">Figure 3E\u003C/a>). There have been reports of similar results, including one from our group (\u003Ca href=\"#B47\">Woo et al., 2016\u003C/a>; \u003Ca href=\"#B25\">Lim et al., 2020\u003C/a>, \u003Ca href=\"#B26\">2021\u003C/a>). Furthermore, the detection limit of NTA is about 60&#x000a0;nm (\u003Ca href=\"#B4\">Bachurski et al., 2019\u003C/a>), and HS-AFM can detect smaller S-EVs that cannot be detected by NTA. The peak particle size in the X&#x02013;Y axis was 8.2&#x000a0;nm (\u003Ca href=\"#F3\">Figure 3E\u003C/a>). The binding of V30M-TTR to S-EVs was analyzed under acidic conditions. The height of the S-EVs immobilized on the substrate increased in a time-dependent manner and V30M-TTR-concentration-dependent manner (\u003Ca href=\"#F3\">Figure 3F\u003C/a>). As the increase in the size of the EVs surface has resulted in a decrease in mobility and amplitude, the fluctuations were suppressed when S-EVs and V30M-TTR interacted with correlation coefficients: Notably, the surface mobility of EVs appeared to reduce upon addition of TTR. This was confirmed by the correlation coefficient analysis for the shapes of S-EVs. Thus, the increase in the height of the S-EVs has resulted in a decrease in the surface mobility of S-EVs (\u003Ca href=\"#F3\">Figure 3G\u003C/a>). These data suggest that purified TTR binds to S-EVs and accumulated on EV membranes.\u003C/p>\u003Ch3 class=\"pt0\">Serum-Derived Extracellular Vesicles are Involved in Transthyretin Aggregation and the Deposition of Transthyretin Aggregates on Cells\u003C/h3>\u003Cp class=\"mb0\">TTR aggregates are deposited on the outside of cells in the stroma. To investigate whether V30M-TTR aggregates were capable of being deposited on the cell periphery, V30M-TTR aggregates, purified V30M-TTR, and S-EVs were added to the culture cells. First, to confirm the pattern of extracellularly deposited V30M-TTR aggregates, a certain amount of V30M-TTR aggregates was added to HEK293T cells. As a result of analysis using TTR aggregate antibodies, almost no deposition signal was detected in cells incubated with S-EVs purified by MagCaputre compared to those incubated with V30M-TTR aggregates (\u003Ca href=\"#F4\">Figure 4A\u003C/a>). Next, we examined whether TTR was aggregated and deposited around the cells when purified V30M-TTR was added to the cell lines. Specifically, 0.22&#x000a0;&#x003bc;m of filtered purified V30M-TTR was added to HEK293T cells, and TTR aggregates deposited around the cells were detected by the same method, as shown in \u003Ca href=\"#F4\">Figure 4A\u003C/a>. V30M-TTR aggregates were not detected in V30M-TTR alone to the same extent as in S-EVs (\u003Ca href=\"#F4\">Figure 4A\u003C/a>). However, when V30M-TTR and S-EVs were simultaneously added, cellular deposition of TTR aggregates was more pronounced than that under other conditions (\u003Ca href=\"#F4\">Figure 4B\u003C/a>). As PKH-labeled EVs is also likely to observe impurities other than EVs (\u003Ca href=\"#B42\">Takov et al., 2017\u003C/a>), the analysis was performed using 293T-EVs purified and labeled by spin column after ultracentrifugation followed by MagCapture. V30M with 293T-EVs not only observed the presence of TTR aggregates but also increased EVs uptake (\u003Ca href=\"#F4\">Figure 4C\u003C/a>). These data indicate that S-EVs promote cell deposition with aggregation of V30M-TTR.\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">FIGURE 4\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g004.jpg\" name=\"Figure4\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g004.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g004.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g004.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g004.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g004.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g004.jpg\" alt=\"www.frontiersin.org\" id=\"F4\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cstrong>FIGURE 4\u003C/strong>. EVs promote the cell deposition of V30M-TTR, and S-EVs change the degree of TTR aggregation and deposition of TTR aggregates on cell lines. \u003Cstrong>(A)\u003C/strong> TTR aggregates spread on HEK293T. Deposited TTR aggregates were detected by the biotinylated TTR aggregate antibody as red fluorescence in immunocytochemistry. Bars: 100&#x000a0;&#x003bc;m. \u003Cstrong>(B)\u003C/strong> Purified V30M-TTR monomer, V30M-TTR monomer with S-EVs, and S-EVs spread on HEK293T. HEK293T showed red fluorescence in only V30M-TTR with S-EVs in appearance. Bars: 100&#x000a0;&#x003bc;m. \u003Cstrong>(C)\u003C/strong> Purified TTR monomer with 293T-EVs, V30M-TTR monomer with 293T-EVs, and 293T-EVs spread on HEK293T. PKH26-labeled 293T-EVs and purified TTR protein (WT or V30M) were mixed and incubated with 293T cells at 37&#x000b0;C for 24&#x000a0;h. The uptake efficiency of EVs was quantified by PKH (right panel), and TTR aggregates were quantified using anti-aggregated TTR antibody (right panel). TTR aggregates were observed only in the presence of V30M-TTR and EVs under this condition. HEK293T showed green fluorescence in only V30M-TTR with 293T-EVs in appearance. Red fluorescence is indicated PKH-labeled EVs that is purified by ultracentrifugation and Magcapture followed by Exosome Spin Columns. Bars: 40&#x000a0;&#x003bc;m. N &#x0003d; 10, mean &#x000b1; S.E.; &#x0002a;&#x0002a;, \u003Cem>p\u003C/em> &#x0003c; 0.001; n.s., not significant, ANOVA with Tukey&#x02019;s post hoc test.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Ch3 class=\"pt0\">Amount of EV Markers and TTR Aggregates in Serum EVs Differ Between Patients and Controls\u003C/h3>\u003Cp class=\"mb0\">In summary, our results showed that S-EVs contain TTR aggregates (\u003Ca href=\"#F3\">Figure 3B\u003C/a>) and that TTR aggregation is an important process in the pathogenesis of ATTR amyloidosis. Here, we investigated whether there is a difference in the amount of TTR aggregates and EV markers in S-EVs between patients with hereditary ATTRv amyloidosis and the healthy controls. First, we analyzed TTR aggregates by immunoblotting analysis of the EVs of patients with ATTRv amyloidosis and healthy individuals (N &#x0003d; 6). A higher rate of TTR tetramer and TTR aggregates was observed in the healthy controls (\u003Ca href=\"#F5\">Figure 5A\u003C/a>). CD9, a marker for EVs, had a high rate of low expression in healthy controls (\u003Ca href=\"#F5\">Figure 5A\u003C/a>). Next, we performed EV ELISA to quantify the tendency of these TTR aggregates and EV markers. Patient and control serum samples were diluted 2-fold or 16-fold, and EV ELISA was performed using a fixed volume (100&#x000a0;&#x000b5;L) of diluted serum. The absorbance was measured, and the amounts of TTR aggregates and CD63 in the serum EVs were compared. The absorbance of TTR aggregates increased to some extent in the control group, but hardly increased in the patient group (\u003Ca href=\"#F5\">Figure 5B\u003C/a>). The absorbance of CD63 increased in both groups but was significantly higher in the patient group than in the control group (\u003Ca href=\"#F5\">Figure 5B\u003C/a>). The amount of TTR aggregates on S-EVs was significantly lower in the patient group than in the healthy group, and the number of EV markers was significantly higher in the patient group than in the healthy group. Taken together, as the uptake of EVs, which promote V30M-TTR aggregation, into cells was increased by the complex of V30M-TTR and EVs (\u003Ca href=\"#F4\">Figures 4A&#x02013;C\u003C/a>), increased EVs levels in ATTRv amyloidosis could enhance tissue deposition of TTR aggregates, which follows a decrease of TTR aggregates in the serum of patients with ATTRv amyloidosis (\u003Ca href=\"#F5\">Figure 5C\u003C/a>).\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">FIGURE 5\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g005.jpg\" name=\"Figure5\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g005.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g005.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g005.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g005.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g005.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g005.jpg\" alt=\"www.frontiersin.org\" id=\"F5\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cstrong>FIGURE 5\u003C/strong>. TTR in Serum-derived EVs is reduced in patients with ATTRv amyloidosis. \u003Cstrong>(A)\u003C/strong> Western blotting analysis of S-EVs derived from patients and controls. TTR ladder bands were more obvious in the controls than in the patients. \u003Cstrong>(B)\u003C/strong> EV ELISA using serum of controls and patients. Absorbance of TTR aggregates was significantly higher in the healthy controls than in the patients with ATTRv amyloidosis, whereas absorbance of CD63 was significantly higher in the patients than in the healthy controls. N &#x0003d; 6, mean &#x000b1; S.E.; &#x0002a;, \u003Cem>p\u003C/em> &#x0003c; 0.05; &#x0002a;&#x0002a;, \u003Cem>p\u003C/em> &#x0003c; 0.005, Mann&#x02013;Whitney U test. \u003Cstrong>(C)\u003C/strong> A model of EV-mediated V30M-TTR cell deposition. TTR is mainly produced by the liver and secreted into the bloodstream, but the majority of patients with ATTRv amyloidosis produce TTR with the V30M mutation, which promotes aggregation of V30M-TTR on the membranes of Serum-derived EVs and facilitates deposition on cells and other surfaces, resulting in reduced TTR in Serum-derived EVs for patients with ATTRv amyloidosis. Increasing the amount of EVs in patients with ATTRv amyloidosis could further promote this deposition.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Ca id=\"h5\" name=\"h5\">\u003C/a>\u003Ch2>Discussion\u003C/h2>\u003Cp class=\"mb15\">In this study, we showed that TTR present in the blood was also present in serum-derived EVs, and that V30M-TTR aggregation is promoted at the surfaces of membranes such as serum-derived EVs. V30M-TTR aggregation is particularly enhanced in the majority of patients with ATTRv amyloidosis. We also showed that monomeric TTR-V30M promoted aggregation and increased cell deposition in the presence of EVs, even under non-acidic conditions. Compared to healthy subjects, patients with ATTRv amyloidosis showed decreased TTR aggregates and increased EV markers.\u003C/p>\u003Cp class=\"mb15\">In amyloidosis, the aggregation of the major causative protein is promoted on the surface of the EV membrane, which is assumed to alleviate the pathological conditions (\u003Ca href=\"#B49\">Yuyama et al., 2012\u003C/a>; \u003Ca href=\"#B9\">Falker et al., 2016\u003C/a>). TTR variant, as a major causative protein, causes TTR aggregation and deposition on specific tissues (\u003Ca href=\"#B5\">Bezerra et al., 2020\u003C/a>). In this study, we showed \u003Cem>via\u003C/em> atomic force microscopy that TTR aggregation is promoted by EVs and that TTR multimerizes on the surface of EVs. TTR forms a strong tetramer in serum (\u003Ca href=\"#B19\">Kanda et al., 1974\u003C/a>) and transports thyroxine and vitamin A through the binding region located in the central channel of the tetramer (\u003Ca href=\"#B36\">Saponaro et al., 2020\u003C/a>). In ATTRv amyloidosis, variants such as V30M in TTR destabilize the tetrameric structure and facilitate aggregation (\u003Ca href=\"#B17\">Saraiva, 1995\u003C/a>; \u003Ca href=\"#B39\">Sekijima et al., 2005\u003C/a>). In this study, the ThT assay and \u003Cem>in vitro\u003C/em> aggregation assay showed that V30M, a major variant of ATTRv amyloidosis, markedly enhanced TTR aggregation, even in the presence of EVs. The \u003Cem>in vitro\u003C/em> aggregation of TTR is hindered under neutral conditions and promoted under acidic conditions (\u003Ca href=\"#B7\">Colon and Kelly, 1992\u003C/a>). Interestingly, in the presence of EVs, TTR aggregation and cell deposition were promoted in this study, even under non-acidic conditions. The addition of purified V30M monomer alone did not cause TTR aggregation, as was observed for the addition of EVs alone as a control, suggesting that EVs did in fact induce TTR aggregation.\u003C/p>\u003Cp class=\"mb15\">In Alzheimer&#x02019;s disease, EVs remove A&#x003b2;, which is a toxic molecule in the brain (\u003Ca href=\"#B32\">P&#x000e9;rez-Gonz&#x000e1;lez et al., 2020\u003C/a>). EV proteins accumulate in the brain plaque of patients with Alzheimer&#x02019;s disease, suggesting their strong involvement in the pathogenesis of this disease (\u003Ca href=\"#B34\">Rajendran et al., 2006\u003C/a>). The enhanced cellular deposition of TTR aggregates by EVs indicates that the EV-mediated tissue deposition of TTR aggregates may be involved in ATTRv amyloidosis as well as Alzheimer&#x02019;s disease. In fact, the amount of EV markers in serum was significantly higher in patients with ATTRv amyloidosis than in healthy subjects. This suggests that EVs may be actively involved in ATTRv amyloidosis. However, although TTR can be transported throughout the body by the bloodstream, TTR aggregate deposits are found in specific tissues. Various membrane proteins are present on the surface of EV membranes, where they act on specific cells (\u003Ca href=\"#B16\">Hoshino et al., 2015\u003C/a>). Therefore, it is possible that tissue-specific deposition of TTR amyloid is mediated by the EV pathway. A detailed analysis of TTR aggregation in the EV pathway will help further elucidate the pathogenesis of ATTRv amyloidosis.\u003C/p>\u003Cp class=\"mb15\">TTR has been implicated in dementia, whereby a lack of TTR can exacerbate cognitive impairment (\u003Ca href=\"#B41\">Sousa et al., 2004\u003C/a>). With regard to Alzheimer&#x02019;s disease in amyloidosis with dementia, reduced TTR levels have been detected in both the cerebrospinal fluid and plasma of patients with Alzheimer&#x02019;s disease (\u003Ca href=\"#B14\">Han et al., 2011\u003C/a>; \u003Ca href=\"#B36\">Saponaro et al., 2020\u003C/a>) and in subjects with mild cognitive impairment, becoming more pronounced as the disease progresses. A&#x003b2;, which is the major causative protein of Alzheimer&#x02019;s disease, and TTR have also been analyzed molecularly. For example, TTR inhibits the primary and secondary nucleation of A&#x003b2; aggregation, restricting each the toxicity of A&#x003b2; oligomers and the proliferative ability of fibrils (\u003Ca href=\"#B11\">Ghadami et al., 2020\u003C/a>; \u003Ca href=\"#B12\">Gi&#x000e3;o et al., 2020\u003C/a>), as well as the proteolytic activity of A&#x003b2; (\u003Ca href=\"#B36\">Saponaro et al., 2020\u003C/a>). In other words, TTR can bind to A&#x003b2; and inhibit A&#x003b2; aggregation and toxicity, suggesting a protecting role for TTR in Alzheimer&#x02019;s disease (\u003Ca href=\"#B37\">Schwarzman et al., 1994\u003C/a>). As A&#x003b2; promotes aggregation at the surface of EV membranes (\u003Ca href=\"#B49\">Yuyama et al., 2012\u003C/a>), it appears consistent with the phenomenon of TTR observed in this study. TTR is expressed in the choroid plexus in the brain (Sakai et al., 2017) in addition to the liver and A&#x003b2; is also expressed in EVs in serum across the brain blood barrier (\u003Ca href=\"#B24\">Lim et al., 2019\u003C/a>), suggesting that A&#x003b2; and TTR can transfer fluidly through EVs. Thus, the targeting of A&#x003b2; degradation and A&#x003b2; aggregation inhibition in the brain \u003Cem>via\u003C/em> EVs and TTR could represent a new therapeutic candidate for Alzheimer&#x02019;s disease. Therefore, it is necessary to further analyze the relationship between TTR and A&#x003b2; in EVs derived from the brain, in addition to EVs derived from the liver and other blood sources.\u003C/p>\u003Ca id=\"h6\" name=\"h6\">\u003C/a>\u003Ch2>Data Availability Statement\u003C/h2>\u003Cp class=\"mb15\">The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.\u003C/p>\u003Ca id=\"h7\" name=\"h7\">\u003C/a>\u003Ch2>Ethics Statement\u003C/h2>\u003Cp class=\"mb0\">The studies involving human participants were reviewed and approved by the Kanzawa University Ethics Committee Reference. The patients/participants provided their written informed consent to participate in this study.\u003C/p>\u003Ca id=\"h8\" name=\"h8\">\u003C/a>\u003Ch2>Author Contributions\u003C/h2>\u003Cp class=\"mb0\">HY, HK, MY, and RH designed the experiments. HY, HK, NK, AK, YT, and ZT performed the experiments. HY, HK, NK, and RH analyzed the data. HY, HK, AK, YT, and RH drafted the manuscript. KS, KO, MY, and RH supervised the study.\u003C/p>\u003Ca id=\"h9\" name=\"h9\">\u003C/a>\u003Ch2>Funding\u003C/h2>\u003Cp class=\"mb0\">This work was supported by Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST) (No. JPMJCR18H4 to RH), Grants-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (No. 19K22578 to RH, No. 15K06710 to HK), and a NanoLSI Transdisciplinary Research Promotion Grant in FY 2018 (HY, HK, and NK).\u003C/p>\u003Ca id=\"h10\" name=\"h10\">\u003C/a>\u003Ch2>Conflict of Interest\u003C/h2>\u003Cp class=\"mb0\">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003C/p>\u003Ca id=\"h11\" name=\"h11\">\u003C/a>\u003Ch2>Publisher&#x02019;s Note\u003C/h2>\u003Cp class=\"mb15\">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.\u003C/p>\u003Ca id=\"h12\" name=\"h12\">\u003C/a>\u003Ch2>Acknowledgments\u003C/h2>\u003Cp class=\"mb03\">We are grateful to Dr. S. Horike for technical advice (Research Center for Experimental Modeling of Human Disease, Kanazawa University); Dr. T. Ando for technical support of HS-AFM analysis (Kanazawa University).\u003C/p>\u003Ca id=\"h13\" name=\"h13\">\u003C/a>\u003Ch2>Supplementary Material\u003C/h2>\u003Cp class=\"mb15\" id=\"SM1\">The Supplementary Material for this article can be found online at: \u003Ca href=\"https://www.frontiersin.org/articles/10.3389/fmolb.2022.839917/full#supplementary-material\">https://www.frontiersin.org/articles/10.3389/fmolb.2022.839917/full&#x00023;supplementary-material\u003C/a>\u003C/p>\u003Ca id=\"h14\" name=\"h14\">\u003C/a>\u003Ch2>References\u003C/h2>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B1\" id=\"B1\">\u003C/a>Agostinho, P., A. Cunha, R., and Oliveira, C. (2010). Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimers Disease. \u003Cem>Cpd\u003C/em> 16, 2766&#x02013;2778. doi:10.2174/138161210793176572\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.2174/138161210793176572\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Neuroinflammation,+Oxidative+Stress+and+the+Pathogenesis+of+Alzheimers+Disease&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B2\" id=\"B2\">\u003C/a>Ando, T., Uchihashi, T., and Kodera, N. (2013). High-speed AFM and Applications to Biomolecular Systems. \u003Cem>Annu. Rev. Biophys.\u003C/em> 42, 393&#x02013;414. doi:10.1146/annurev-biophys-083012-130324\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23541159/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1146/annurev-biophys-083012-130324\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=High-speed+AFM+and+Applications+to+Biomolecular+Systems&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B3\" id=\"B3\">\u003C/a>Ando, Y., Suhr, O., and el-Salhy, M. (1998). Oxidative Stress and Amyloidosis. \u003Cem>Histol. Histopathol\u003C/em> 13, 845&#x02013;850. doi:10.14670/HH-13.845\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/9690141/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.14670/HH-13.845\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Oxidative+Stress+and+Amyloidosis&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B4\" id=\"B4\">\u003C/a>Bachurski, D., Schuldner, M., Nguyen, P.-H., Malz, A., Reiners, K. S., Grenzi, P. C., et al. (2019). Extracellular Vesicle Measurements with Nanoparticle Tracking Analysis - an Accuracy and Repeatability Comparison between NanoSight NS300 and ZetaView. \u003Cem>J. Extracellular Vesicles\u003C/em> 8, 1596016. doi:10.1080/20013078.2019.1596016\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30988894/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1080/20013078.2019.1596016\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Extracellular+Vesicle+Measurements+with+Nanoparticle+Tracking+Analysis+-+an+Accuracy+and+Repeatability+Comparison+between+NanoSight+NS300+and+ZetaView&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B5\" id=\"B5\">\u003C/a>Bezerra, F., Saraiva, M. J., and Almeida, M. R. (2020). Modulation of the Mechanisms Driving Transthyretin Amyloidosis. \u003Cem>Front. Mol. Neurosci.\u003C/em> 13, 592644. doi:10.3389/fnmol.2020.592644\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33362465/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3389/fnmol.2020.592644\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Modulation+of+the+Mechanisms+Driving+Transthyretin+Amyloidosis&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B6\" id=\"B6\">\u003C/a>Buxbaum, J. N., and Linke, R. P. (2012). A Molecular History of the Amyloidoses. \u003Cem>J. Mol. Biol.\u003C/em> 421, 142&#x02013;159. doi:10.1016/j.jmb.2012.01.024\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1016/j.jmb.2012.01.024\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=A+Molecular+History+of+the+Amyloidoses&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B7\" id=\"B7\">\u003C/a>Colon, W., and Kelly, J. W. (1992). Partial Denaturation of Transthyretin Is Sufficient for Amyloid Fibril Formation \u003Cem>In Vitro\u003C/em>. \u003Cem>Biochemistry\u003C/em> 31, 8654&#x02013;8660. doi:10.1021/bi00151a036\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/1390650/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1021/bi00151a036\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Partial+Denaturation+of+Transthyretin+Is+Sufficient+for+Amyloid+Fibril+Formation+In+Vitro&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B8\" id=\"B8\">\u003C/a>Dong, R., Liu, Y., Yang, Y., Wang, H., Xu, Y., and Zhang, Z. (2019). MSC-derived Exosomes-Based Therapy for Peripheral Nerve Injury: A Novel Therapeutic Strategy. \u003Cem>Biomed. Res. Int.\u003C/em> 2019, 1&#x02013;12. doi:10.1155/2019/6458237\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31531362/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1155/2019/6458237\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=MSC-derived+Exosomes-Based+Therapy+for+Peripheral+Nerve+Injury:+A+Novel+Therapeutic+Strategy&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B9\" id=\"B9\">\u003C/a>Falker, C., Hartmann, A., Guett, I., Dohler, F., Altmeppen, H., Betzel, C., et al. (2016). Exosomal Cellular Prion Protein Drives Fibrillization of Amyloid Beta and Counteracts Amyloid Beta-Mediated Neurotoxicity. \u003Cem>J. Neurochem.\u003C/em> 137, 88&#x02013;100. doi:10.1111/jnc.13514\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1111/jnc.13514\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Exosomal+Cellular+Prion+Protein+Drives+Fibrillization+of+Amyloid+Beta+and+Counteracts+Amyloid+Beta-Mediated+Neurotoxicity&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B10\" id=\"B10\">\u003C/a>Fan, B., Chopp, M., Zhang, Z. G., and Liu, X. S. (2021). Treatment of Diabetic Peripheral Neuropathy with Engineered Mesenchymal Stromal Cell-Derived Exosomes Enriched with microRNA-146a Provide Amplified Therapeutic Efficacy. \u003Cem>Exp. Neurol.\u003C/em> 341, 113694. doi:10.1016/j.expneurol.2021.113694\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33727097/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.expneurol.2021.113694\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Treatment+of+Diabetic+Peripheral+Neuropathy+with+Engineered+Mesenchymal+Stromal+Cell-Derived+Exosomes+Enriched+with+microRNA-146a+Provide+Amplified+Therapeutic+Efficacy&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B11\" id=\"B11\">\u003C/a>Ghadami, S. A., Chia, S., Ruggeri, F. S., Meisl, G., Bemporad, F., Habchi, J., et al. (2020). Transthyretin Inhibits Primary and Secondary Nucleations of Amyloid-&#x003b2; Peptide Aggregation and Reduces the Toxicity of its Oligomers. \u003Cem>Biomacromolecules\u003C/em> 21, 1112&#x02013;1125. doi:10.1021/acs.biomac.9b01475\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32011129/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1021/acs.biomac.9b01475\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Transthyretin+Inhibits+Primary+and+Secondary+Nucleations+of+Amyloid-+Peptide+Aggregation+and+Reduces+the+Toxicity+of+its+Oligomers&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B12\" id=\"B12\">\u003C/a>Gi&#x000e3;o, T., Saavedra, J., Cotrina, E., Quintana, J., Llop, J., Arsequell, G., et al. (2020). Undiscovered Roles for Transthyretin: From a Transporter Protein to a New Therapeutic Target for Alzheimer&#x00027;s Disease. \u003Cem>Ijms\u003C/em> 21, 2075. doi:10.3390/ijms21062075\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.3390/ijms21062075\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Undiscovered+Roles+for+Transthyretin:+From+a+Transporter+Protein+to+a+New+Therapeutic+Target+for+Alzheimer's+Disease&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B13\" id=\"B13\">\u003C/a>Gomperts, S. N. (2016). Lewy Body Dementias. \u003Cem>CONTINUUM: Lifelong Learn. Neurol.\u003C/em> 22, 435&#x02013;463. doi:10.1212/CON.0000000000000309\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27042903/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1212/CON.0000000000000309\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Lewy+Body+Dementias&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B14\" id=\"B14\">\u003C/a>Han, S.-H., Jung, E. S., Sohn, J.-H., Hong, H. J., Hong, H. S., Kim, J. W., et al. (2011). Human Serum Transthyretin Levels Correlate Inversely with Alzheimer&#x00027;s Disease. \u003Cem>Jad\u003C/em> 25, 77&#x02013;84. doi:10.3233/JAD-2011-102145\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/21335655/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3233/JAD-2011-102145\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Human+Serum+Transthyretin+Levels+Correlate+Inversely+with+Alzheimer's+Disease&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B15\" id=\"B15\">\u003C/a>Hashimoto, T., Fujii, D., Naka, Y., Kashiwagi-Hakozaki, M., Matsuo, Y., Matsuura, Y., et al. (2020). Collagenous Alzheimer Amyloid Plaque Component Impacts on the Compaction of Amyloid-&#x003b2; Plaques. \u003Cem>Acta Neuropathol. Commun.\u003C/em> 8, 212. doi:10.1186/s40478-020-01075-5\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33287899/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1186/s40478-020-01075-5\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Collagenous+Alzheimer+Amyloid+Plaque+Component+Impacts+on+the+Compaction+of+Amyloid-+Plaques&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B16\" id=\"B16\">\u003C/a>Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., et al. (2015). Tumour Exosome Integrins Determine Organotropic Metastasis. \u003Cem>Nature\u003C/em> 527, 329&#x02013;335. doi:10.1038/nature15756\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26524530/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/nature15756\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Tumour+Exosome+Integrins+Determine+Organotropic+Metastasis&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B17\" id=\"B17\">\u003C/a>Jo&#x000e3;o, M., and Saraiva, M. (1995). Transthyretin Mutations in Health and Disease. \u003Cem>Hum. Mutat.\u003C/em> 5, 191&#x02013;196. doi:10.1002/humu.1380050302\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/7599630/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1002/humu.1380050302\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Transthyretin+Mutations+in+Health+and+Disease&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B18\" id=\"B18\">\u003C/a>Kalluri, R., and LeBleu, V. S. (2020). The Biology , Function , and Biomedical Applications of Exosomes. \u003Cem>Science\u003C/em> 367, eaau6977. doi:10.1126/science.aau6977\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32029601/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1126/science.aau6977\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+Biology+,+Function+,+and+Biomedical+Applications+of+Exosomes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B19\" id=\"B19\">\u003C/a>Kanda, Y., Goodman, D. S., Canfield, R. E., and Morgan, F. J. (1974). The Amino Acid Sequence of Human Plasma Prealbumin. \u003Cem>J. Biol. Chem.\u003C/em> 249, 6796&#x02013;6805. doi:10.1016/s0021-9258(19)42128-5\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1016/s0021-9258(19)42128-5\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+Amino+Acid+Sequence+of+Human+Plasma+Prealbumin&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B20\" id=\"B20\">\u003C/a>Kawahara, H., Imai, T., Imataka, H., Tsujimoto, M., Matsumoto, K., and Okano, H. (2008). Neural RNA-Binding Protein Musashi1 Inhibits Translation Initiation by Competing with eIF4G for PABP. \u003Cem>J. Cell Biol.\u003C/em> 181, 639&#x02013;653. doi:10.1083/jcb.200708004\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/18490513/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1083/jcb.200708004\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Neural+RNA-Binding+Protein+Musashi1+Inhibits+Translation+Initiation+by+Competing+with+eIF4G+for+PABP&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B21\" id=\"B21\">\u003C/a>Kawahara, H., Okada, Y., Imai, T., Iwanami, A., Mischel, P. S., and Okano, H. (2011). Musashi1 Cooperates in Abnormal Cell Lineage Protein 28 (Lin28)-Mediated Let-7 Family microRNA Biogenesis in Early Neural Differentiation. \u003Cem>J. Biol. Chem.\u003C/em> 286, 16121&#x02013;16130. doi:10.1074/jbc.M110.199166\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/21378162/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1074/jbc.M110.199166\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Musashi1+Cooperates+in+Abnormal+Cell+Lineage+Protein+28+(Lin28)-Mediated+Let-7+Family+microRNA+Biogenesis+in+Early+Neural+Differentiation&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B22\" id=\"B22\">\u003C/a>Kodera, N., Abe, H., Nguyen, P. D. N., and Ono, S. (2021). Native Cyclase-Associated Protein and Actin from \u003Cem>Xenopus laevis\u003C/em> Oocytes Form a Unique 4:4 Complex with a Tripartite Structure. \u003Cem>J. Biol. Chem.\u003C/em> 296, 100649. doi:10.1016/j.jbc.2021.100649\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1016/j.jbc.2021.100649\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Native+Cyclase-Associated+Protein+and+Actin+from+Xenopus+laevis+Oocytes+Form+a+Unique+4:4+Complex+with+a+Tripartite+Structure&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B23\" id=\"B23\">\u003C/a>Kori, S., Ferry, L., Matano, S., Jimenji, T., Kodera, N., Tsusaka, T., et al. (2019). Structure of the UHRF1 Tandem Tudor Domain Bound to a Methylated Non-histone Protein, LIG1, Reveals Rules for Binding and Regulation. \u003Cem>Structure\u003C/em> 27, 485&#x02013;496. doi:10.1016/j.str.2018.11.012\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30639225/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.str.2018.11.012\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Structure+of+the+UHRF1+Tandem+Tudor+Domain+Bound+to+a+Methylated+Non-histone+Protein,+LIG1,+Reveals+Rules+for+Binding+and+Regulation&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B24\" id=\"B24\">\u003C/a>Lim, C. Z. J., Zhang, Y., Chen, Y., Zhao, H., Stephenson, M. C., Ho, N. R. Y., et al. (2019). Subtyping of Circulating Exosome-Bound Amyloid &#x003b2; Reflects Brain Plaque Deposition. \u003Cem>Nat. Commun.\u003C/em> 10, 1144. doi:10.1038/s41467-019-09030-2\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30850633/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/s41467-019-09030-2\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Subtyping+of+Circulating+Exosome-Bound+Amyloid++Reflects+Brain+Plaque+Deposition&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B25\" id=\"B25\">\u003C/a>Lim, K., Kodera, N., Wang, H., Mohamed, M. S., Hazawa, M., Kobayashi, A., et al. (2020). High-Speed AFM Reveals Molecular Dynamics of Human Influenza A Hemagglutinin and its Interaction with Exosomes. \u003Cem>Nano Lett.\u003C/em> 20, 6320&#x02013;6328. doi:10.1021/acs.nanolett.0c01755\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32787163/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1021/acs.nanolett.0c01755\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=High-Speed+AFM+Reveals+Molecular+Dynamics+of+Human+Influenza+A+Hemagglutinin+and+its+Interaction+with+Exosomes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B26\" id=\"B26\">\u003C/a>Lim, K., Nishide, G., Yoshida, T., Watanabe&#x02010;Nakayama, T., Kobayashi, A., Hazawa, M., et al. (2021). Millisecond Dynamic of SARS&#x02010;CoV&#x02010;2 Spike and its Interaction with ACE2 Receptor and Small Extracellular Vesicles. \u003Cem>J. Extracellular Vesicle\u003C/em> 10, e12170. doi:10.1002/jev2.12170\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1002/jev2.12170\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Millisecond+Dynamic+of+SARSCoV2+Spike+and+its+Interaction+with+ACE2+Receptor+and+Small+Extracellular+Vesicles&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B27\" id=\"B27\">\u003C/a>Merlini, G., Seldin, D. C., and Gertz, M. A. (2011). Amyloidosis: Pathogenesis and New Therapeutic Options. \u003Cem>Jco\u003C/em> 29, 1924&#x02013;1933. doi:10.1200/JCO.2010.32.2271\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/21483018/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1200/JCO.2010.32.2271\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Amyloidosis:+Pathogenesis+and+New+Therapeutic+Options&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B28\" id=\"B28\">\u003C/a>Nakai, W., Yoshida, T., Diez, D., Miyatake, Y., Nishibu, T., Imawaka, N., et al. (2016). A Novel Affinity-Based Method for the Isolation of Highly Purified Extracellular Vesicles. \u003Cem>Sci. Rep.\u003C/em> 6, 33935. doi:10.1038/srep33935\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27659060/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/srep33935\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=A+Novel+Affinity-Based+Method+for+the+Isolation+of+Highly+Purified+Extracellular+Vesicles&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B29\" id=\"B29\">\u003C/a>Ngo, K. X., Kodera, N., Katayama, E., Ando, T., and Uyeda, T. Q. (2015). Cofilin-induced Unidirectional Cooperative Conformational Changes in Actin Filaments Revealed by High-Speed Atomic Force Microscopy. \u003Cem>Elife\u003C/em> 4. doi:10.7554/eLife.04806\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25642645/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.7554/eLife.04806\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Cofilin-induced+Unidirectional+Cooperative+Conformational+Changes+in+Actin+Filaments+Revealed+by+High-Speed+Atomic+Force+Microscopy&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B30\" id=\"B30\">\u003C/a>Nonaka, S., Salim, E., Kamiya, K., Hori, A., Nainu, F., Asri, R. M., et al. (2020). Molecular and Functional Analysis of Pore-Forming Toxin Monalysin from Entomopathogenic Bacterium Pseudomonas Entomophila. \u003Cem>Front. Immunol.\u003C/em> 11, 520. doi:10.3389/fimmu.2020.00520\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32292407/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3389/fimmu.2020.00520\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Molecular+and+Functional+Analysis+of+Pore-Forming+Toxin+Monalysin+from+Entomopathogenic+Bacterium+Pseudomonas+Entomophila&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B31\" id=\"B31\">\u003C/a>On&#x000f3;di, Z., Pelyhe, C., Ter&#x000e9;zia Nagy, C., Brenner, G. B., Alm&#x000e1;si, L., Kittel, &#x000c1;., et al. (2018). Isolation of High-Purity Extracellular Vesicles by the Combination of Iodixanol Density Gradient Ultracentrifugation and Bind-Elute Chromatography from Blood Plasma. \u003Cem>Front. Physiol.\u003C/em> 9, 1479. doi:10.3389/fphys.2018.01479\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30405435/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3389/fphys.2018.01479\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Isolation+of+High-Purity+Extracellular+Vesicles+by+the+Combination+of+Iodixanol+Density+Gradient+Ultracentrifugation+and+Bind-Elute+Chromatography+from+Blood+Plasma&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B32\" id=\"B32\">\u003C/a>P&#x000e9;rez&#x02010;Gonz&#x000e1;lez, R., Kim, Y., Miller, C., Pacheco&#x02010;Quinto, J., Eckman, E. A., and Levy, E. (2020). Extracellular Vesicles: where the Amyloid Precursor Protein Carboxyl&#x02010;terminal Fragments Accumulate and Amyloid&#x02010;&#x003b2; Oligomerizes. \u003Cem>FASEB j.\u003C/em> 34, 12922&#x02013;12931. doi:10.1096/fj.202000823R\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32772431/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1096/fj.202000823R\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Extracellular+Vesicles:+where+the+Amyloid+Precursor+Protein+Carboxylterminal+Fragments+Accumulate+and+Amyloid+Oligomerizes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B33\" id=\"B33\">\u003C/a>Picken, M. M. (2020). The Pathology of Amyloidosis in Classification: A Review. \u003Cem>Acta Haematol.\u003C/em> 143, 322&#x02013;334. doi:10.1159/000506696\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32392555/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1159/000506696\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+Pathology+of+Amyloidosis+in+Classification:+A+Review&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B34\" id=\"B34\">\u003C/a>Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., et al. (2006). Alzheimer&#x00027;s Disease Beta-Amyloid Peptides Are Released in Association with Exosomes. \u003Cem>Proc. Natl. Acad. Sci.\u003C/em> 103, 11172&#x02013;11177. doi:10.1073/pnas.0603838103\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/16837572/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1073/pnas.0603838103\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Alzheimer's+Disease+Beta-Amyloid+Peptides+Are+Released+in+Association+with+Exosomes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B35\" id=\"B35\">\u003C/a>Saito, S., Ando, Y., Nakamura, M., Ueda, M., Kim, J., Ishima, Y., et al. (2005). Effect of Nitric Oxide in Amyloid Fibril Formation on Transthyretin-Related Amyloidosis. \u003Cem>Biochemistry\u003C/em> 44, 11122&#x02013;11129. doi:10.1021/bi050327i\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/16101296/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1021/bi050327i\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Effect+of+Nitric+Oxide+in+Amyloid+Fibril+Formation+on+Transthyretin-Related+Amyloidosis&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B36\" id=\"B36\">\u003C/a>Saponaro, F., Kim, J. H., and Chiellini, G. (2020). Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer&#x00027;s Disease? \u003Cem>Ijms\u003C/em> 21, 8672. doi:10.3390/ijms21228672\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33212973/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3390/ijms21228672\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Transthyretin+Stabilization:+An+Emerging+Strategy+for+the+Treatment+of+Alzheimer's+Disease?&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B37\" id=\"B37\">\u003C/a>Schwarzman, A. L., Gregori, L., Vitek, M. P., Lyubski, S., Strittmatter, W. J., Enghilde, J. J., et al. (1994). Transthyretin Sequesters Amyloid Beta Protein and Prevents Amyloid Formation. \u003Cem>Proc. Natl. Acad. Sci.\u003C/em> 91, 8368&#x02013;8372. doi:10.1073/pnas.91.18.8368\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/8078889/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1073/pnas.91.18.8368\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Transthyretin+Sequesters+Amyloid+Beta+Protein+and+Prevents+Amyloid+Formation&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B38\" id=\"B38\">\u003C/a>Sekijima, Y., Ueda, M., Koike, H., Misawa, S., Ishii, T., and Ando, Y. (2018). Diagnosis and Management of Transthyretin Familial Amyloid Polyneuropathy in Japan: Red-Flag Symptom Clusters and Treatment Algorithm. \u003Cem>Orphanet J. Rare Dis.\u003C/em> 13, 6. doi:10.1186/s13023-017-0726-x\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1186/s13023-017-0726-x\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Diagnosis+and+Management+of+Transthyretin+Familial+Amyloid+Polyneuropathy+in+Japan:+Red-Flag+Symptom+Clusters+and+Treatment+Algorithm&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B39\" id=\"B39\">\u003C/a>Sekijima, Y., Wiseman, R. L., Matteson, J., Hammarstr&#x000f6;m, P., Miller, S. R., Sawkar, A. R., et al. (2005). The Biological and Chemical Basis for Tissue-Selective Amyloid Disease. \u003Cem>Cell\u003C/em> 121, 73&#x02013;85. doi:10.1016/j.cell.2005.01.018\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/15820680/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.cell.2005.01.018\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+Biological+and+Chemical+Basis+for+Tissue-Selective+Amyloid+Disease&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B40\" id=\"B40\">\u003C/a>Sipe, J. D., and Cohen, A. S. (2000). Review: History of the Amyloid Fibril. \u003Cem>J. Struct. Biol.\u003C/em> 130, 88&#x02013;98. doi:10.1006/jsbi.2000.4221\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1006/jsbi.2000.4221\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Review:+History+of+the+Amyloid+Fibril&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B41\" id=\"B41\">\u003C/a>Sousa, J. C., Grandela, C., Fern&#x000e1;ndez-Ruiz, J., de Miguel, R., de Sousa, L., Magalh&#x000e3;es, A. I., et al. (2004). Transthyretin Is Involved in Depression-like Behaviour and Exploratory Activity. \u003Cem>J. Neurochem.\u003C/em> 88, 1052&#x02013;1058. doi:10.1046/j.1471-4159.2003.02309.x\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1046/j.1471-4159.2003.02309.x\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Transthyretin+Is+Involved+in+Depression-like+Behaviour+and+Exploratory+Activity&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B42\" id=\"B42\">\u003C/a>Takov, K., Yellon, D. M., and Davidson, S. M. (2017). Confounding Factors in Vesicle Uptake Studies Using Fluorescent Lipophilic Membrane Dyes. \u003Cem>J. Extracellular Vesicles\u003C/em> 6, 1388731. doi:10.1080/20013078.2017.1388731\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1080/20013078.2017.1388731\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Confounding+Factors+in+Vesicle+Uptake+Studies+Using+Fluorescent+Lipophilic+Membrane+Dyes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B43\" id=\"B43\">\u003C/a>Tangthavewattana, S., Leelawatwattana, L., and Prapunpoj, P. (2019). The Hydrophobic C&#x02010;terminal Sequence of Transthyretin Affects its Catalytic Kinetics towards Amidated Neuropeptide Y. \u003Cem>FEBS Open Bio\u003C/em> 9, 594&#x02013;604. doi:10.1002/2211-5463.12604\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30984535/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1002/2211-5463.12604\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+Hydrophobic+Cterminal+Sequence+of+Transthyretin+Affects+its+Catalytic+Kinetics+towards+Amidated+Neuropeptide+Y&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B44\" id=\"B44\">\u003C/a>Tasaki, M., Ueda, M., Ochiai, S., Tanabe, Y., Murata, S., Misumi, Y., et al. (2010). Transmission of Circulating Cell-free AA Amyloid Oligomers in Exosomes Vectors via a Prion-like Mechanism. \u003Cem>Biochem. Biophysical Res. Commun.\u003C/em> 400, 559&#x02013;562. doi:10.1016/j.bbrc.2010.08.101\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1016/j.bbrc.2010.08.101\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Transmission+of+Circulating+Cell-free+AA+Amyloid+Oligomers+in+Exosomes+Vectors+via+a+Prion-like+Mechanism&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B45\" id=\"B45\">\u003C/a>Tong, M., Cheng, S.-B., Chen, Q., DeSousa, J., Stone, P. R., James, J. L., et al. (2017). Aggregated Transthyretin Is Specifically Packaged into Placental Nano-Vesicles in Preeclampsia. \u003Cem>Sci. Rep.\u003C/em> 7, 6694. doi:10.1038/s41598-017-07017-x\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28751735/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/s41598-017-07017-x\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Aggregated+Transthyretin+Is+Specifically+Packaged+into+Placental+Nano-Vesicles+in+Preeclampsia&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B46\" id=\"B46\">\u003C/a>Uchihashi, T., Kodera, N., and Ando, T. (2012). Guide to Video Recording of Structure Dynamics and Dynamic Processes of Proteins by High-Speed Atomic Force Microscopy. \u003Cem>Nat. Protoc.\u003C/em> 7, 1193&#x02013;1206. doi:10.1038/nprot.2012.047\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22635111/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/nprot.2012.047\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Guide+to+Video+Recording+of+Structure+Dynamics+and+Dynamic+Processes+of+Proteins+by+High-Speed+Atomic+Force+Microscopy&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B47\" id=\"B47\">\u003C/a>Woo, J., Sharma, S., and Gimzewski, J. (2016). The Role of Isolation Methods on a Nanoscale Surface Structure and its Effect on the Size of Exosomes. \u003Cem>J. Circulating Biomarkers\u003C/em> 5, 11. doi:10.5772/64148\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28936259/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.5772/64148\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+Role+of+Isolation+Methods+on+a+Nanoscale+Surface+Structure+and+its+Effect+on+the+Size+of+Exosomes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B48\" id=\"B48\">\u003C/a>Yee, A. W., Aldeghi, M., Blakeley, M. P., Ostermann, A., Mas, P. J., Moulin, M., et al. (2019). A Molecular Mechanism for Transthyretin Amyloidogenesis. \u003Cem>Nat. Commun.\u003C/em> 10, 925. doi:10.1038/s41467-019-08609-z\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30804345/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/s41467-019-08609-z\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=A+Molecular+Mechanism+for+Transthyretin+Amyloidogenesis&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B49\" id=\"B49\">\u003C/a>Yuyama, K., Sun, H., Mitsutake, S., and Igarashi, Y. (2012). Sphingolipid-modulated Exosome Secretion Promotes Clearance of Amyloid-&#x003b2; by Microglia. \u003Cem>J. Biol. Chem.\u003C/em> 287, 10977&#x02013;10989. doi:10.1074/jbc.M111.324616\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1074/jbc.M111.324616\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Sphingolipid-modulated+Exosome+Secretion+Promotes+Clearance+of+Amyloid-+by+Microglia&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B50\" id=\"B50\">\u003C/a>Yuyama, K., Sun, H., Sakai, S., Mitsutake, S., Okada, M., Tahara, H., et al. (2014). Decreased Amyloid-&#x003b2; Pathologies by Intracerebral Loading of Glycosphingolipid-Enriched Exosomes in Alzheimer Model Mice. \u003Cem>J. Biol. Chem.\u003C/em> 289, 24488&#x02013;24498. doi:10.1074/jbc.M114.577213\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1074/jbc.M114.577213\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Decreased+Amyloid-+Pathologies+by+Intracerebral+Loading+of+Glycosphingolipid-Enriched+Exosomes+in+Alzheimer+Model+Mice&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003C/div>\u003Cdiv class=\"thinLineM20\">\u003C/div>\u003Cdiv class=\"AbstractSummary\">\u003Cp>\u003Cspan>Keywords:\u003C/span> amyloidosis, transthyretin, extracellular vesicle, ATTRv amyloidosis, atomic force microscope\u003C/p>\u003Cp>\u003Cspan>Citation:\u003C/span> Yamaguchi H, Kawahara H, Kodera N, Kumaki A, Tada Y, Tang Z, Sakai K, Ono K, Yamada M and Hanayama R (2022) Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis. \u003Cem>Front. Mol. Biosci.\u003C/em> 9:839917. doi: 10.3389/fmolb.2022.839917\u003C/p>\u003Cp id=\"timestamps\">\u003Cspan>Received:\u003C/span> 20 December 2021; \u003Cspan>Accepted:\u003C/span> 22 February 2022;\u003Cbr>\u003Cspan>Published:\u003C/span> 23 March 2022.\u003C/p>\u003Cdiv>\u003Cp>Edited by:\u003C/p> \u003Ca href=\"https://loop.frontiersin.org/people/822476/overview\">Chiara Porro\u003C/a>, University of Foggia, Italy\u003C/div>\u003Cdiv>\u003Cp>Reviewed by:\u003C/p> \u003Ca href=\"https://loop.frontiersin.org/people/104701/overview\">Mauro Manno\u003C/a>, National Research Council (CNR), Italy\u003Cbr>\u003Ca href=\"https://loop.frontiersin.org/people/1193304/overview\">Gefei Chen\u003C/a>, Karolinska Institutet (KI), Sweden\u003C/div>\u003Cp>\u003Cspan>Copyright\u003C/span> &#x000a9; 2022 Yamaguchi, Kawahara, Kodera, Kumaki, Tada, Tang, Sakai, Ono, Yamada and Hanayama. This is an open-access article distributed under the terms of the \u003Ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/4.0/\" target=\"_blank\">Creative Commons Attribution License (CC BY).\u003C/a> The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.\u003C/p>\u003Cp>\u003Cspan>&#x0002a;Correspondence:\u003C/span> Hironori Kawahara, \u003Ca id=\"encmail\">a2F3YWhhcmFAbWVkLmthbmF6YXdhLXUuYWMuanA=\u003C/a>; Rikinari Hanayama, \u003Ca id=\"encmail\">aGFuYXlhbWFAbWVkLmthbmF6YXdhLXUuYWMuanA=\u003C/a>\u003C/p>\u003Cdiv class=\"clear\">\u003C/div>\u003C/div>","\u003Cul class=\"flyoutJournal\">\u003Cli>\u003Ca href=\"#h1\">Abstract\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h2\">Introduction\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h3\">Materials and Methods\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h4\">Results\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h5\">Discussion\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h6\">Data Availability Statement\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h7\">Ethics Statement\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h8\">Author Contributions\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h9\">Funding\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h10\">Conflict of Interest\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h11\">Publisher&#x02019;s Note\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h12\">Acknowledgments\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h13\">Supplementary Material\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h14\">References\u003C/a>\u003C/li>\u003C/ul>",[686,691,697,700,706],{"name":687,"fileServerPackageEntryId":19,"fileServerId":688,"fileServerVersionNumber":395,"type":689},"EPUB.epub","839917/epub",{"code":690,"name":690},"EPUB",{"name":692,"fileServerPackageEntryId":693,"fileServerId":694,"fileServerVersionNumber":395,"type":695},"fmolb-09-839917.pdf","fmolb-09-839917/fmolb-09-839917.pdf","839917/pubmed-zip",{"code":696,"name":696},"PDF",{"name":692,"fileServerPackageEntryId":19,"fileServerId":698,"fileServerVersionNumber":395,"type":699},"839917/publishers-proof/pdf",{"code":696,"name":696},{"name":701,"fileServerPackageEntryId":702,"fileServerId":694,"fileServerVersionNumber":395,"type":703},"fmolb-09-839917.xml","fmolb-09-839917/fmolb-09-839917.xml",{"code":704,"name":705},"NLM_XML","XML",{"name":707,"fileServerPackageEntryId":19,"fileServerId":708,"fileServerVersionNumber":395,"type":709},"Provisional PDF.pdf","839917/provisional-pdf",{"code":696,"name":696},"v3",{"title":712,"link":713,"meta":717,"script":847},"Frontiers | Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis",[714],{"rel":715,"href":716},"canonical","https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/full",[718,721,724,726,729,733,736,740,743,746,749,751,753,755,757,759,762,765,767,770,772,774,777,780,783,786,789,793,797,800,802,805,808,811,813,816,818,821,823,826,829,832,834,837,839,842,844],{"hid":719,"property":719,"name":719,"content":720},"description","Hereditary (variant) transthyretin amyloidosis (ATTRv amyloidosis), which is caused by variants in the transthyretin (TTR) gene, leads to TTR amyloid deposit...",{"hid":722,"property":722,"name":723,"content":712},"og:title","title",{"hid":725,"property":725,"name":719,"content":720},"og:description",{"hid":727,"name":727,"content":728},"keywords","Amyloidosis,transthyretin,Extracellular vesicle,ATTRv amyloidosis,Atomic Force Microscope",{"hid":730,"property":730,"name":731,"content":732},"og:site_name","site_name","Frontiers",{"hid":734,"property":734,"name":388,"content":735},"og:image","https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/839917/fmolb-09-839917-HTML/image_m/fmolb-09-839917-g001.jpg",{"hid":737,"property":737,"name":738,"content":739},"og:type","type","article",{"hid":741,"property":741,"name":742,"content":716},"og:url","url",{"hid":744,"name":744,"content":745},"twitter:card","summary_large_image",{"hid":747,"name":747,"content":748},"citation_volume","9",{"hid":750,"name":750,"content":116},"citation_journal_title",{"hid":752,"name":752,"content":732},"citation_publisher",{"hid":754,"name":754,"content":667},"citation_journal_abbrev",{"hid":756,"name":756,"content":668},"citation_issn",{"hid":758,"name":758,"content":539},"citation_doi",{"hid":760,"name":760,"content":761},"citation_firstpage","839917",{"hid":763,"name":763,"content":764},"citation_language","English",{"hid":766,"name":766,"content":540},"citation_title",{"hid":768,"name":768,"content":769},"citation_keywords","Amyloidosis; transthyretin; Extracellular vesicle; ATTRv amyloidosis; Atomic Force Microscope",{"hid":771,"name":771,"content":545},"citation_abstract",{"hid":773,"name":773,"content":554},"citation_article_type",{"hid":775,"name":775,"content":776},"citation_pdf_url","https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/pdf",{"hid":778,"name":778,"content":779},"citation_xml_url","https://public-pages-files-2025.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.839917/xml",{"hid":781,"name":781,"content":782},"citation_fulltext_world_readable","yes",{"hid":784,"name":784,"content":785},"citation_online_date","2022/02/22",{"hid":787,"name":787,"content":788},"citation_publication_date","2022/03/23",{"hid":790,"name":791,"content":792},"citation_author_0","citation_author","Yamaguchi, Hiroki ",{"hid":794,"name":795,"content":796},"citation_author_institution_0","citation_author_institution","Department of Immunology, Japan",{"hid":798,"name":791,"content":799},"citation_author_1","Kawahara, Hironori ",{"hid":801,"name":795,"content":796},"citation_author_institution_1",{"hid":803,"name":791,"content":804},"citation_author_2","Kodera, Noriyuki ",{"hid":806,"name":795,"content":807},"citation_author_institution_2","WPI Nano Life Science Institute (NanoLSI), Japan",{"hid":809,"name":791,"content":810},"citation_author_3","Kumaki, Ayanori ",{"hid":812,"name":795,"content":796},"citation_author_institution_3",{"hid":814,"name":791,"content":815},"citation_author_4","Tada, Yasutake ",{"hid":817,"name":795,"content":796},"citation_author_institution_4",{"hid":819,"name":791,"content":820},"citation_author_5","Tang, Zixin ",{"hid":822,"name":795,"content":796},"citation_author_institution_5",{"hid":824,"name":791,"content":825},"citation_author_6","Sakai, Kenji ",{"hid":827,"name":795,"content":828},"citation_author_institution_6","Department of Neurology and Neurobiology of Aging, Japan",{"hid":830,"name":791,"content":831},"citation_author_7","Ono, Kenjiro ",{"hid":833,"name":795,"content":828},"citation_author_institution_7",{"hid":835,"name":791,"content":836},"citation_author_8","Yamada, Masahito ",{"hid":838,"name":795,"content":828},"citation_author_institution_8",{"hid":840,"name":791,"content":841},"citation_author_9","Hanayama, Rikinari ",{"hid":843,"name":795,"content":796},"citation_author_institution_9",{"hid":845,"name":845,"content":846},"dc.identifier","doi:10.3389/fmolb.2022.839917",[848,851,853,855,857],{"src":849,"body":13,"type":850,"async":13},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":852,"body":13,"type":850,"async":13},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML",{"src":854,"body":13,"type":850,"async":13},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":856,"body":13,"type":850,"async":13},"https://api.altmetric.com/v1/doi/10.3389/fmolb.2022.839917?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":858,"body":13,"type":850,"async":13},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"articleHubSlug":19,"articleHubPage":860,"articleHubArticlesList":861,"canJournalHasArticleHub":335,"articleDoiList":862},{},[],[],{"title":19,"image":-1,"breadcrumbs":864,"linksCollection":865,"metricsCollection":867},[],{"total":392,"items":866},[],{"total":392,"items":868},[]]</script>
<script>window.__NUXT__={};window.__NUXT__.config={public:{isDevMode:false,appName:"article-pages-2024",baseUrl:"https://www.frontiersin.org",domain:"frontiersin.org",loopUrl:"https://loop.frontiersin.org",ssMainDomain:"frontiersin.org",contentfulUrl:"https://graphql.contentful.com/content/v1/spaces",spaceId:1,spaceName:"Frontiers",liveSpaceId:1,tenantLogoUrl:"",frontiersGraphUrl:"https://apollo-federation-gateway.frontiersin.org",registrationApiUrl:"https://onboarding-ui.frontiersin.org",emailDigestApiUrl:"https://api-email-digest.frontiersin.org",journalFilesApiUrl:"https://files-journal-api.frontiersin.org",publicPagesFilesUrl:"https://public-pages-files-2025.frontiersin.org",searchApiUrl:"https://search-api.frontiersin.org",productionForumApiUrl:"https://production-forum-api-v2.frontiersin.org",gtmServerUrl:"https://tag-manager.frontiersin.org",gtmId:"GTM-M322FV2",gtmAuth:"owVbWxfaJr21yQv1fe1cAQ",gtmPreview:"env-1",figsharePluginUrl:"https://widgets.figshare.com/static/figshare.js",figshareApiUrl:"https://api.figshare.com/v2/collections/search",figshareTimeout:3000,crossmarkPublishedDate:"2015/08/24",googleRecaptchaSiteKey:"6LdG3i0UAAAAAOC4qUh35ubHgJotEHp_STXHgr_v",googleRecaptchaKeyName:"FrontiersRecaptchaV2",faviconSize16:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png",faviconSize32:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png",faviconSize180:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_180-tenantFavicon-Frontiers.png",faviconSize192:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_192-tenantFavicon-Frontiers.png",faviconSize512:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_512-tenantFavicon-Frontiers.png",socialMediaImg:"https://brand.frontiersin.org/m/1c8bcb536c789e11/Guidelines-Frontiers_Logo_1200x628_1-91to1.png",linkedArticleCopyText:"'{\"articleTypeCopyText\":[{\"articleTypeId\":0,\"originalArticleCopyText\":\"Part of this article's content has been mentioned in:\",\"linkedArticleCopyText\":\"This article mentions parts of:\"},{\"articleTypeId\":122,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an erratum on:\"},{\"articleTypeId\":129,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an addendum to:\"},{\"articleTypeId\":128,\"originalArticleCopyText\":\"A correction has been applied to this article in:\",\"linkedArticleCopyText\":\"This article is a correction to:\"},{\"articleTypeId\":134,\"originalArticleCopyText\":\"A retraction of this article was approved in:\",\"linkedArticleCopyText\":\"This article is a retraction of:\"},{\"articleTypeId\":29,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"},{\"articleTypeId\":30,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"}],\"articleIdCopyText\":[]}'\n",acceptedArticleExcludedJournalIds:"'[2766,979]'\n",articleTypeConfigurableLabel:"\u003C\u003Carticle-type:uppercase>> article",settingsFeaturesSwitchers:"'{\"displayTitlePillLabels\":true,\"displayRelatedArticlesBox\":true,\"showEditors\":true,\"showReviewers\":true,\"showLoopImpactLink\":true,\"enableFigshare\":false}'\n",journalsWithArticleHub:"'{\"strings\":[\"science\"]}'\n",terminologySettings:"'{\"terms\":[{\"sequenceNumber\":1,\"key\":\"frontiers\",\"tenantTerm\":\"Frontiers\",\"frontiersDefaultTerm\":\"Frontiers\",\"category\":\"Customer\"},{\"sequenceNumber\":2,\"key\":\"submission_system\",\"tenantTerm\":\"submission system\",\"frontiersDefaultTerm\":\"submission system\",\"category\":\"Product\"},{\"sequenceNumber\":3,\"key\":\"public_pages\",\"tenantTerm\":\"public pages\",\"frontiersDefaultTerm\":\"public pages\",\"category\":\"Product\"},{\"sequenceNumber\":4,\"key\":\"my_frontiers\",\"tenantTerm\":\"my frontiers\",\"frontiersDefaultTerm\":\"my frontiers\",\"category\":\"Product\"},{\"sequenceNumber\":5,\"key\":\"digital_editorial_office\",\"tenantTerm\":\"digital editorial office\",\"frontiersDefaultTerm\":\"digital editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":6,\"key\":\"deo\",\"tenantTerm\":\"DEO\",\"frontiersDefaultTerm\":\"DEO\",\"category\":\"Product\"},{\"sequenceNumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantTerm\":\"digital editorial office for chiefs\",\"frontiersDefaultTerm\":\"digital editorial office for chiefs\",\"category\":\"Product\"},{\"sequenceNumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantTerm\":\"digital editorial office for eof\",\"frontiersDefaultTerm\":\"digital editorial office for eof\",\"category\":\"Product\"},{\"sequenceNumber\":9,\"key\":\"editorial_office\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":10,\"key\":\"eof\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"Product\"},{\"sequenceNumber\":11,\"key\":\"research_topic_management\",\"tenantTerm\":\"research topic management\",\"frontiersDefaultTerm\":\"research topic management\",\"category\":\"Product\"},{\"sequenceNumber\":12,\"key\":\"review_forum\",\"tenantTerm\":\"review forum\",\"frontiersDefaultTerm\":\"review forum\",\"category\":\"Product\"},{\"sequenceNumber\":13,\"key\":\"accounting_office\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"Product\"},{\"sequenceNumber\":14,\"key\":\"aof\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"Product\"},{\"sequenceNumber\":15,\"key\":\"publishing_office\",\"tenantTerm\":\"publishing office\",\"frontiersDefaultTerm\":\"publishing office\",\"category\":\"Product\"},{\"sequenceNumber\":16,\"key\":\"production_office\",\"tenantTerm\":\"production office forum\",\"frontiersDefaultTerm\":\"production office forum\",\"category\":\"Product\"},{\"sequenceNumber\":17,\"key\":\"pof\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"Product\"},{\"sequenceNumber\":18,\"key\":\"book_office_forum\",\"tenantTerm\":\"book office forum\",\"frontiersDefaultTerm\":\"book office forum\",\"category\":\"Product\"},{\"sequenceNumber\":19,\"key\":\"bof\",\"tenantTerm\":\"BOF\",\"frontiersDefaultTerm\":\"BOF\",\"category\":\"Product\"},{\"sequenceNumber\":20,\"key\":\"aira\",\"tenantTerm\":\"AIRA\",\"frontiersDefaultTerm\":\"AIRA\",\"category\":\"Product\"},{\"sequenceNumber\":21,\"key\":\"editorial_board_management\",\"tenantTerm\":\"editorial board management\",\"frontiersDefaultTerm\":\"editorial board management\",\"category\":\"Product\"},{\"sequenceNumber\":22,\"key\":\"ebm\",\"tenantTerm\":\"EBM\",\"frontiersDefaultTerm\":\"EBM\",\"category\":\"Product\"},{\"sequenceNumber\":23,\"key\":\"domain\",\"tenantTerm\":\"domain\",\"frontiersDefaultTerm\":\"domain\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":24,\"key\":\"journal\",\"tenantTerm\":\"journal\",\"frontiersDefaultTerm\":\"journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":25,\"key\":\"section\",\"tenantTerm\":\"section\",\"frontiersDefaultTerm\":\"section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":26,\"key\":\"domains\",\"tenantTerm\":\"domains\",\"frontiersDefaultTerm\":\"domains\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":27,\"key\":\"specialty_section\",\"tenantTerm\":\"specialty section\",\"frontiersDefaultTerm\":\"specialty section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":28,\"key\":\"specialty_journal\",\"tenantTerm\":\"specialty journal\",\"frontiersDefaultTerm\":\"specialty journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":29,\"key\":\"journals\",\"tenantTerm\":\"journals\",\"frontiersDefaultTerm\":\"journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":30,\"key\":\"sections\",\"tenantTerm\":\"sections\",\"frontiersDefaultTerm\":\"sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":31,\"key\":\"specialty_sections\",\"tenantTerm\":\"specialty sections\",\"frontiersDefaultTerm\":\"specialty sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":32,\"key\":\"specialty_journals\",\"tenantTerm\":\"specialty journals\",\"frontiersDefaultTerm\":\"specialty journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":33,\"key\":\"manuscript\",\"tenantTerm\":\"manuscript\",\"frontiersDefaultTerm\":\"manuscript\",\"category\":\"Core\"},{\"sequenceNumber\":34,\"key\":\"manuscripts\",\"tenantTerm\":\"manuscripts\",\"frontiersDefaultTerm\":\"manuscripts\",\"category\":\"Core\"},{\"sequenceNumber\":35,\"key\":\"article\",\"tenantTerm\":\"article\",\"frontiersDefaultTerm\":\"article\",\"category\":\"Core\"},{\"sequenceNumber\":36,\"key\":\"articles\",\"tenantTerm\":\"articles\",\"frontiersDefaultTerm\":\"articles\",\"category\":\"Core\"},{\"sequenceNumber\":37,\"key\":\"article_type\",\"tenantTerm\":\"article type\",\"frontiersDefaultTerm\":\"article type\",\"category\":\"Core\"},{\"sequenceNumber\":38,\"key\":\"article_types\",\"tenantTerm\":\"article types\",\"frontiersDefaultTerm\":\"article types\",\"category\":\"Core\"},{\"sequenceNumber\":39,\"key\":\"author\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":40,\"key\":\"authors\",\"tenantTerm\":\"authors\",\"frontiersDefaultTerm\":\"authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":41,\"key\":\"authoring\",\"tenantTerm\":\"authoring\",\"frontiersDefaultTerm\":\"authoring\",\"category\":\"Core\"},{\"sequenceNumber\":42,\"key\":\"authored\",\"tenantTerm\":\"authored\",\"frontiersDefaultTerm\":\"authored\",\"category\":\"Core\"},{\"sequenceNumber\":43,\"key\":\"accept\",\"tenantTerm\":\"accept\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":44,\"key\":\"accepted\",\"tenantTerm\":\"accepted\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantTerm\":\"Assistant Field Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editor\",\"description\":\"An editorial role on a Field Journal that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantTerm\":\"Assistant Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantTerm\":\"Assistant Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":48,\"key\":\"associate_editor\",\"tenantTerm\":\"Associate Editor\",\"frontiersDefaultTerm\":\"Associate Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":49,\"key\":\"specialty_chief_editor\",\"tenantTerm\":\"Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":50,\"key\":\"specialty_chief_editors\",\"tenantTerm\":\"Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":51,\"key\":\"chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":52,\"key\":\"chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":53,\"key\":\"call_for_participation\",\"tenantTerm\":\"call for participation\",\"frontiersDefaultTerm\":\"call for participation\",\"category\":\"Process\"},{\"sequenceNumber\":54,\"key\":\"citation\",\"tenantTerm\":\"citation\",\"frontiersDefaultTerm\":\"citation\",\"category\":\"Misc.\"},{\"sequenceNumber\":55,\"key\":\"citations\",\"tenantTerm\":\"citations\",\"frontiersDefaultTerm\":\"citations\",\"category\":\"Misc.\"},{\"sequenceNumber\":56,\"key\":\"contributor\",\"tenantTerm\":\"contributor\",\"frontiersDefaultTerm\":\"contributor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":57,\"key\":\"contributors\",\"tenantTerm\":\"contributors\",\"frontiersDefaultTerm\":\"contributors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":58,\"key\":\"corresponding_author\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":59,\"key\":\"corresponding_authors\",\"tenantTerm\":\"corresponding authors\",\"frontiersDefaultTerm\":\"corresponding authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":60,\"key\":\"decline\",\"tenantTerm\":\"decline\",\"frontiersDefaultTerm\":\"decline\",\"category\":\"Process\"},{\"sequenceNumber\":61,\"key\":\"declined\",\"tenantTerm\":\"declined\",\"frontiersDefaultTerm\":\"declined\",\"category\":\"Process\"},{\"sequenceNumber\":62,\"key\":\"reject\",\"tenantTerm\":\"reject\",\"frontiersDefaultTerm\":\"reject\",\"category\":\"Process\"},{\"sequenceNumber\":63,\"key\":\"rejected\",\"tenantTerm\":\"rejected\",\"frontiersDefaultTerm\":\"rejected\",\"category\":\"Process\"},{\"sequenceNumber\":64,\"key\":\"publish\",\"tenantTerm\":\"publish\",\"frontiersDefaultTerm\":\"publish\",\"category\":\"Core\"},{\"sequenceNumber\":65,\"key\":\"published\",\"tenantTerm\":\"published\",\"frontiersDefaultTerm\":\"published\",\"category\":\"Core\"},{\"sequenceNumber\":66,\"key\":\"publication\",\"tenantTerm\":\"publication\",\"frontiersDefaultTerm\":\"publication\",\"category\":\"Core\"},{\"sequenceNumber\":67,\"key\":\"peer_review\",\"tenantTerm\":\"peer review\",\"frontiersDefaultTerm\":\"peer review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":68,\"key\":\"peer_reviewed\",\"tenantTerm\":\"peer reviewed\",\"frontiersDefaultTerm\":\"peer reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":69,\"key\":\"initial_validation\",\"tenantTerm\":\"initial validation\",\"frontiersDefaultTerm\":\"initial validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":70,\"key\":\"editorial_assignment\",\"tenantTerm\":\"editorial assignment\",\"frontiersDefaultTerm\":\"editorial assignment\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":71,\"key\":\"independent_review\",\"tenantTerm\":\"independent review\",\"frontiersDefaultTerm\":\"independent review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":72,\"key\":\"interactive_review\",\"tenantTerm\":\"interactive review\",\"frontiersDefaultTerm\":\"interactive review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":73,\"key\":\"review\",\"tenantTerm\":\"review\",\"frontiersDefaultTerm\":\"review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":74,\"key\":\"reviewing\",\"tenantTerm\":\"reviewing\",\"frontiersDefaultTerm\":\"reviewing\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":75,\"key\":\"reviewer\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":76,\"key\":\"reviewers\",\"tenantTerm\":\"reviewers\",\"frontiersDefaultTerm\":\"reviewers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":77,\"key\":\"review_finalized\",\"tenantTerm\":\"review finalized\",\"frontiersDefaultTerm\":\"review finalized\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":78,\"key\":\"final_decision\",\"tenantTerm\":\"final decision\",\"frontiersDefaultTerm\":\"final decision\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":79,\"key\":\"final_validation\",\"tenantTerm\":\"final validation\",\"frontiersDefaultTerm\":\"final validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantTerm\":\"recommend to accept manuscript\",\"frontiersDefaultTerm\":\"accept manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":81,\"key\":\"fee\",\"tenantTerm\":\"fee\",\"frontiersDefaultTerm\":\"fee\",\"category\":\"Accounting\"},{\"sequenceNumber\":82,\"key\":\"fees\",\"tenantTerm\":\"fees\",\"frontiersDefaultTerm\":\"fees\",\"category\":\"Accounting\"},{\"sequenceNumber\":83,\"key\":\"guest_associate_editor\",\"tenantTerm\":\"Guest Associate Editor\",\"frontiersDefaultTerm\":\"Guest Associate Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":84,\"key\":\"guest_associate_editors\",\"tenantTerm\":\"Guest Associate Editors\",\"frontiersDefaultTerm\":\"Guest Associate Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":85,\"key\":\"in_review\",\"tenantTerm\":\"in review\",\"frontiersDefaultTerm\":\"in review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":86,\"key\":\"institutional_member\",\"tenantTerm\":\"institutional partner\",\"frontiersDefaultTerm\":\"institutional partner\",\"category\":\"Accounting\"},{\"sequenceNumber\":87,\"key\":\"institutional_membership\",\"tenantTerm\":\"institutional partnership\",\"frontiersDefaultTerm\":\"institutional partnership\",\"category\":\"Accounting\"},{\"sequenceNumber\":88,\"key\":\"article_processing_charge\",\"tenantTerm\":\"article processing charge\",\"frontiersDefaultTerm\":\"article processing charge\",\"category\":\"Accounting\"},{\"sequenceNumber\":89,\"key\":\"article_processing_charges\",\"tenantTerm\":\"article processing charges\",\"frontiersDefaultTerm\":\"article processing charges\",\"category\":\"Accounting\"},{\"sequenceNumber\":90,\"key\":\"apcs\",\"tenantTerm\":\"APCs\",\"frontiersDefaultTerm\":\"APCs\",\"category\":\"Accounting\"},{\"sequenceNumber\":91,\"key\":\"apc\",\"tenantTerm\":\"APC\",\"frontiersDefaultTerm\":\"APC\",\"category\":\"Accounting\"},{\"sequenceNumber\":92,\"key\":\"received\",\"tenantTerm\":\"received\",\"frontiersDefaultTerm\":\"received\",\"description\":\"Date manuscript was received on.\",\"category\":\"Core\"},{\"sequenceNumber\":93,\"key\":\"transferred\",\"tenantTerm\":\"transferred\",\"frontiersDefaultTerm\":\"transferred\",\"category\":\"Core\"},{\"sequenceNumber\":94,\"key\":\"transfer\",\"tenantTerm\":\"transfer\",\"frontiersDefaultTerm\":\"transfer\",\"category\":\"Core\"},{\"sequenceNumber\":95,\"key\":\"research_topic\",\"tenantTerm\":\"research topic\",\"frontiersDefaultTerm\":\"research topic\",\"category\":\"Core\"},{\"sequenceNumber\":96,\"key\":\"research_topics\",\"tenantTerm\":\"research topics\",\"frontiersDefaultTerm\":\"research topics\",\"category\":\"Core\"},{\"sequenceNumber\":97,\"key\":\"topic_editor\",\"tenantTerm\":\"Topic Editor\",\"frontiersDefaultTerm\":\"Topic Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":98,\"key\":\"review_editor\",\"tenantTerm\":\"Community Reviewer\",\"frontiersDefaultTerm\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":99,\"key\":\"title\",\"tenantTerm\":\"title\",\"frontiersDefaultTerm\":\"title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":100,\"key\":\"running_title\",\"tenantTerm\":\"running title\",\"frontiersDefaultTerm\":\"running title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":101,\"key\":\"submit\",\"tenantTerm\":\"submit\",\"frontiersDefaultTerm\":\"submit\",\"category\":\"Process\"},{\"sequenceNumber\":102,\"key\":\"submitted\",\"tenantTerm\":\"submitted\",\"frontiersDefaultTerm\":\"submitted\",\"category\":\"Process\"},{\"sequenceNumber\":103,\"key\":\"submitting\",\"tenantTerm\":\"submitting\",\"frontiersDefaultTerm\":\"submitting\",\"category\":\"Process\"},{\"sequenceNumber\":104,\"key\":\"t_e\",\"tenantTerm\":\"TE\",\"frontiersDefaultTerm\":\"TE\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":105,\"key\":\"topic\",\"tenantTerm\":\"topic\",\"frontiersDefaultTerm\":\"topic\",\"category\":\"Process\"},{\"sequenceNumber\":106,\"key\":\"topic_summary\",\"tenantTerm\":\"topic summary\",\"frontiersDefaultTerm\":\"topic summary\",\"category\":\"Process\"},{\"sequenceNumber\":107,\"key\":\"figure\",\"tenantTerm\":\"figure\",\"frontiersDefaultTerm\":\"figure\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":108,\"key\":\"figures\",\"tenantTerm\":\"figures\",\"frontiersDefaultTerm\":\"figures\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":109,\"key\":\"editorial_file\",\"tenantTerm\":\"editorial file\",\"frontiersDefaultTerm\":\"editorial file\",\"category\":\"Core\"},{\"sequenceNumber\":110,\"key\":\"editorial_files\",\"tenantTerm\":\"editorial files\",\"frontiersDefaultTerm\":\"editorial files\",\"category\":\"Core\"},{\"sequenceNumber\":111,\"key\":\"e_book\",\"tenantTerm\":\"e-book\",\"frontiersDefaultTerm\":\"e-book\",\"category\":\"Core\"},{\"sequenceNumber\":112,\"key\":\"organization\",\"tenantTerm\":\"organization\",\"frontiersDefaultTerm\":\"organization\",\"category\":\"Core\"},{\"sequenceNumber\":113,\"key\":\"institution\",\"tenantTerm\":\"institution\",\"frontiersDefaultTerm\":\"institution\",\"category\":\"Core\"},{\"sequenceNumber\":114,\"key\":\"reference\",\"tenantTerm\":\"reference\",\"frontiersDefaultTerm\":\"reference\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":115,\"key\":\"references\",\"tenantTerm\":\"references\",\"frontiersDefaultTerm\":\"references\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":116,\"key\":\"sce\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"description\":\"Abbreviation for Specialty Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":117,\"key\":\"submission\",\"tenantTerm\":\"submission\",\"frontiersDefaultTerm\":\"submission\",\"category\":\"Process\"},{\"sequenceNumber\":118,\"key\":\"submissions\",\"tenantTerm\":\"submissions\",\"frontiersDefaultTerm\":\"submissions\",\"category\":\"Process\"},{\"sequenceNumber\":119,\"key\":\"editing\",\"tenantTerm\":\"editing\",\"frontiersDefaultTerm\":\"editing\",\"category\":\"Process\"},{\"sequenceNumber\":120,\"key\":\"in_preparation\",\"tenantTerm\":\"in preparation\",\"frontiersDefaultTerm\":\"in preparation\",\"category\":\"Process\"},{\"sequenceNumber\":121,\"key\":\"country_region\",\"tenantTerm\":\"country/region\",\"frontiersDefaultTerm\":\"country/region\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":122,\"key\":\"countries_regions\",\"tenantTerm\":\"countries/regions\",\"frontiersDefaultTerm\":\"countries/regions\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":123,\"key\":\"specialty\",\"tenantTerm\":\"specialty\",\"frontiersDefaultTerm\":\"specialty\",\"category\":\"Core\"},{\"sequenceNumber\":124,\"key\":\"specialties\",\"tenantTerm\":\"specialties\",\"frontiersDefaultTerm\":\"specialties\",\"category\":\"Core\"},{\"sequenceNumber\":125,\"key\":\"associate_editors\",\"tenantTerm\":\"Associate Editors\",\"frontiersDefaultTerm\":\"Associate Editors\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":126,\"key\":\"reviewed\",\"tenantTerm\":\"reviewed\",\"frontiersDefaultTerm\":\"reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":127,\"key\":\"institutional_members\",\"tenantTerm\":\"institutional partners\",\"frontiersDefaultTerm\":\"institutional partners\",\"category\":\"Accounting\"},{\"sequenceNumber\":128,\"key\":\"institutional_memberships\",\"tenantTerm\":\"institutional partnerships\",\"frontiersDefaultTerm\":\"institutional partnerships\",\"category\":\"Accounting\"},{\"sequenceNumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantTerm\":\"Assistant Field Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":130,\"key\":\"publications\",\"tenantTerm\":\"publications\",\"frontiersDefaultTerm\":\"publications\",\"category\":\"Process\"},{\"sequenceNumber\":131,\"key\":\"ae_accepted\",\"tenantTerm\":\"recommended acceptance\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":132,\"key\":\"field_journal\",\"tenantTerm\":\"field journal\",\"frontiersDefaultTerm\":\"field journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":133,\"key\":\"field_journals\",\"tenantTerm\":\"field journals\",\"frontiersDefaultTerm\":\"field journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":134,\"key\":\"program_manager\",\"tenantTerm\":\"program manager\",\"frontiersDefaultTerm\":\"program manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":135,\"key\":\"journal_manager\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":136,\"key\":\"journal_specialist\",\"tenantTerm\":\"journal specialist\",\"frontiersDefaultTerm\":\"journal specialist\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":137,\"key\":\"program_managers\",\"tenantTerm\":\"program managers\",\"frontiersDefaultTerm\":\"program managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":138,\"key\":\"journal_managers\",\"tenantTerm\":\"journal managers\",\"frontiersDefaultTerm\":\"journal managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":139,\"key\":\"journal_specialists\",\"tenantTerm\":\"journal specialists\",\"frontiersDefaultTerm\":\"journal specialists\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":140,\"key\":\"cover_letter\",\"tenantTerm\":\"manuscript contribution to the field\",\"frontiersDefaultTerm\":\"manuscript contribution to the field\",\"category\":\"Process\"},{\"sequenceNumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantTerm\":\"recommended to accept manuscript\",\"frontiersDefaultTerm\":\"accepted manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":142,\"key\":\"recommend_for_rejection\",\"tenantTerm\":\"recommend for rejection\",\"frontiersDefaultTerm\":\"recommend for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":143,\"key\":\"recommended_for_rejection\",\"tenantTerm\":\"recommended for rejection\",\"frontiersDefaultTerm\":\"recommended for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":144,\"key\":\"ae\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"description\":\"Associate Editor - board member\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":145,\"key\":\"re\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"description\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":146,\"key\":\"rev\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"description\":\"Reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":147,\"key\":\"aut\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"description\":\"Author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":148,\"key\":\"coraut\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"description\":\"Corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":149,\"key\":\"saut\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"description\":\"Submitting author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":150,\"key\":\"coaut\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"description\":\"co-author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":151,\"key\":\"tsof\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"description\":\"Typesetter\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":152,\"key\":\"typesetting_office\",\"tenantTerm\":\"typesetting office\",\"frontiersDefaultTerm\":\"typesetting office\",\"category\":\"Product\"},{\"sequenceNumber\":153,\"key\":\"config\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"description\":\"Configuration office role\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":154,\"key\":\"jm\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"description\":\"Journal Manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":155,\"key\":\"rte\",\"tenantTerm\":\"RTE\",\"frontiersDefaultTerm\":\"RTE\",\"description\":\"Research topic editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":156,\"key\":\"organizations\",\"tenantTerm\":\"organizations\",\"frontiersDefaultTerm\":\"organizations\",\"category\":\"Core\"},{\"sequenceNumber\":157,\"key\":\"publishing\",\"tenantTerm\":\"publishing\",\"frontiersDefaultTerm\":\"publishing\",\"category\":\"Core\"},{\"sequenceNumber\":158,\"key\":\"acceptance\",\"tenantTerm\":\"acceptance\",\"frontiersDefaultTerm\":\"acceptance\",\"category\":\"Process\"},{\"sequenceNumber\":159,\"key\":\"preferred_associate_editor\",\"tenantTerm\":\"preferred associate editor\",\"frontiersDefaultTerm\":\"preferred associate editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":160,\"key\":\"topic_editors\",\"tenantTerm\":\"Topic Editors\",\"frontiersDefaultTerm\":\"Topic Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":161,\"key\":\"institutions\",\"tenantTerm\":\"institutions\",\"frontiersDefaultTerm\":\"institutions\",\"category\":\"Core\"},{\"sequenceNumber\":162,\"key\":\"author(s)\",\"tenantTerm\":\"author(s)\",\"frontiersDefaultTerm\":\"author(s)\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":163,\"key\":\"figure(s)\",\"tenantTerm\":\"figure(s)\",\"frontiersDefaultTerm\":\"figure(s)\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":164,\"key\":\"co-authors\",\"tenantTerm\":\"co-authors\",\"frontiersDefaultTerm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":165,\"key\":\"editorial_board_members\",\"tenantTerm\":\"editorial board members\",\"frontiersDefaultTerm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":166,\"key\":\"editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"Product\"},{\"sequenceNumber\":167,\"key\":\"co-authorship\",\"tenantTerm\":\"co-authorship\",\"frontiersDefaultTerm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"Misc.\"},{\"sequenceNumber\":168,\"key\":\"role_id_1\",\"tenantTerm\":\"registration office\",\"frontiersDefaultTerm\":\"registration office\",\"category\":\"User Role\"},{\"sequenceNumber\":169,\"key\":\"role_id_2\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"User Role\"},{\"sequenceNumber\":170,\"key\":\"role_id_7\",\"tenantTerm\":\"field chief editor\",\"frontiersDefaultTerm\":\"field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":171,\"key\":\"role_id_8\",\"tenantTerm\":\"assistant field chief editor\",\"frontiersDefaultTerm\":\"assistant field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":172,\"key\":\"role_id_9\",\"tenantTerm\":\"specialty chief editor\",\"frontiersDefaultTerm\":\"specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":173,\"key\":\"role_id_10\",\"tenantTerm\":\"assistant specialty chief editor\",\"frontiersDefaultTerm\":\"assistant specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":174,\"key\":\"role_id_11\",\"tenantTerm\":\"associate editor\",\"frontiersDefaultTerm\":\"associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":175,\"key\":\"role_id_12\",\"tenantTerm\":\"guest associate editor\",\"frontiersDefaultTerm\":\"guest associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":176,\"key\":\"role_id_13\",\"tenantTerm\":\"review editor\",\"frontiersDefaultTerm\":\"review editor\",\"category\":\"User Role\"},{\"sequenceNumber\":177,\"key\":\"role_id_14\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":178,\"key\":\"role_id_15\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"User Role\"},{\"sequenceNumber\":179,\"key\":\"role_id_16\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"User Role\"},{\"sequenceNumber\":180,\"key\":\"role_id_17\",\"tenantTerm\":\"submitting author\",\"frontiersDefaultTerm\":\"submitting author\",\"category\":\"User Role\"},{\"sequenceNumber\":181,\"key\":\"role_id_18\",\"tenantTerm\":\"co-author\",\"frontiersDefaultTerm\":\"co-author\",\"category\":\"User Role\"},{\"sequenceNumber\":182,\"key\":\"role_id_20\",\"tenantTerm\":\"production office\",\"frontiersDefaultTerm\":\"production office\",\"category\":\"User Role\"},{\"sequenceNumber\":183,\"key\":\"role_id_22\",\"tenantTerm\":\"typesetting office (typesetter)\",\"frontiersDefaultTerm\":\"typesetting office (typesetter)\",\"category\":\"User Role\"},{\"sequenceNumber\":184,\"key\":\"role_id_24\",\"tenantTerm\":\"registered user\",\"frontiersDefaultTerm\":\"registered user\",\"category\":\"User Role\"},{\"sequenceNumber\":185,\"key\":\"role_id_35\",\"tenantTerm\":\"job office\",\"frontiersDefaultTerm\":\"job office\",\"category\":\"User Role\"},{\"sequenceNumber\":186,\"key\":\"role_id_41\",\"tenantTerm\":\"special event administrator\",\"frontiersDefaultTerm\":\"special event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":187,\"key\":\"role_id_42\",\"tenantTerm\":\"special event reviewer\",\"frontiersDefaultTerm\":\"special event reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":188,\"key\":\"role_id_43\",\"tenantTerm\":\"submit abstract\",\"frontiersDefaultTerm\":\"submit abstract\",\"category\":\"User Role\"},{\"sequenceNumber\":189,\"key\":\"role_id_52\",\"tenantTerm\":\"events office\",\"frontiersDefaultTerm\":\"events office\",\"category\":\"User Role\"},{\"sequenceNumber\":190,\"key\":\"role_id_53\",\"tenantTerm\":\"event administrator\",\"frontiersDefaultTerm\":\"event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":191,\"key\":\"role_id_89\",\"tenantTerm\":\"content management office\",\"frontiersDefaultTerm\":\"content management office\",\"category\":\"User Role\"},{\"sequenceNumber\":192,\"key\":\"role_id_98\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"User Role\"},{\"sequenceNumber\":193,\"key\":\"role_id_99\",\"tenantTerm\":\"projects\",\"frontiersDefaultTerm\":\"projects\",\"category\":\"User Role\"},{\"sequenceNumber\":194,\"key\":\"role_id_103\",\"tenantTerm\":\"configuration office\",\"frontiersDefaultTerm\":\"configuration office\",\"category\":\"User Role\"},{\"sequenceNumber\":195,\"key\":\"role_id_104\",\"tenantTerm\":\"beta user\",\"frontiersDefaultTerm\":\"beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":196,\"key\":\"role_id_106\",\"tenantTerm\":\"wfconf\",\"frontiersDefaultTerm\":\"wfconf\",\"category\":\"User Role\"},{\"sequenceNumber\":197,\"key\":\"role_id_107\",\"tenantTerm\":\"rt management beta user\",\"frontiersDefaultTerm\":\"rt management beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":198,\"key\":\"role_id_108\",\"tenantTerm\":\"deo beta user\",\"frontiersDefaultTerm\":\"deo beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":199,\"key\":\"role_id_109\",\"tenantTerm\":\"search beta user\",\"frontiersDefaultTerm\":\"search beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":200,\"key\":\"role_id_110\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"User Role\"},{\"sequenceNumber\":201,\"key\":\"role_id_111\",\"tenantTerm\":\"myfrontiers beta user\",\"frontiersDefaultTerm\":\"myfrontiers beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":202,\"key\":\"role_id_21\",\"tenantTerm\":\"copy editor\",\"frontiersDefaultTerm\":\"copy editor\",\"category\":\"User Role\"},{\"sequenceNumber\":203,\"key\":\"role_id_1_abr\",\"tenantTerm\":\"ROF\",\"frontiersDefaultTerm\":\"ROF\",\"category\":\"User Role\"},{\"sequenceNumber\":204,\"key\":\"role_id_2_abr\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"User Role\"},{\"sequenceNumber\":205,\"key\":\"role_id_7_abr\",\"tenantTerm\":\"FCE\",\"frontiersDefaultTerm\":\"FCE\",\"category\":\"User Role\"},{\"sequenceNumber\":206,\"key\":\"role_id_8_abr\",\"tenantTerm\":\"AFCE\",\"frontiersDefaultTerm\":\"AFCE\",\"category\":\"User Role\"},{\"sequenceNumber\":207,\"key\":\"role_id_9_abr\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"category\":\"User Role\"},{\"sequenceNumber\":208,\"key\":\"role_id_10_abr\",\"tenantTerm\":\"ASCE\",\"frontiersDefaultTerm\":\"ASCE\",\"category\":\"User Role\"},{\"sequenceNumber\":209,\"key\":\"role_id_11_abr\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"category\":\"User Role\"},{\"sequenceNumber\":210,\"key\":\"role_id_12_abr\",\"tenantTerm\":\"GAE\",\"frontiersDefaultTerm\":\"GAE\",\"category\":\"User Role\"},{\"sequenceNumber\":211,\"key\":\"role_id_13_abr\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"category\":\"User Role\"},{\"sequenceNumber\":212,\"key\":\"role_id_14_abr\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"category\":\"User Role\"},{\"sequenceNumber\":213,\"key\":\"role_id_15_abr\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":214,\"key\":\"role_id_16_abr\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":215,\"key\":\"role_id_17_abr\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":216,\"key\":\"role_id_18_abr\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":217,\"key\":\"role_id_20_abr\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"User Role\"},{\"sequenceNumber\":218,\"key\":\"role_id_22_abr\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"category\":\"User Role\"},{\"sequenceNumber\":219,\"key\":\"role_id_24_abr\",\"tenantTerm\":\"RU\",\"frontiersDefaultTerm\":\"RU\",\"category\":\"User Role\"},{\"sequenceNumber\":220,\"key\":\"role_id_35_abr\",\"tenantTerm\":\"JOF\",\"frontiersDefaultTerm\":\"JOF\",\"category\":\"User Role\"},{\"sequenceNumber\":221,\"key\":\"role_id_41_abr\",\"tenantTerm\":\"SE-ADM\",\"frontiersDefaultTerm\":\"SE-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":222,\"key\":\"role_id_42_abr\",\"tenantTerm\":\"SE-REV\",\"frontiersDefaultTerm\":\"SE-REV\",\"category\":\"User Role\"},{\"sequenceNumber\":223,\"key\":\"role_id_43_abr\",\"tenantTerm\":\"SE-AUT\",\"frontiersDefaultTerm\":\"SE-AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":224,\"key\":\"role_id_52_abr\",\"tenantTerm\":\"EVOF\",\"frontiersDefaultTerm\":\"EVOF\",\"category\":\"User Role\"},{\"sequenceNumber\":225,\"key\":\"role_id_53_abr\",\"tenantTerm\":\"EV-ADM\",\"frontiersDefaultTerm\":\"EV-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":226,\"key\":\"role_id_89_abr\",\"tenantTerm\":\"COMOF\",\"frontiersDefaultTerm\":\"COMOF\",\"category\":\"User Role\"},{\"sequenceNumber\":227,\"key\":\"role_id_98_abr\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"User Role\"},{\"sequenceNumber\":228,\"key\":\"role_id_99_abr\",\"tenantTerm\":\"Projects\",\"frontiersDefaultTerm\":\"Projects\",\"category\":\"User Role\"},{\"sequenceNumber\":229,\"key\":\"role_id_103_abr\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"category\":\"User Role\"},{\"sequenceNumber\":230,\"key\":\"role_id_104_abr\",\"tenantTerm\":\"BETA\",\"frontiersDefaultTerm\":\"BETA\",\"category\":\"User Role\"},{\"sequenceNumber\":231,\"key\":\"role_id_106_abr\",\"tenantTerm\":\"WFCONF\",\"frontiersDefaultTerm\":\"WFCONF\",\"category\":\"User Role\"},{\"sequenceNumber\":232,\"key\":\"role_id_107_abr\",\"tenantTerm\":\"RTBETA\",\"frontiersDefaultTerm\":\"RTBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":233,\"key\":\"role_id_108_abr\",\"tenantTerm\":\"DEOBETA\",\"frontiersDefaultTerm\":\"DEOBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":234,\"key\":\"role_id_109_abr\",\"tenantTerm\":\"SEARCHBETA\",\"frontiersDefaultTerm\":\"SEARCHBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":235,\"key\":\"role_id_110_abr\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"category\":\"User Role\"},{\"sequenceNumber\":236,\"key\":\"role_id_111_abr\",\"tenantTerm\":\"MFBETA\",\"frontiersDefaultTerm\":\"MFBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":237,\"key\":\"role_id_21_abr\",\"tenantTerm\":\"COPED\",\"frontiersDefaultTerm\":\"COPED\",\"category\":\"User Role\"},{\"sequenceNumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"This is the label for the review editorial board\",\"category\":\"Label\"},{\"sequenceNumber\":239,\"key\":\"field_chief_editor\",\"tenantTerm\":\"Field Chief Editor\",\"frontiersDefaultTerm\":\"Field Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":240,\"key\":\"field_chief_editors\",\"tenantTerm\":\"Field Chief Editors\",\"frontiersDefaultTerm\":\"Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":241,\"key\":\"editor\",\"tenantTerm\":\"editor\",\"frontiersDefaultTerm\":\"editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":242,\"key\":\"editors\",\"tenantTerm\":\"editors\",\"frontiersDefaultTerm\":\"editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":243,\"key\":\"board\",\"tenantTerm\":\"board\",\"frontiersDefaultTerm\":\"board\",\"category\":\"Label\"},{\"sequenceNumber\":244,\"key\":\"boards\",\"tenantTerm\":\"boards\",\"frontiersDefaultTerm\":\"boards\",\"category\":\"Label\"},{\"sequenceNumber\":245,\"key\":\"article_collection\",\"tenantTerm\":\"article collection\",\"frontiersDefaultTerm\":\"article collection\",\"category\":\"Label\"},{\"sequenceNumber\":246,\"key\":\"article_collections\",\"tenantTerm\":\"article collections\",\"frontiersDefaultTerm\":\"article collections\",\"category\":\"Label\"},{\"sequenceNumber\":247,\"key\":\"handling_editor\",\"tenantTerm\":\"handling editor\",\"frontiersDefaultTerm\":\"associate editor\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":248,\"key\":\"handling_editors\",\"tenantTerm\":\"handling editors\",\"frontiersDefaultTerm\":\"associate editors\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":249,\"key\":\"ae_accept\",\"tenantTerm\":\"recommend acceptance\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":250,\"key\":\"rtm\",\"tenantTerm\":\"RTM\",\"frontiersDefaultTerm\":\"RTM\",\"category\":\"Product\"},{\"sequenceNumber\":251,\"key\":\"frontiers_media_sa\",\"tenantTerm\":\"Frontiers Media S.A\",\"frontiersDefaultTerm\":\"Frontiers Media S.A\",\"category\":\"Customer\"},{\"sequenceNumber\":252,\"key\":\"review_editors\",\"tenantTerm\":\"Community Reviewers\",\"frontiersDefaultTerm\":\"Review Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":255,\"key\":\"call_for_papers\",\"tenantTerm\":\"Call for papers\",\"frontiersDefaultTerm\":\"Call for papers\",\"category\":\"Label\"},{\"sequenceNumber\":256,\"key\":\"calls_for_papers\",\"tenantTerm\":\"Calls for papers\",\"frontiersDefaultTerm\":\"Calls for papers\",\"category\":\"Label\"},{\"sequenceNumber\":257,\"key\":\"supervising_editor\",\"tenantTerm\":\"Supervising Editor\",\"frontiersDefaultTerm\":\"Supervising Editor\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editor\"},{\"sequenceNumber\":258,\"key\":\"supervising_editors\",\"tenantTerm\":\"Supervising Editors\",\"frontiersDefaultTerm\":\"Supervising Editors\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editors\"},{\"sequenceNumber\":259,\"key\":\"reviewer_endorse\",\"tenantTerm\":\"endorse\",\"frontiersDefaultTerm\":\"endorse\",\"category\":\"Label\"},{\"sequenceNumber\":260,\"key\":\"reviewer_endorsed\",\"tenantTerm\":\"endorsed\",\"frontiersDefaultTerm\":\"endorsed\",\"category\":\"Label\"},{\"sequenceNumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantTerm\":\"endorse publication\",\"frontiersDefaultTerm\":\"endorse publication\",\"category\":\"Label\"},{\"sequenceNumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantTerm\":\"endorsed publication\",\"frontiersDefaultTerm\":\"endorsed publication\",\"category\":\"Label\"},{\"sequenceNumber\":263,\"key\":\"editor_role\",\"tenantTerm\":\"editor role\",\"frontiersDefaultTerm\":\"Editor Role\",\"category\":\"Label\"},{\"sequenceNumber\":264,\"key\":\"editor_roles\",\"tenantTerm\":\"editor roles\",\"frontiersDefaultTerm\":\"Editor Roles\",\"category\":\"Label\"},{\"sequenceNumber\":265,\"key\":\"editorial_role\",\"tenantTerm\":\"editorial role\",\"frontiersDefaultTerm\":\"Editorial Role\",\"category\":\"Label\"},{\"sequenceNumber\":266,\"key\":\"editorial_roles\",\"tenantTerm\":\"editorial roles\",\"frontiersDefaultTerm\":\"Editorial Roles\",\"category\":\"Label\"},{\"sequenceNumber\":267,\"key\":\"call_for_paper\",\"tenantTerm\":\"Call for paper\",\"frontiersDefaultTerm\":\"Call for paper\",\"category\":\"Label\"},{\"sequenceNumber\":268,\"key\":\"research_topic_abstract\",\"tenantTerm\":\"manuscript summary\",\"frontiersDefaultTerm\":\"manuscript summary\",\"category\":\"Process\"},{\"sequenceNumber\":269,\"key\":\"research_topic_abstracts\",\"tenantTerm\":\"manuscript summaries\",\"frontiersDefaultTerm\":\"manuscript summaries\",\"category\":\"Process\"},{\"sequenceNumber\":270,\"key\":\"submissions_team_manager\",\"tenantTerm\":\"Journal Manager\",\"frontiersDefaultTerm\":\"Content Manager\",\"category\":\"Process\"},{\"sequenceNumber\":271,\"key\":\"submissions_team\",\"tenantTerm\":\"Journal Team\",\"frontiersDefaultTerm\":\"Content Team\",\"category\":\"Process\"},{\"sequenceNumber\":272,\"key\":\"topic_coordinator\",\"tenantTerm\":\"topic coordinator\",\"frontiersDefaultTerm\":\"topic coordinator\",\"category\":\"Process\"},{\"sequenceNumber\":273,\"key\":\"topic_coordinators\",\"tenantTerm\":\"topic coordinators\",\"frontiersDefaultTerm\":\"topic coordinators\",\"category\":\"Process\"},{\"sequenceNumber\":274,\"key\":\"frontiers_journal_team\",\"tenantTerm\":\"frontiers journal team\",\"frontiersDefaultTerm\":\"frontiers journal team\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":275,\"key\":\"research_topic_ic_submission\",\"tenantTerm\":\"RT:IC Submission\",\"frontiersDefaultTerm\":\"RT:IC Submission\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":276,\"key\":\"research_topic_ic_submission_participant\",\"tenantTerm\":\"RT:IC Submission participant\",\"frontiersDefaultTerm\":\"RT:IC Submission participant\",\"category\":\"Label (Role)\"}]}'\n",impactGtmId:"GTM-NJF2ML9B",impactGtmAuth:"fYo-7NoDm9w37QgFMs03SA",impactGtmPreview:"env-1",impactGoogleMapsApiKey:"AIzaSyCTEhX2EU8PWfi86GW9FI00FTcyKk6Ifr8",qualtricsV4ToV3:"'{\"enabled\":true,\"interceptId\":\"SI_er0E2ze69Oz8Yn4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsUmux:"'{\"enabled\":false,\"interceptId\":\"SI_89fPHY3eTxQBwtU\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsContinuousBrand:"'{\"enabled\":true,\"interceptId\":\"SI_9ZuT94UT81FcRh4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",defaultArticleTemplate:"v3"},app:{baseURL:"/",buildId:"ed555f16-85f7-4f41-8f2f-451827c59120",buildAssetsDir:"ap-2024/_nuxt",cdnURL:""}}</script>
<script src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6" type="text/javascript" async></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML" type="text/javascript" async></script>
<script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js" type="text/javascript" async></script>
<script src="https://api.altmetric.com/v1/doi/10.3389/fmolb.2022.839917?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15" type="text/javascript" async></script>
<script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript" async></script></body></html>